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ABSTRACT
Skin reactions are unavoidable side effects of radiotherapy for breast
cancer that may limit the amount of treatment a patient is able to 1eceive As well.
the discomfort associated with the treatment may negatively affect the patient's
quality of life and their willingness to complete a course of treatment that typically
extends over seven weeks
Prior literature suggests that variations in patients' tissue reactions to
radiation may be related to individual patient characteristics. Before health c..are
providers can intervene to prevent or minimise skin reactions. a clinical model that
helps predict which patients will experience more skin reactions is needed. The
purpose of the study was twofold: firstly, to test the theoretical relationships
between factors that impair healing and the severity of radiation skin reactions: and
secondly, to develop a model to predict the severity of radiation skin reactions in
women being treated for breast cancer.
The theoretical framework for the study was based on two bodies of
knowledge, radiobiology and wound healing. This framework specified three sets of
potential predictors of radiation induced skin reactions. These were radiation
factors (e.g. dose, fractionation). genetic factors (e.g. personal and family history of
cancer. radiosensitive conditions) and personal factors (e.g. age, smoking history,
nutritional status). It was hypothesised that the severity of the skin reaction was a
function of the relationship between these constructs.
A sample of 126 women was recruited to the study over a 14-month data
collection period. All the women had undergone lumpectomy and were
commencing a standard radiation protocol of 45 Gray to the whole breast delivered
in daily fractions of 1.8 Gray over five weeks, and a 20 Gray electron boost to the
lumpectomy site deliver3d in daily fractions of 2 Gray over two weeks. After

iii
obtaining written informed consent, data on potential factors were collected by
interview at the commencement of treatment and from the medical records. Weekly
observations of the skin using the Radiation Therapy Oncology Group scoring
system were recorded throughout the seven weeks of treatment. The breast was
divided into eight anatomical sites to increase specificity 1n the final analysis Tne
mean inter-rater reliability of RTOG scoring between the three observers was O 85
Chi square analysis revealed that several factors were associated with a
more severe reaction. Significant factors from the "personal construct''. included
smoking, chemotherapy, history of skin cancer, reaction of the skin to UV radiation,
lymphocele aspiration, condition of the lumpectomy scar at the commencement of
treatment, weight, and the size of the breast.
Stepwise logistic regression analysis revealed the relative risk and
predictive value of the factors. A predictive model was developed for each of the
eight anatomical sites of the breast for weeks three to seven of radiation treatment.
The principal predictors were a large breast size, smoking during the treatment
period, and having had a lymphocele aspirated on at least one occasion prior to
radiotherapy. The results show that it is possible to predict the severity of skin
reactions in individual patients.
The research contributes to theory development in radiation skin reactions
and to the practice of radiation oncology nursing. Practice implications centre on
individualising the preparation, education and management of women undergoing
radiation therapy for breast cancer. Further research with larger samples and using
different anatomical sites will contribute to the development of a skin reaction risk
assessr,ent tool for general use in radiation oncology nursing.
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CHAPTER ONE
INTRODUCTION
Radiotherapy is an important non-surgical treatment for cancer that can be
used alone or in conjunction with surgery and/or chemotherapy. It is a principal
treatment modality in the cure of breast cancer. Effective radiotherapy treatment
depends, in large part, on the patient's compliance and willingness to complete a
course of treatment that typically extends over seven weeks.
Radiotherapy for the treatment of breast cancer can be stressful for several
reasons. Whilst adjusting to the diagnosis of cancer, the patient must commence a
treatment that is unfamiliar and time consuming. Patients often begin radiotherapy
with limited infomiation about the treatment, or with inaccurate infom,ation from
sources such as other patients or well meaning people who have known someone
who has had radiotherapy. One area of concern to patients who undergo treatment
for breast cancer, and one fraught with misinformation, is the occurrence of skin
reactions as a side effect of treatment.
Skin reaction is the most common side effect of radiotherapy with as many as
95% of patients experiencing some degree of reaction (De Conno, Ventafridda &
Saita, 1991; King, Nail, Kreamer, Strohl & Johnson, 1985). Given that in developed
countries such as the United States of America, Europe and Australia, at least 50%
of all cancer patients will receive radiotherapy at some stage during the course of
their illness (Bentzen & Overgaard, 1994a; Holmes, 1988), this represents a
substantial number of people who can expect to experience a radiation skin
reaction.
The ionizing radiation used in radiotherapy causes damage to all living cells,
both normal and malignant. Side effects from radiotherapy are caused primarily by
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damage to normal tissue. The acute side effects result from damage to cells that
divide rapidly and frequently such as skin, bone marrow and gastrointestinal
mucosa Some side effects for example fibrosis and loss of pigmentation, can be
observed months or even years later. These permanent effects occur in cells such
as connective tissues that divide less frequently.
Acute radiation reactions of the skin are the focus of this study. Acute
radiation reactions typically appear between 10 and 14 days from commencement
of radiotherapy and continue to increase in severity until the completion of
treatment. The appearance of the skin is often described as a severe sunburn with
peeling (dry desquamation) and itching. The reaction may become more severe
with varying degrees of epidermal loss (moist desquamation) and in very rare
occasions, necrosis. Discomfort ranges from mildly irritating to severe pain.
Many texts and journal articles on radiotherapy include information on
radiation-induced side effects in normal tissue. The variation in side effects
experienced by individuals is often raised and is explained as being dependent on
several variables or factors. The factors are usually listed as: radiation dose; quality
(type or energy) of radiation; time period over which the dose is administered; size
of field (volume); anatomic location; and other factors (Casarett, 1980: Sitton,
1992; McDonald, 1992). Holmes (1988) describes the "other factors as being
0

previous or CO' ,current chemotherapy or surgery and individual susceptibility
dependent on age and general health. Sitton (1992) includes poor nutritional status
and age as factors impairing normal tissue repair and thus worsening the skin
reaction.
Common knowledge in radiotherapy is the role of radiation factors in
producing variations in the expression of side effects. Without radiation, there
would be no skin reaction and work continues on the manipulation of these factors:
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for example, hyperfractionation protocols The advances made using knowledge of
radiotherapy have already made a significant impact in reducing the seventy of
radiation reactions: for example, megavoltage linear accelerators have earned the
name "skin-sparing" machines because of their protection of the skin by the
delivery of higher energy radiation.
Despite advances in radiotherapy knowledge and probably because of the
importance of tumour eradication, development of knowledge in the role of
personal characteristics or factors has not received the same research attention.
Now the necessity to know more about personal factors has arisen due to
consumer pressure for knowledge about what will happen to the individual; calls for
professional accountability for interventions and advice on the management of
reactions; and the need for knowledge to aid decision making in respect to
treatment choices.
Several notable authors in the medical literature have identified the potential
importance of personal factors, recognizing that the degree of radiation skin
reaction experienced is not due solely to the radiation received but that particular
individual characteristics contribute to its expression (Bentzen & Overgaard, 1994b;
Tucker, Turesson & Thames, 1992).
Furthermore, the need for research investigating the impact of personal
factors on normal tis.:;ue reactions has been documented. Dische (1991) called for
research that not only included large numbers of patients but also gathered
detailed data about the patients in order to identify predictive factors. More
recently, the need for prospective research focussing on the influence of gender,
age, site and previous sun exposure on the manifestation of early skin reactions
was suggested by Hamilton et al. (1996). These studies will be discussed in greater
detail in subsequent chapters.

Introduction

4

There has been increased interest in the medical and nursing literature on
the individual differences in radiation skin reactions experienced by patients
receiving radiotherapy (Bentzen & Overgaard, 1994b; Dische, 1994; Tucker,
Turesson & Thames, 1992) This worl<. has led to the identification of factors
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patient that may predict the degree of skin reaction. Patient factors are those that
impair the normal processes of tissue healing, such as smoking, infection and
nutritional deficits. An assumption underlying this research was that by considering
both radiation and patient factors together a clearer picture of patient-to-patient
variation in radiation skin reactions would emerge making possible the prediction of
individual risk.
The Benefits of Risk Prediction in Radiation Skin Reactions
Skin reactions are currently viewed as an unavoidable part of treatment and
nursing management is often directed toward the palliation of skin reaction
symptoms. Skin care guidelines given to patients usually entail a change in
hygiene routine, restrictions in clothing and, in some cases. restriction on activities
such as swimming. The rationale behind these guidelines is not to prevent the
development of skin reactions. but to prevent exacerbation of the inevitable
radiation damage. In addition, there are no studies that have described the
proportion of patients who suffer mild, moderate or severe radiation reactions. This
lack of information means that skin care guidelines are applied to all patients even
though it is apparent clinically that only a small proportion of patients will develop a
severe acute radiation skin reaction.
Self-regulation theory specifies that when a patient is prepared for a stressful
event, accurate concrete descriptions of the event guide the patient's coping
mechanisms (Johnson, Fieler, Wlasowicz, Mitchell & Jones, 1997). According to
this theory, a schema (or mental picture) is formed in anticipation of an impending
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stressful event. Schemata are formed from various sources, including the patient's
own experiences and new information from health professionals, family members
or the media. Based on this schema, the patient's expectations about the nature of
the event are formed. Patients use their interpretations of the schema to cope with
the physical and functional aspects of the event.
Application of self-regulation theory leads to the postulation that providing
patients with an accurate description of what is most likely to happen to them,
rather than what is the general rule for all patients, will help them cope and prepare
for treatment. This hypothesis was tested in earlier research which found
educational preparation of this kind results in a significant reduction in anxiety and
improvement in patients' satisfaction with nursing care (Poroch, 1995).
The development of accurate individual predictions for radiation skin
reactions means that if the patient were likely to have no reaction or a mild
reaction, then s/he would be reassured. The description of a mild skin reaction
would be given and options for skin management tailored appropriately. If the
patient were likely to have a more severe reaction then s/ha would be prepared for
the experience and options for skin management could be discussed on the basis
of individual need.
Benefits to the nurse, in addition to the ability to individualise skin
manc1gement information, would be prioritisation of care through identification of
high-risk patients and consideration of interventions that may counteract the risk
factors. For example, the nurse might advise the patient regarding smoking
cessation, or nutritional needs.
There are also research benefits associated with accurate prediction of skin
reactions. To date, methodological problems occur when attempting to assess the
efficacy of diffe~nt skin care guidelines or dressing materials due to the patient-to-
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patient variation in severity of skin reactions. This problem makes matching
subjects or controlling for extraneous variables virtually impossible Therefore. 1f 1t
were possible to predict the severity of reactions, new dressings and changes to
guidelines could be tested against the prediction. For example, if a patient was
reliably scored as high risk, then the difference between the prediction and the final
appearance of the skin when trying a new dressing would indicate the advantages
(or otherwise) of the dressing.
In summary, radiation skin reactions are a well recognised, common problem
in the cancer patient population. To date, research has proved difficult due to the
patient-to-patient variation in reactions. Although the benefits of predicting the
severity of radiation skin reactions are evident, and there has been discussion in
the literature to suggest some causal relationships, no attempt has been made to
quantify these relationships or use them to predict patient outcomes. This study
aimed to address this empirical gap.

Statement of Purpose
The principal purpose of this work was the investigation of relationships
between personal characteristics of patients and their differing responses to
ionizing radiation revealed by the severity of the radiation skin reactions. Sufficient
literature and clinical knowledge were available to suggest that the degree of
radiation skin reaction experienced by the patient is not due solely to the radiation
received, but that particular individual characteristics contribute to the expression of
radiation damage in nonnal tissues (Bentzen & Overgaard, 1994b; Tucker,
Turesson & Thames, 1992). Two assumptions underscored the research: firstly
that factors known to impair wound healing would also affect the development of
skin reactions; and secondly that these factors had a measurable effect.
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The findings of this study will ultimately lead to the development of an
instrument for clinical and research use that would enable nurses to predict the
sever :y of radiation skin reactions for individuals commencing radiotherapy. The
research process proceeded in three phases:
1. Development of hypotheses for testing relationships between the severity of
radiation skin reactions and potential predictors identified from the wound
healing and radiation oncology literature and from clinical experience.
2. Development of the research protocol and testing of hypotheses with a sample
of women with breast cancer receiving post lumpectomy radiation therapy.
3. Development of predictive models and calculation of relative risks associated
with significant predictors using stepwise logistic regression analysis.

Organisation of the Thesis
Chapter Two presents the conceptual framework for the study and critically
examines the research and knowledge of radiation oncology and wound healing in
relation to patient-to-patient variation in the severity of radiation skin reactions.
Chapter Three details the research process including the development of new
measures and the validity and reliability testing conducted. Chapter Four reports
the findings of the statistical analysis commencing with descriptive statistics
followed by testing the hypotheses on univariate and multivariate levels and
presenting the prediction models. The final chapter includes an interpretation and
discussion of the findings in light of previous research and literature. Clinical
implications and future research directions are also presented.

Theoretical Foundations and Literature Review

a

CHAPTER TWO
THEORETICAL FOUNDATIONS ANO LITERATURE REVIEW
The purpose of this chapter is to review the published literature and clinical
knowledge on normal tissue reactions to ionizing radi.:ition in order to construct a
testable model of potential predictors of severe radiation skin reactions. This review
will show that patient-to-patient variability expressed in normal tissue reactions to
radiation can be explained theoretically by the interplay of three groups of factors:
radiation, genetic and personal. These factor groups form the constructs of the
conceptual model. The proposed relationships between the constructs form a
hypothesis to test the theoretical explanation of the variation of radiation reaction
expressed in individual patients. The arguments supporting the hypothesis are
based on current knowledge in radiobiology and wound management as well as a
critical review of relevant research.

Conceptual Framework
The conceptual framework proposes the physiological factors that may have
value in predicting the severity of radiation reactions in individual patients. Two
assumptions underpin the framework: firstly that factors known to impair wound
healing would also affect the development of skin reactions; and secondly that
these factors have a measurable effect.
The constructs are comprised of factors (concepts) arranged together to form
a theoretically meaningful framework to guide empirical study. Some concepts
overlap, finding a theoretical home within more than one construct. For example,
skin type could be located in both the personal construct and the genetic construct,
or chemotherapy could be located in both the personal construct and as a
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radiosensitiser in the radiation construct The theoretical underpinnings and
substantive evidence for the constructs and concepts of the framework are
analysed in the following discourse Figure 2 1 presents the model used to design
the study and guide the analysis of potential predictive factors.
The model is also used to organise the information presented in this chapter
The published and clinical knowledge relevant to the outcome variable, radiation
skin reactions. will be reviewed first followed by the three constructs. The chapter
will conclude with discussion of the hypothesised relationships between the
constructs and the dependent variables.

RADIATION

RADIOTHERAPY

GENETIC

PERSONAL

SKIN

CONSTRUCT

CONSTRUCT

CONSTRUCT

REACTION

0

Age

0

Sex

... Coexisting disease

...

Coexisting

0

Drug therapy

0

Dose

.

Absorbed dose

Radiosensitive

0

Chemotherapy

Dry skin loss

0

Volume

Disease

0

Nutrition

0

Moist skin loss

0

Fractionation

Cancer prone

0

Smoking/alcohol

0

Necrosis

e

Radiosensitisers
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Figure 2.1 Conceptual Framework of Radiation Skin Reaction Predictors

Radiation Skin Reactions
The skin forms an important function in the protective mechanisms of the
body providing a specialised covering based on an epithelial outer layer and a
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deeper cor .nective tissue layer The health of the skin and the body's ability to
repair damage significantly affects the quality of life of patients undergoing
anticancer treatment. A review of the normal anatomy and physiology of skin can
be found in Appendix A
Radiation Histopathology of the Skin
Histopathologic changes of the skin range from minimal degenerative
changes in epidermal germinal cells to total necrosis and are categorised as either
acute or chronic. Acute reactions in normal tissues manifest damage early, that is,
within a few weeks to a few months after irradiation. Damage to normal tissues
exhibited months to years after irradiation is described as chronic reaction.
However, acute reactions are the focus of this research and specifically those
reactions occurring during the treatment period.
An acute skin reaction develops within two to three weeks o~ irradiation as
manifested by erythema, then dry and/or moist desquamation erosions, epilation
and ultimately healing. The germinal epithelial cells of the skin respond to the
effects of irradiation immediately. Damage to these cells can be dose-limiting,
meaning that the severity of acute reactions may require time off treatment,
potentially interfering with the effectiveness of radiotherapy in terms of tumour
eradication. Although the skin may not always represent the critical dose-limiting
normal tissue reaction for megavoltage radiotherapy, the skin is recognised as the
model for other acute reacting normal-tissues, therefore knowledge of its response
is important in understanding all normal-tissue reactions (Hamilton, et al., 1996).
Recovery from acute effects is also variable, ranging from complete recovery
by primary intention to healing solely by secondary intention, if healing occurs at
all. The following points, taken from Casarett (1980, p. 94), describe the main
sequence of histopathologic changes occurring after irradiation.
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1. Early mitotic inhibition, degeneration and necrosis of the sensitive germinal

cells of the epidermis, hair follicles and sebaceous glands
2. Degenerative and inflammatory changes in the moderately sensitive fine
vasculature.
3. Vascular and circulatory responses with erythema and oedema.
4. Depilation and functional and morphologic changes in the glands of the
skin.
5. Desquamation (dry or moist) and sloughing of the epidermis.
6. Pigmentation.
7. Recovery processes.
8. Chronic and delayed or late changes including epidermal atrophy, sclerotic
changes in underlying vessels and connective tissue, late necrosis.

The presence of erythema indicates histopathologic changes to vascular and
connective tissue. Erythema manifests progressively, and has been categorised
into four phases by Casarett (1980, p. 96) as follows:

1. The initial phase occurs within minutes or an hour or so after irradiation
and lasts for a few hours.
2. The second phase occurs in a day or so and lasts a day or so.
3. The third phase (erythema proper) b~gins in the second or third week and
lasts for several days to a week.
4. The fourth phase (and possibly additional subsequent phases) may occur
a month or later after irradiation.

The first three phases are most significant to the study of acute skin
reactions All the phases of erythema are associated with vasodilatation and
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vascular congestion, increased permeability of the endothelium. plasmat1c
extravasation and oedema into and/or through vessel walls as a result of the
inflammatory response
After subsidence of initial erythema (phases one and two), there 1s a latent
period before phase three. Phase three includes residual oedema with thinning of
the epidermis and reduced secretion of sebum and sweat indicating damage to
epithelial cells and degeneration of glands. Obstructive changes in arterioles
causing hypoxia also seem to be associated with erythema proper Consequently,
an increased dilation and hyperaemia may occur in surviving capillaries through
collateral channels of circulation to the area (Casarett, 1980).
Damage to epithelial cells and degeneration of sebaceous and sweat glands
manifests as dry desquamation during the phase of erythema proper. Temporary or
partial permanent depilation may occur concurrently with dry desquamation If dry
desquamation is the most acute reaction experienced, then the recovery of the
epidermis will be functionally normal. However, the following permanent changes
will have occurred: fibrosis of fine vessels in vasculoconnective tissue;
hyperpigmentation in metanocytes; thinning of the epidermis; and changes to hair
follicles and sebaceous glands. If damage to the basal cells and glands is more
severe, moist desquamation occurs.
Casarett (1980) described moist desquamation in terms of the consequences
of vasculoconnective tissue changes in the epithelium. The manifestation of moist
desquamation results from the formation of small blisters in and around the basal
layer of the epidermis that may also extend into the more superficial layers. The
epidermis sloughs when these blisters rupture and coalesce. denuding the dermis
and causing permanent depilation.
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Epithelialisation occurs after one to two weeks following sloughing of the
epidermis if the dose has not been prohibitive and the acute vasculoconnective
tissue damage has not been too severe Provided the blood supply is adequate.
surviving basal cells will re-epithelialise the area.
Doses at which moist desquamation occur vary by mode of delivery Fowler
and Stein (1960) experimented with pigs' skins and found that similar moist
desquamation was produced by: 20Gy in one fraction; 30Gy in five fractions over
five consecutive days; and 50Gy in 20 fractions over 28 days The ability to
increase the total dose through fractionation, thereby achieving more effective
tumour eradication, without exacerbating the normal skin reaction may be a result
of what is known as the four Rs of radiotherapy: repopulation (regeneration),
redistribution, repair, and reoxygenation which are discussed as part of the
radiotherapy construct.
Furthermore, recent research by Denham. et al., (1995) suggests that the
inflammatory response alone does not explain the patient-to-patient variability.
Denham, et al., continue that in addition to the effect of inflammatory mediators,
other factors such as age, gender and prior sun damage, may influence the
reactivity of vascular tissue.

Radiotherapy Construct
The aim of radiotherapy is described by Perez and Brady (1992, p. 1) as
follows:
deliver a precisely measured dose of ionizing radiation to a defined tumour
volume with as minimal damage as possible to surrounding healthy tissue,
resulting in the eradication of the tumour, a high quality of life, and
prolongation of survival at reasonable cost.
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The importance of this objective lies in the fact that radiation affects all living cells
both malignant and normal. A balance between the destruction of malignant cells
and the preservation of normal cells must be maintained in order to achieve the
best possible results for the patient with cancer. The science studying the effects of
radiation on cells is radiobiology.
Fletcher (1980, cited in Hilderley, 1992, p. 10) describes radiobiology as an
essential part of radiotherapy stating "As pharmacology is to the internist, so is
radiation biology to the radiotherapist'. Hilderley goes on to say, " ... radiobiology is
no less important to the radiotherapy nurse" (p 10).
Overview of Radiobiology
The cell can be damaged by ionizing radiation directly, through immediate
damage to DNA synthesis, or indirectly, through the production of free radicals in
the cell. The mechanism of damage occurs at the cellular level and is intimately
connected with the process of replication. The process of replication is similar for
both normal and malignant cells and comprises a progression through four distinct
phases known as the cell cycle. Figure 2.2 illustrates the phases and briefly
outlines the functions of each phase.
The cell is most vulnerable to direct damage from ionizing radiation during the
phases of the cell cycle when DNA synthesis or mitosis can be disrupted.
Specifically, radiation damage affects the following three phases: G,. when
substances necessary for DNA synthesis are altered; G 2, when protein synthesis is
inhibited and changes occur in the chromosomes; and during mitosis, when the
altered chromosomes lose their ability to reproduce. The mechanisms of injury to
DNA are summarised in Table 2.1.
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G0 = Quiescent, resting phase. Cell functions continue but the cell is unable to
divide.
G 1 = Pre-synthetic phase. Enzymes needed for DNA synthesis are produced.
S = DNA synthesis occurs in preparation for cell division.
G2 = Pre-mitotic gap during which specialised proteins and RNA are synthesised in
preparation for division.

M = Mitotic phase. Cell divides to produce two identical daughter cells

Figure 2.2 Phases of Cell Cycle (Holmes, 1988, p 23).

Table 2.1
Mechanism of direct damage to DNA from ionizing radiation
Mechanism of injury to DNA
•

Breakage in one or both chains of the DNA
molecule

o

Faulty crosslinking of chains after breakage

o

Damage or loss of the nitrogenous base

o

Breakage of the hydrogen bond between the two
chains of DNA molecule
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However. the primary cause of damage is induced by the ionization events
derived from the indirect action of radiation, as, at the moment of irradiation, most
cells are more likely to be in cell cycle phases other than active mitosis. The cellular
response to radiation involves the creation of free radicals in the cell by the
interaction of cell water and electrons ejected from atomic structures by the
passage of radiation through the cell. Free radicals alter the atomic and molecular
structures damaging the DNA in the cell nucleus. It is estimated that approximately
70% of the biological damage produced by X-rays is due to the indirect action
mediated by free radicals (Hall, 1985). The presence of oxygen acts as a sensitiser
in the cell causing further damage to DNA through the formation of oxidising
substances, such as hydrogen peroxide, which occurs when oxygen reacts with
free radicals (Hildertey, 1993; Holmes, 1988). Ultimately the effects of radiation,
whether direct or indirect, damage the cell's DNA, leading to the inhibition or failure
of mitosis. Depending on the dose of radiation. cell death may occur immediately or
within hours but is usually preceded by one or more cell cycles post radiation
(Hilderfey, 1993).
Radiation Factors
The radiation factors associated with normal tissue reactions are well
documented and used to advantage wherever possible in clinical practice.
Underlying these factors is the principle of balancing tumour eradication with
damage to surrounding normc:.. tissue. Perez and Brady (1992) call this principle
the therapeutic ratio providing a formula thus:

Therapeutic
Ratio

= % tumour control
% major complications

The higher the therapeutic ratio, the more efficient the particular therapy. The
formula can be used to make comparisons between treatment protocols. It has
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been used this way in both clinical practice and research However, Andrews
(1981) noted that although the development of a formula was a logical step in
decision making for optimal radiotherapy, it could not be absolute because clinical
considerations were important. The most important of these clinical considerations
are the interaction of total radiation do~e. the volume treated, the fractionation
schedule and the overall treatment time
Absorbed Radiation Dose
The close relationship between total dose, volume of treated tissue,
fractionation and treatment time is fundamental to predicting the severity of
radiation skin reactions. Normal tissue tolerances, that is the point at which
erythema, dry or moist desquamation or necrosis occur, are usually reported in
terms of the dose of radiation received. However the dose absorbed by the body is
affected by a number of factors which are used to enhance the efficacy and
accuracy of radiation
The quality {type and energy) of radiation directly affects skin reaction and is
related to the amount of energy absorbed by the skin. The skin-sparing effect
achieved with the megavoltage linear accelerators is somewhat diminished when
the beams hit the body's surface at a tangent, that is, at an angle other than 90°.
This is because penetration is lost as the beam travels more along the surface than
straight through the body.
Electrons are high energy, low mass particles which have only superficial
penetration and are used to treat the skin surfaces thereby increasing the severity

of the skin reaction. An increased dose may be desired in some treatment
protocols such as in breast cancer where the lumpectomy scar is treated with
electrons following treatment to the whole breast with photons.
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The application of a tissue-equivalent material, or bolus, to the skin surface
also increases the dose to the skin The bolus acts as tissue and the skin absorbs
the higher dose that underlying tissue would have received; thus the use of a bolus
increases the skin reaction.
In an Australian study of 110 patients being treated palliatively, Denham et al
(1995) was unable to demonstrate a dose-rate effect on the development of
erythema in the range of 3 to 8.2 Gy. Although it is logical to assume that such an
effect exists, the patient-to-patient variability associated with a heterogeneous
group of patients was enough to obscure the dose-rate effect. The variables
Denham and colleagues found that affected skin reactions were: age, gender, site
of treatment and a history of prior sun damage.

Volume
From the 1940s until the 1980s it was thought that nonnal tissue tolerances
decreased when larger volumes of tissue were treated (Perez & Brady, 1992).
Maciejewski, Withers, Taylor and Hliniak (1990) disputed this belief in a
retrospective study of 268 patients with head and neck cancers treated with various
total doses and fractions. The researchers observed no difference in the acute or
chronic effects in patients treated with large or small fields. The differences in
conclusions from these two studies may be due to the advantages of contemporary
techniques, in particular, megavoltage radiation. Due to the limitations of
retrospective design, however, the findings of Maciejewski et al. must be viewed
with caution. Thus the volume of tissue treated remains a factor that cannot be
discounted with current empirical evidence.
The number of fields radiated is logically linked with the total volume because
more surface area is exposed to radiation. In some instances the dose is divided
between the fields to ensure that nonnal tissue, particularly of vital organs, is
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spared higher doses. In the treatment of breast cancer. however, additional fields
usually indicate more extensiv& disease and each field has an equivalent dose
The significance therefore. of volume of irradiated tissue lies more in the fact that
the patient may have: reduced tolerance to the effects of radiation with the
increased volume (a small area of skin loss is quicker and easier to heal than a
large area); increased discomfort or skin breakdown with a larger treatment
volume; and/or a greater variation in skin dose as the beam strikes the varying
contours of the skin's surface

Fractionation and Treatment Time
Fractionation is the division of the total dose of radiation into smaller doses
(fractions). By the 1970s, giving multiple small daily doses of radiation over a
period of time, was found to lead to better tumour control than the large single dose
of early treatment protocols (Kaplan, 1970). The relationship between dose and
time is directly associated with increasing the therapeutic ratio and substantial
research effort is currently being invested in refining fractionation schedules. The
conventional or standard fractionation is one fraction of 2Gy given daily, five days
per week over two to eight weeks. Fractionation is based on the four Rs of
radiotherapy: repopulation, redistribution, repair and reoxygenation. These four
basic factors are considered to be the mechanisms by which fractionation improves
tumour eradication and minimises normal tissue damage (Hilderley, 1993; Withers,
1992).

Repopulation
Germinal cells of the skin and mucous membranes show an early
regenerative response through increased rates of cell proliferation. Repopulation
may begin before the course of radiotherapy has ended and as with the
physiological response to any trauma, the repopulation rate accelerates, creating
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what is termed an 'avalanche effect' (Withers, 1992). In a standard course of
treatment, where a daily fraction of 2 Gy is given five days per week, repopulation
begins about day 28 for the skin (Turesson & Notter, 1984).
Research by Turesson and Notter (1984) on women treated for breast cancer
indicates that radiation-induced accelerated repopulation of the basal cells of the
epidermis began with an abrupt onset after four weeks of standard fractionation.
This group had a significantly more pronounced skin erythema as measured by
reflectance spectrometry than a comparison group who received twice-a-week
fractions of 4 Gy.
Thus fractionation is assumed to have a protective effect on the skin. The
assumpLon is limited however, by the fact thcit repopulation of cells may occur over
a prolonged period (Fowler, 1979). If the overall treatment time is over-extended or
interrupted unexpectedly, the extra time between fractions or any time off treatment
allows regeneration of tumour cells as well as normal cells. In order to achieve
optimal tumour eradication, additional fractions would be required resulting in a
higher total dose. A higher total dose has implications for the overall normal tissue
damage both in the acute and chronic phases. The optimal effect is achieved by
planning for the overall treatment time to be as short as possible.
Redistribution
As stated previously, the effect on tumor eradication can be enhanced if the
treatment is given over a shorter time. This effect is further enhanced if smaller,
more frequent fractions are also given (accelerated hyperfractionation). Cells vary
in their radiosensitivity as they move through the phases of the cell cycle, with the
greatest radiosensitivity for direct damage occurring in the late S-phase and the G2
- M. Following each fraction of radiation, surviving cells, which are in relatively
radiation resistant phases of the cell cycle, progress to more sensitive phases. The
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net gain in this process, in terms of tumour eradication, is that cells 'self-sensitise',
resulting in more cells reaching the mitotic phase as the next dose is given
(Hildertey, 1993; Withers, 1992) Protocols exploiting this phenomenon are the
subject of current clinical trials and redistribution is the mechanism thought to be
responsible.
Redistribution is a phenomenon of acute-responding tissues (such as tumour,
and normal skin, mucosa and bone marrow) and not of late-responding tissues
(such as spinal cord, brain or kidney). Therefore hyperfractionation exacerbates
acute effects, but reduces, theoretically, the late effects.
Combining radiation with chemotherapeutic agents, such as methotrexate
and hydroxyurea, is proving to be another method of exploiting redistribution
(Hildertey, 1993). The effect of multiple modalities on skin reactions will be
discussed in detail in a later part of the radiation construct.
Repair
Tile ability of the cell to repair following each fraction of radiation is the key to
the survival of acute-responding normal tissues. Withers (1992) cites research from
as long ago as 1959 that showed cells could be repaired following radiation given a
few hours of normal metabolic activity. A review of the process of normal tissue
repair can ·

3

found in Appendix 8.

Repair is initiated by the body immediately and wntinues in acute-responding
tissues for three to four hours following each fraction of radiation. The quality and
speed of the repair response depends on personal factors to be described in
section on the Personal Construct. It is this aspect of the individual's capacity to
repair damage that is the focal point of this study.
Tumour cells also can repair between fractions, but the assumption
underlying all radiation treatment is that less repair of radiation damage occurs in
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tumour cells than in normal tissues In addition. reoxygenation further
radiosensitises the tumour resulting in improved tumour kill when the next fraction
is given.
Reoxygenation
As discussed in the previous section on radiobiology, oxygen is necessary for
the production of some free radicals important in the mechanism for indirect
damage to DNA. Hypoxia, therefore. causes the cellular response to radiation to be
reduced (Holmes, 1988; Noll, 1992). The importance of oxygen concentration at
the time of radiotherapy has been known for over 60 years (Hall, 1985). In the
laboratory it has been shown that the dose required to eradicate all tumour cells
may be doubled where just 2-3% of the cells are hypoxic (Gray, Conger, Ebert,
Homsey & Scott, 1953; Dische, 1991). As a result, studies have been undertaken
to identify methods to increase the radiosensitivity of hypoxic tumour cells.
Reoxygenation occurs after each fraction of radiation as part of the normal
tissue repair process. Fractionation optimises the reoxygenation process by
increasing the oxygen concentration in the tumour. Cater and Silver (1960, cited in
Perez & Brady, 1992) found that reoxygenation relates primarily to tumour cells
and oxygen changes in normal tissues were slight or non-existent.
The use of oxygen to deliberately sensitise tumours led to experimentation
with hyperbaric (high-pressure) oxygen therapy. Dische (1991), in a review of the
literature, cited research using hyperbaric oxygen to sensitise tumour cells to the
effects of radiotherapy. He concluded that the effect of oxygen is just as great on
normal cells as on malignant cells when the patient is subjected to hyperbaric
oxygen therapy. Dische concluded that the therapeutic ratio (improved tumour cell
eradication versus damage to normal tissue) is altered with hyperbaric oxygen to
the degree that the increase in damage to normal tissue may outweigh the benefits
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of the increased tumour eradication. As a result. the technique has largely been
abandoned (Noll, 1992). Nevertheless, the mechanisms of injury caused by
ionizing radiation and the substances that enhance its effects are important to
consider when applying this knowledge to the radiohistopathology of the skin
Radiosensitisers
Radiosensitisers are substances that enhance the damaging effects of
ionizing radiation. Oxygen, as discussed in the previous section, is an important
radiosensitiser. However, more pertinent to this study are the anticancer drugs.
The combined use of radiotherapy and some chemotherapy agents, known
as combined modality treatment (CMT) has been well documented as potentiating
skin reactions. A significant amount of research has been conducted on the effect
of combining these two modalities. Although most of the research has been
conducted in laboratories on mice, there is sufficient evidence from clinical
research to identify specific chemotherapeutic agents that enhance cutaneous
effects of radiotherapy (Bentzen & Overgaard, 1993; Fu, 1985; O'Rourke, 1987;
von der Maase, 1994).
There are three classifications of drug interactions with radiation:
independent action, protection, and enhancement action. The radiation-drug
interaction is said to have independent action when the drug has no effect on the
irradiated tissue. Some experimental drugs have a protective effect on irradiated
tissue, reducing the toxic effects on normal tissue and thereby allowing a higher
cancerocidal dose of radiation to be delivered to the tumour (Brown et al., 1984;
Hirshfield-Bartek, 1992). Drugs specifically used for a protection effect were not in
use at the study site and so are not included in any further discussion.
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Enhancement interactions.
Enhancement interactions occur when damage to normal and tumour tissue
is greater with the combined effect of radiation and chemotherapy than either of
the treatments alone. Enhancement is determined by looking at the cell survival
curves for each agent. radiation and chemotherapy, and then mathematically
determining the theoretical amount of tumour kill (Phillips, 1980). Enhancement
interactions are further classified as additive, superadditive and sensitising.
Hirshfield-Bartek (1992, p. 255) explains the difference between classifications
thus:
Additive reactions occur if the cell killing obtained with CMT is equal to the
cell killing produced by each modality alone (i.e., 1+1=2) ... Superadditive
reactions occur when the amount of cell kill is greater than would be
expected from either modality alone (i.e., 1+1=3) ... Sensitisation responses
result when agents that are relatively nontoxic when given alone produce an
increase in tumour kill when given with radiation.

It is logical to assume that chemotherapeutic agents that enhance the effect
of raaiation on tumour cells will have a similar effect on normal cells thus increasing
the severity of normal-tissue reactions. The agents with the highest likelihood of an
additive or superadditive effect on the skin are adriamycin, actinomycin D,
bleomycin sulfate, hydroxyurea, 5-fluorouracil, and methotrexate (McDonald,
1992). Fu (1985) lists six possible mechanisms to explain the interaction between
chemotherapy and radiotherapy that result in an enhanced effect (see Table 2.2).
Appendix C lists 15 commonly used chemotherapeutic agents along with their
mechanism of cytotoxicity and the possible mechanism of enhancement.
The first three mechanisms focus on preventing the tumour cells from
repairing following each fraction of radiation. The fourth mechanism, perturbation in
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cell kinetics, relies on the effect of redistribution The fifth and sixth mechanisms,
the improved blood supply and increased drug delivery and uptake, rely on the
effect of reoxygenation. The enhancing effects of CMT have positive outcomes 1n
terms of tumour eradication but the same effects on normal cells, such as the skin,
will impact negatively.

Table 2.2
Possible Mechanisms of Interaction between Chemotherapy and Radiotherapy
Resulting in an Enhanced Effect
Mechanism of interaction
o

Modification of the slope of the response curve

•

Decreased accumulation of or inhibition of repair of sublethal damage

•

Inhibition of recovery from potentially lethal damage

•

Perturbation in cell kinetics with an increased proportion of cells in sensitive
cell cycle phase and proliferative state

•

Decrease in tumour bulk -l> improved blood supply -l> reoxygenation and
recruitment -l> increased radiosensitivity and chemosensitivity

o

Increased drug delivery and uptake

Fu, K (1985). Biological basis for the interaction of chemotherapeutic agents and
radiation therapy. Cancer(Suppl), May 12, p. 2125.

Site of Treatment
The variability in skin reaction by anatomic location has been documented.
For example, the scalp has the greatest tolerance for radiation, followed in
decreasing order by the face, neck, trunk, ears, groin, and extremities (Dutreix,

1986). Hamilton et al. (1996) found that anatomical site was a significant factor in
the variation of skin reaction severity. Interestingly, the relational factor suggested
was sun exposure. In looking at the order Dutreix documented, the face and neck
would be expected to have had greater sun exposure than the groin. Hamilton's
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study shows that increased sun exposure increases the early erythema rather than
making the skin more tolerant. Thus, there is a contradiction between the findings
of the two studies. It is important to note that the study by Hamilton et al was
conducted in Australia, known for its high levels of Ultra Violet (UV) radiation The
impact of chronic exposure to UV radiation is discussed in greater detail in the
section on the Personal Construct.
Sitton (1992) discussed differences in skin reactions at sites where there was
appositional skin. Areas such as that found in the axilla, inframammary area, groin
and perineum, well known clinically to have mom severe reactions, are situated
where there is close skin-to-skin contact. There is increased moisture, warmth and
friction along with poor aeration at these sites. The mechanism increasing the
reaction in these areas probably relates to the stratum comeum being shed at a
faster rate than the newly forming epithelium can maintain. Any anatomical site at
which friction is common, whether it be due to movement or clothing, is at risk of a
more severe reaction. Typical trouble s~ >ts are the neck, where the collars of
clothes rub; the axilla, where clothes and movement cause friction. and the
inframammary fold, where there can be friction from a brassiere. Obesity or

tr:
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wearing of tight clothing can further exacerbate this problem.
Prediction Models
Some fair1y sophisticated models for predicting normal tissue damage have
been proposed, including the Nominal Standard Dose (Ellis, 1969), and the
Cumulated Radiation Effect (Kirk, Gray & Watson, 1971). Some criticisms of these
methods are evident in the literature. Notable authors such as Peters and Withers
(1981) suggest that no single set of correction factors can be universally applied to
an exact relationship of dose and time and that good clinical observation and
judgement are necessary in dealing with nonn;il tissue damage.
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More recently, predictions of acute and chronic effects have been based on
the Linear Quadratic Equation (LOE) (Perez & Brady, 1992) which has been used
widely since the early 1980s However. Hamilton et al. (1996) found, in a well
controlled clinical study of 65 patients being treated palliatively, that erythema was
much greater at low doses of radiation than the LOE would predict. The
researchers noted the effect of pre-treatment erythema. gender, age and site of
treatment. Erythema was measured in the study by reflectance spectrometry.
These findings highlight the need to complete the 'picture' of nonnal tissue
radiation reactions by including other factors other than radiation factors alone.
Summary of the Radiation Construct
The principal radiation factors influencing normal tissue damage are total
dose, dose per fraction, volume treated, overall time taken for radiotherapy to be
completed, quality of radiation, use of tangential beams. site of treatment and the
presence of bolus material. Although it is well known that these factors impact on
the severity of skin reactions, their predictive value has not been calculated on an
individual patient basis. The literature presented has also highlighted the need to
explore individual characteristics of patients to explain more fully patient-to-patient
variation.

Genetic Construct
Observation and scientific investigation into the differences in radiosensitivity

of cells bagan in the early 1900s when the French scientist, Regaud, found that
seminiferous epithelia became less radiosensitive as they differentiated (Regaud,
1906 cited in Peters, 1990, p. 178). These differences in radiosensitivity were
noted, not only in different cell types from the same person but also in the same
cell type from different people. This led to the hypothesis that genetically based
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radiobiologic prognostic factors or predict:ve assays were possible (Peters. 1990)
Although the research in this area has focussed on the radiosensitivity of tumour
cells, some extrapolation has been made to normal cells. The concept that
individual differences can be explained by genetic diversity is supported by the
existence of inheritable syndromes that are partislly characterised by
hypersensitivity to radiation. The most well known of these disorders is ataxia
telangiectasia and clinical papers have been published considering the treatment
modifications required in the case of such striking hypersensitivity (Abidir &
Hakami, 1983; Hart, Kimler & Evans, 1987). Although rare, other genetic
syndromes associated with increased susceptibility to cancer and hypersensitivity
to radiation and chemical agents are Bloom's syndrome, Fanconi's anaemia,
retinoblastoma, Down's syndrome, basal cell naevus syndrome, progeria and
cancer prone families (Mahon & Casperson, 1995; Peters, 1990).
Because hypersensitivity to radiation can be observed both in tissue
reactions, and in cell cultures derived from them, the techniques used to develop
predictive assays have found fibroblast and keratinocyte cultures to be particularly
useful (Geara, Peters, Ang, Wike & Brock, 1992). Thus far, the research on the
radiosensitivity of normal tissue has concentrated mainly on the late effects of
treatment, often using telangiectasis as a model of late normal-tissue damage
(Burnet, Nyman, Turesson, Wurma, Yamold & Peacock, 1992; Turesson, 1989;
Turesson, 1990; Turesson & Thames, 1989). There is little work on the acute
effects despite a long standing assumption that the acute skin reaction influences
the course of the radiation reaction (Jolles & Harrison, 1966; Tucker, Turesson &
Thames, 1992) and despite clinical research suggesting that moist desquamation
in the acute phase is highly associated with the risk of developing telangiectasia

(Bentzen & Overgaard, 1993).

Theoretical Foundations a11d Literature Review

29

The research. using cell cultures. is progressing and is gradually revealing
the relative sensitivities of cell types. For example, fibroblasts show more variation
in radiosensitivity between individuals than keratinocytes (Geara et al., 1992)
Geara and colleagues call for further studies using the techniques developed to
predict normal tissue responses to radiotherapy. Burnett et al. (1992) suggest that
these techniques may be most useful in detecting patients at the extremes of
reaction severity. Nevertheless, Burnett et al. suggest that there are practical
problems associated with the processes of cell culture prediction: namely that they
are slow, they require a high level of expertise and they are labour intensive. These
features mean that cell culture predictive assays in their present form could not be
used in clinical practice. These practical problems will no doubt be solved as the
research in this area continues.
The ability to identify genetic markers capable of predicting radiosensitivity of
both tumour and normal cells and the development of cell culture techniques to test
radiosensitivity in individuals would at first seem to negate the need for any other
method of predicting radiosensitivity of normal tissue. However, the extensive effort
that has been invested in the development of predictive assays has not yet
explained why the same cell type (whether tumour or normal) in different people
has such variability in its radiosensitivity (Bentzen, Overgaard & Overgaard, 1993;
Tucker, Turesson & Thames, 1992). Tucker et al. also suggest that radiosensitivity
is not the same for all cells in an individual, contrary to the prevailing theory that
intrinsic radiosensitivity is dominated by a genetic component common to all cells.
Bentzen and Overgaard {1993) support this suggestion deducing from their clinical
research that the hypothesis specifying that all normal tissues of individual patients
have a generally high or low radiosensitivity cannot be corroborated.
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Moreover, in an extensive review of the literature, Peters (1990) concluded
that cellular radiosensitivity, determined by in vitro diagnosis, is but one factor
influencing treatment outcomes. This view is supported by Tucker et al., (1992, p.
1783) who state" ... whether these [individual} differences are dominated by
heterogeneity in intrinsic cell sensitivity or by other factors has yet to be
determined". The other factors which Tucker et al., suggest are personal
characteristics, such as age and smoking. These comments regarding the interplay
of genetically based prediction and the role of "other factors" form the foundations
for developing the conceptual framework and hypothesis of this study.
Hendry (1994) applies the knowledge of these relationships, suggesting the
possibility of moderating normal tissue damage through modifying individual
characteristics such as diet and supporting the individual's resistance to infection
with prophylactic antibiotics. Hendry recognises the impact of surgery t.nd
chemotherapy on the promotion of cell proliferation and suggests that appropriate
supportive therapy in the form of fluids, electrolytes and antibiotics may positively
affect morbidity, ultimately resulting in an ability to give higher doses of radiation.
Hendry's conclusions are based on animal models, but it is an interesting
proposition to suggest that not only can "other factors· affect the individual
expression of radiation reactions, but also the modification of these factors may in
fact moderate the impact of genetically determined radiosensitivity. The importance
of determining the relationship between these "other factors" is clear. Such
knowledge could lead to preventative and supportive nursing management
approaches.
Summary of the Genetic Construct
Understanding the impact of genetic make-up on the variability of
radiosensitivity between people is vital to completing the picture of individual
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differences in radiation reactions. It is clear there is substantial support for a
genetic basis to individual differences in radiation reactions, but at this time the
gene markers have not been identified and a feasible clinical method of
detenrnning prediction through cell cultures has not been developed
'Cancer proneness' may well be an indicator of heritable radiosensitivity, but
the relationship between individual radiosensitivity expressed as a skin reaction
and coming from a cancer prone family or having a hereditary cancer may, at best.
be tenuous.
There is also support for the influence of "other factors" in the expression and
perhaps even moderation of the genetic radiosensitivity component. The strength
of the relationships between potential factors has not yet been determined in
humans. The "other factors" suggested in relation to the genetic component of
individual differences in the expression of radiation reactions are discussed as
concepts in the Personal Construct of the conceptual framework.

Personal Construct
The concepts included in the Personal Construct are those which are unique
in combination to each individual. Although some may be considered as hereditary,
such as allergy, or due to uncontrollable environmental factors, such as exposure
to UV radiation, their impact is expressed uniquely in each individual. A principal
argument in this construct is that the patient-to-patient variability in the expression
of damage to normal tissue relates to the presence in the individual of factors

known to affect tissue repair generally. To date there has been no empirical
research investigating the relationship between the presence of factors that impair
normal tissue repair and normal tissue damage in radiation skin reactions.
Many factors affect the repair of normal tissue and those most pertinent to
radiation reactions will be described. Although specific headings have been used to
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organise this information, it should be noted that tissue repair is often affected by
the interplay of several factors. Each factor is considered in the light of research on
the healing of normal tissue and radiotherapy or cancer.

Age
The impact of increasing age on healing is difficult to isolate because of the
general deterioration of all body systems and the likelihood of coexisting disease
such as diabetes. The effects of ageing on the skin are as follows. Epidermal
turnover decreases with age resulting in extended healing times and a greater
likelihood of secondary infection following trauma. The ageing of cell lines results in
thinning of the epidermis, particular1y in sun exposed areas and atrophy of the
dermis through loss of collagen and reduction in the capillary network. Elastin
fibres thicken and fragment while the vascular bed, collagen layers and fibroblasts
diminish. Thinning of vascular walls explains the tendency of the skin in the older
adult to bruise. Blister formation and the susceptibility to skin tear injuries occur as
collagen fibres lose their elasticity (Staab & Hodges, 1996).
It is logical that sun damage to the skin would accumulate with age due to the
time available for exposure. Lifestyle habits, anatomic site and geographic location
of course, temper this factor (Goldfarb, Ellis & Voorhees, 1990). Sun exposure also
causes hyperplasia of sebaceous glands with a resulting increase

in

cyst,

comedone and papule formation (Ogawa, 1975; Staab & Hodges, 1996).
The vasculoconnective damage caused by ionizing radiation, as described in
the section on radiohistopathology, when combined with the degenerative changes
to the epidermis and underlying structures as described above, points to an
exacerbation of the skin reactions as age increases.
Age also brings with it an increased risk of malnutrition {Goldfarb et al.,
1990). Exton-Smith (1971) divided the causes into primary and secondary. Primary
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causes included ignorance. social isolation. physical disability, mental disturbance.
iatrogenic disorder and poverty. Secondary causes were impaired appetite,
masticatory inefficiency, malabsorption, alcoholism, and medications. As the skin is
composed of rapidly proliferating cells, they are among the first tissues to be
affected by nutritional deficiency.
Obesity, which is associated with increasing age and mature onset diabetes.
may have a negative effect on the efficiency of healing (Carville, 1995; Dealey,
1994). Excessive adipose tissue can compromise healing principally due to the
poor vascularity of adipose tissue. Obesity can also cause excessive wear and tear
on skin through increased friction on movement, causing abrasion. Obesity in
surgical patients is also a factor in increased risk of postoperative infection.
It is estimated that 50% of cancers occur in persons over the age of 65 years
(Strohl, 1992). With the presence of co-existing illness or conditions and the ageing
of normal cell lines, it is accepted that increasing age limits the healing ability of
skin. It would seem logical to assume that any skin reaction will be more severe as
age increases. Many authors cite age as one of the probable "other factors"
(Denham et al., 1995; Hamilton et al., 1996; Holmes 1988; Tucker et al., 1992;
Turesson, Nyman, Holmberg & Oden, 1996). However. the reducing frequency of
mitosis that accompanies ageing needs to be considered. Less frequent mitosis
may reduce the severity of acute reactions because the effects of ionizing radiation
damage become apparent on cell replication. There may, then, be a balance
between these two mechanisms with age not making a significant contribution to
the skin reaction.
Coexisting Disease
Several illnesses directly impede the healing process and others affect
healing through medication or reduced physical mobility inhibiting nutritional intake
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and hygiene respectively. Age is a significant factor in increasing the likelihood of
these problems.

Diabetes mellitus.
Uncontrolled glycosut,a weakens the inflammatory phase and impairs
macrophage production. n,e increased iisk of infection and the retarded healing
that results are further comi!ilour1ed bJ/ the presence of the diabetic complicatiors
of neuropathy and ischaemia. Ulabetes mellitus has been investigated as a
possible factor in unusually severe reactions to radiotherapy. Kucera,
Enzelsberger, Eppel and Weghaupt (1987) found no differences between diabetics
and non-diabetics in any side effects although a significant increase in urinary
complications in diabetics was suggested by Bentzen and Overgaard (1994b). In
view of the lack of published research in this area there is insufficient evidence on
which to draw a conclusion about the role of diabetes on radiation reactions with
nomial tissue.

Autoimmune diseases.
There are two general categories of autoimmune disease: collagen diseases
(including systemic lupus erythematosis [SLE], demiatomyositis, poly-arteritis
nodosa, sclerodem,a and rheumatoid arthritis); and haemolytic diseases (including
idiopathic thrombocytopoenic purpura, acquired haemolytic anaemia and
autoimmune leucopoenia).
Autoimmune disorders retard healing in the inflammatory phase of tissue
repair and the risk of infection is increased due to reduced leucocyte numbers. In
addition to these conditions predisposing the patient to problems of pain and
immobility, which of themselves inhibit healing, treatment of autoimmune diseases
centres on the use of steroids, anti-inflammatory drugs, and immunosuppressive

drugs.
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A common assertion in the literature is that patients with a collagen vascular
disease {CVD) such as rheumatoid arthritis or SLE, dermatomyositis and
scleroderma are at greater risk for radiation side effects (Fleck, McNeese,
Ellerbroek, Hunter & Holmes, 1989; Teo, Tai & Choy, 1989). Although case reports
have highlighted the differences between CVD and non-CVD patients, a study
using a retrospective matched pair design found no difference in the incidence of
earty or late side effects (Ross, Hussey, Mayr & Davis, 1993).
There is convincing evidence that patients with certain genetic diseases such
as ataxia telangiectasia (AT) differ in their radiosensitivity. These diseases have
been discussed in the section titled, Genetic Construct.

Stress and Depression.
The physiological responses to stress are well documented. The primary
biochemical response to stress is the increased production of adrenocorticotrophic
hormone (ACTH) stimulated by the release of adrenalin. ACTH stimulates the
adrenal cortex in the production of glucocorticoids, cortisol and hydrocortisol
(Vander et al., 1994). Glucocorticoids break down the body's glucose stores,
raising the blood sugar. They also suppress the inflammatory response mediated
by the immune system by reducing the mobility of granulocytes and macrophages,
impeding their migration to the wound. Glucocorticoids also increase protein
breakdown and nitrogen excretion which in tum inhibits endothelial cell
regeneration and delays collagen synthesis (Dealey, 1994).
Stress and anxiety can also be exacerbated by pain (Hayward, 1975) and
socioeconomic problems including social isolation and poor housing (Dealey,
1994). Grief and depression also affect appetite and represent yet another layer of
complexity in the interplay of factors affecting the repair of normal tissue. The
measurement of stress and depression was not within the scope of this study.
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Allergy and/or Skin Sensitivities.
Skin sensitivities or allergies may have an impact on the severity of reaction.
The response of the skin to radiotherapy can be described in the same terms as a
response to any physical trauma. When an abrasion, a cut or a bum damages skin,
the body responds initially with inflammation. The inflammatory response, mediated
by the immune system, rallies the body's resources to repair tissue and prevent
infection. Similarly, when a known allergen is brought in contact with the skin, the
immune response is rapid and an exaggerated reaction is noted. Clinical
observation suggests that patients who have a history of allergic reaction may
respond to irradiation in a similarly exaggerated way, potentially exacerbating the
radiation skin reaction. This may also include patients who have a family history of
allergic response.
Pruritus is a common symptom of radiation skin reaction. The principal risk
associated with pruritus is the overwhelming urge to scratch, causing further skin
damage including skin loss. In addition to skin allergies, there are many benign and
malignant diseases associated with pruritus. Benign diseases include diabetes,
hyper- and hypothyroidism, parasitic infections, multiple sclerosis,
psychophysiological or idiopathic conditions, drug reactions, chronic renal failure,
iron-deficiency anaemia and non-malignant obstructive biliary disease. Malignant
conditions particularly associated with itching are lymphoma, leukemia, sarcoma
and carcinomas of the lung, biliary tree and pancreas (McDonald, 1992). In
addition, pruritus is known to occur in the advanced and terminal stages of many
carcinomas (De Conno et al., 1991).

Infection
The presence of infection or immunosuppression may also affect normal
tissue response to radiation (Bentzen & Overgaard, 1994b; Chak, Gill, Levine,
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Meyer, Anselmo & Petrovich, 1988). lmmunosuppression may be part of the causal
chain in the development of infection in radiation reactions where the integrity of
the skin has been compromised.
Bacteria exist as part of the natural flora of the skin and mouth and will cause
infection, given the opportunity that epithelial loss allows. There are four levels for
classifying infection in wounds as described by Carville (1995):

1. Clean, where the wound is made under aseptic conditions but does not
interfere with the integrity of mucous membranes.
2. Clean/contaminated, where either a surgical wound does interfere with
mucous membranes or there is contamination by resident flora of the
cavities, but there is no host reaction.
3. Contaminated, where bacterial contamination results in a host reaction
but no pus formation.
4. Infected, where the clinical signs of infection are present with increased
leucocyte and macrophage levels.

Contamination in an open wound does "'':It affect healing, but clinical infection
does by prolonging the inflammatory phase and inhibiting the ability of fibroblasts
to produce collagen (Senter & Pringle, 1985}. Healing is also affected by the
presence of infection due to the competition for white cells and nutrients. Healing
may be delayed until the body has dealt with the infection. In addition. systemic
infection causes fever, raising the metabolic rate, thus increasing catabolism and
tissue breakdown. Pain, also produced by infection. may further increase the
metabolic rate.
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There are also many factors that may predispose an individual to infection
Some of these care age, obesity, diabetes (Cruse & Foord, 1973); and drugs,
particularly immunosuppressive drugs and steroids (Bibby, Collins & Ayliffe, 1986).
Drug Therapy
The effect of drugs in radiation skin reactions fall into two categories. those
that enhance the effects of ionizing radiation and those that impair healing. The
drugs that enhance the effects of radiation, specifically the anticancer
chemotherapy agents, have been discussed under the heading Radiosensitisers. in
section one of the chapter. Here. the focus will be on the impact of drugs on tissue
repair.

Steroids and Non Steroidal Anti-inflammatory Drugs [NSAIDs].
Both steroids and NSAIDs are used for a range of chronic and acute
inflammatory conditions to reduce the swelling and pain of the inflammatory
response by blocking prostaglandin synthesis. As prostaglandins are the principal
mediators of inflammation, both drugs impair the healing process, particularly if
they are used over a long term (Laurence & Bennett, 1987).
Steroids also suppress the inflammatory and reconstruction phases of the
healing process through inhibiting fibroblast proliferation (Westaby, 1995).

Chemotherapeutic agents.
Chemotherapeutic agents used to destroy cancer cells are unable to
differentiate between normal and malignant cells. The majority of drugs destroy
DNA in replicating cells or interfere with protein synthesis, directly affecting
fibroblast production and collagen synthesis. In addition to the direct effect of
cytotoxic drugs on normal tissue, the side effects often cause nausea, vomiting and
diarrhoea thereby affecting nutritional status. Alopecia caused by some cytotoxic
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drugs may result in changes in body image that may cause or exacerbate stress
and feelings of depression.
It would be expected that the effect of chemotherapy on normal cells when
given prior to. or concurrently with, radiotherapy would impair the normal processes
of tissue repair. The body would be less able to cope with the demands on the
healing process in response to treatment with both radiotherapy and
chemotherapy.
In addition to their damaging effect on normal cells, cytotoxic drugs also have
a suppressing effect on the immune system. The principal nsks of immune
suppression are infection and bleeding. Healing is specifically impaired by a delay
in clearance of debris through reduced white cell activity (Laurence & Bennett.
1987). As a result. patients receiving chemotherapy are expected to be at risk of
infection. This would be extended to patients receiving chemotherapy as an
adjuvant to radiotherapy thereby increasing the risk of infection in any skin reaction
particularly where moist desquamation has occurred.
Other drugs may cause photosensitivity reactions (see Appendix D for a list
of these drugs). The major difficulty with photosensitivity reactions is in masking the
severity and recovery of skin reactions.
Nutritional Status
A balanced diet rich in essential nutrients is necessary to provide an ideal
environment for optimal tissue repair. Malnutrition causes delay in healing and is
generally the result of either insufficient intake or a problem of malabsc:'"'tion.
Several factors affect nutritional status and often their impact has a
compound effect on healing. Age and obesity have already been discussed in the
light of their influence on healing and nutritional status. Hospitalisation, undergoing
medical procedures, and surgery also affect patients' nutrition. Patients who are
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not obviously at risk of undernutrition may fail to eat adequately for optimal healing
whilst in hospital. Brown (1993) studied medical and surgical patients considered to
have no special dietary requirements. Due to a failure to eat the food provided.
68% of the patients had intakes of less than 1000 kcal and large deficits in a range

of vitamins and minerals. Many patients with cancer, having had recent
hospitalisations for surgery, are at greater risk of malnourishment given the
additional nutrient depletion that can occur with malignancy (Smale, Mullen, Buzby
& Rosato, 1981).

Malignant disease is well recognised in compromising nutritional status.
Bruera and MacDonald (1988) discuss malnutrition as one of the most frequent
complications of advanced cancer, alleging that the prevalence is far greater in
patients with solid tumours, children and the elderly. From their research, they
found 51% of patients with advanced cancer and 80% of patients with terminal
cancer were malnourished compared with just 2.3% of patients with breast cancer
in the early stages of the disease. In reporting other studies with a total sample of
3,047 patients, Bruera and MacDonald revealed that weight loss ranged from 37%
of a sample of lymphoma patients to 87% in a sample of patients with gastric or
pancreatic carcinomas. In a study of 54 hospitalised cancer patients, almost all
patients had loss of adipose tissue, skeletal muscle or visceral protein (Nixon,
Heynesfield & Cohen, 1980). The use or abuse of alcohol, smoking and prescribed
or illicit drugs may also have an impact on the nutritional status of the patient
generally.
Some drugs, commonly used in the treatment of cancer and associated side
effects, affect nutritional status directly or indirectly. The following are examples of
drugs with a direct effect on nutrition: Neomycin, used for treatment of candidiasis,
reduces the absorption of vitamins K and D; and Methotrexate, a cytotoxic agent
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used in the treatment of breast cancer. interferes with folic acid and vitamin
metabolism ultimately affecting the synthesis of DNA Smoking can have a direct
effect on nutritional status as smokers in general have been found to be deficient 1n
vitamins B,. ~. 8 12 and C
A number of drugs are well known to affect nuiritional status indirectly by
decreasing appetite. lndomethacin, morphine. digoxin, and cytotoxic drugs in
general cause anorexia and they are in common use amongst patients with cancer
(Dealey, 1994). Nicotine and excessive amounts of alcohol also act as appetite
suppressants. Continued smoking and alcohol use during the treatment period is
well known to potentiate the normal tissue damage in the mouth and throat
(Bentzen & Overgaard, 1994b; Browman et al., 1993).
Reduced Vascularjty and Impaired Oxygenation
Turesson et al.. (1996) tested the predictive value of several patient
characteristics in a sarr,ple of 402 women having 45Gy to the whole breast. The
treatment protoco!s were varied as the sample was drawn from a larger study so a
score was specially devised to represent the "total effect (TE)" of the radiation.
Other than the TE, hypertension and specifically a high systolic blood pressure,
was found to be predictive of more severe erythema as measured by reflectance
spectrometry. These two variables accounted for about 30% of the variance in
patient-to-patient variability. This study was published after the data collection for
the present study was well underway, so measurement of blood pressure was not
included in the research protocol.
A good blood supply and an adequate supply of oxygen are essential to
healing. Impaired oxygenation can be due to a number of illnesses affecting the
haematological, respiratory, cardiovascular and/or peripheral vascular systems.
Although tissue hypoxia stimulates angiogenesis (Knighton, Silver & Hunt, 1981)
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continued hypoxia impairs all metabolism and the overall growth rate (Dealey.
1994).

Anaemia is important in radiotherapy because of its role in the transport of
oxygen. No studies have specifically investigated the effect of haemoglobin level
on normal skin exposed to radiotherapy and the study of the effect on other normal
tissues has been minimal. One group of investigators identified a significant
correlation between high haemoglobin concentration and the risk of radiation
myelitis and speculated that the haemoglobin concentration affected the oxygen
concentration in the spinal cord (Dische, Saunders & Warburton, 1986; Dische,
Warburton & Saunders, 1988). It was also suggested in the 1986 study that a
slightly depressed haemoglobin level led to a reduction in late normal tissue
damage. However, in these reports no allowances were made for the smoking
habits of the subjects which would alter the oxygen unloading capacity of
haemoglobin (Overgaard, Nielson & Grau, 1992).
Research from the wound healing literature suggests that cigarette smoke
contains three to six percent carbon monoxide that in tum produced
carboxyhaemoglobin. In addition to limiting the oxygen-carrying capacity, elevated
carboxyhaemoglobin levels have been associated with changes in the endothelium
and increased platelet stickiness. The latter problem can add to the limitation of
local blood flow particularly in the presence of atherosclerosis (Cohen, Diegelmann
& Lindblad, 1992). Also, in a review of literature on the effects of smoking on
wound healing, Siana, Frankild and Gottrup (1992), found that nicotine affected
macrophage activity and reduced epithelialisation.
Early research by Moseley, Finseth and Goody (1978) investigated the effect
of nicotine alone on the healing capacity of rabbit's ears. The rate of healing in the
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experimental group was significantly retarded up to day 10, although healing
continued at equal rates from day 12 to day 20.
The primary mechanism of smoking on wound healing seems to be
cutaneous vasoconstriction. The effect may be due to one or more of the
constituents of cigarette smoke (Cohen. Diegelmann & Lindblad, 1992). In terms of
radiotherapy where increasing the oxygenation of tissues is associated with
increasing radiosensitivity. smoking may seem to have a potentially protective
effect. The degree of reduced oxygenation due to cigarette smoking is probably
insufficient to decrease radiosensitivity. In all likelihood, however, the reduced
oxygenation will be sufficient to reduce the body's ability to heal.
Cigarette smoking and nicotine abuse has been studied in regard to
radiotherapy-related morbidity. The focus of most studies has been the ear1y or late
reactions of the mucosa in head and neck cancers. that is, anatomical sites that
are in direct contact with the cigarette smoke (Browman et al., 1993; Oes-Rochers,
Dische & Saunders, 1992; Rugg, Saunders & Dische, 1990}. No studies have
specifically investigated the severity of skin reactions and smoking. In a study of
the effects of cigarette smoking and diabetes mellitus, a greater proportion of
smokers were found to suffer from severe irreversible side effects than the nonsmokers (Kucera, Enzelberger, Eppel & Weghaupt, 1987). Unfortunately, these
side effects were not described in any detail. Nevertheless, the research is on
oxygenation is conclusive that it is an important component in influencing the
response of tumour and normal tissue to irradiation.
Skin Colour and Condition
There is no research available on the possible impact of the colour or
condition of the skin in the treatment field. However, there is some anecdotal
support to suggest that individuals with fair or pale skin have more severe skin

Theoretical Foundations and Literature Review

44

reactions. The colour of the skin is, as previously described, created by the number
of melanocytes present, the basic yellowness of the subcutaneous fat and the
vascularity of the area. Basic skin colour has a genetic basis but the colour is
modified through exposure to the elements, in particular UV radiation. Melanocytes
protect underlying structures from the effects of UV radiation and are activated
whenever exposure occurs. The mechanisms for damage to skin cells from ionizing
radiation and UV radiation are not the same: it may be that where the skin has
suffered damage from chronic UV exposure its ability to heal may be impaired.
The type of skin reaction to the sun in terms of tanning and burning, which
individuals experience may determine the extent of UV damage. If an individual
bums easily in the sun and does not tan readily then the probability that they have
spent a lot of time in the sun unprotected by clothing or sunscreen is reduced.
Individuals with a propensity to tan and not bum are more likely to spend time in
the sun unprotected and therefore have more chronic sun damage.
The condition of the skin, whether it is dry, normal or oily indicates the normal
rate of desquamation of the stratum comeum. If dry skin is present in the radiation
treatment area then the effects of the ionizing radiation may be more pronounced
and the usual management of skin in reducing the normal rate of desquamation
from the stratum comeum less effective.
Exposure to Ultraviolet Radiation
Ultraviolet (UV} radiauon, emitted by the sun, can be divided into three
components UV-A, UV-8 and UV-C. UV radiation has some beneficial effects, such
as its role in Vitamin D synthesis; in the treatment of neonatal jaundice; and in the
treatment of skin conditions such as psoriasis but the effects, particularly of UV-B,
can also be detrimental. UV-B is known for its role in mediating damaging
photochemical reactions in the skin, including DNA damage, through the
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generation of free oxygen radicals (Browder & Beers, 1993). These reactions can
cause mutation, death or transformation in a number of cells including epidermal
cells, with the resultant effect of causing carcinogenesis (Young, 1990).
Most of the research in this area focuses on the development of skin cancer.
Of relevance here, however, is that the mechanism for carcinogenesis is based on
systemic immune suppression caused by UV-B (Jacobson & Flowers, 1996). This
alteration to the immune system may also have a suppressing effect on the
inflammatory phase of normal tissue repair.
Melanocytes are activated by UV radiation to produce melanin, creating a
protective chemical barrier against the effects of UV radiation. The effects of UV
radiation are cumulative and, therefore, the evidence of exposure is a noticeable
aspect of ageing skin. Chronic sun exposure thins the epidermis and atypical
keratinocytes become more prevalent (Jacobson & Flowers, 1996). Although
melanocytes are normally activated by UV radiation, with chronic exposure, some
melanocytes are destroyed by UV radiation and some are stimulated. This nonuniform reaction manifests as spotty hypopigmentation juxtaposed with areas of
hyperpigmentation (Goldfarb et al., 1990).
Marked changes occur to the dermis with years of UV exposure. The
connective tissue forms irregular clumps in a process called solar elastosis. The
first noticeable change of solar elastosis is wrinkling. Wrinkling does not c.1ccur in
some of the most sun exposed areas such as the nose or ears, thus it seems to be
confined to skin that is elastic (Goldfarb et al., 1990). Solar elastosis is also
responsible for the yellowing and roughened texture of skin giving it a ...weatherbeaten" appearance (Gilchrist, 1984).
Cutis Rhomboidalis Nuchae is a common condition in men after many years
of sun exposure characterised by deep furrows on the back of the neck forming a
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rhomboid pattern (Ogawa, 1975). The skin is thickened and may be yellow or red
(Goldfarb et al., 1990).
UV exposure is known to have a detrimental effect on the condition of the
skin, affecting its ability to protect the body from UV radiation damage and
impairing the healing of the skin. It seems logical to suggest, then, that the effects
of UV radiation may also exacerbate the severity of radiation skin reactions. This
phenomenon has received only fleeting mention in the published radiation
oncology nursing literature (Sitton, 1992). It has, however, been noted clinically that
the reaction observed in areas commonly exposed to UV such as the he~d. neck
and upper chest can be dramatically worse than adjacent areas of skin that are
less commonly exposed.
Furthermore, work published by a radiation oncology research group in
Australia suggests that prior sun damage increases the baseline erythema when
measured by reflectance spectrometry (Denham et al., 1995) and increases the
severity of early erythema. Neither of these studies specified how prior sun
damage was assessed. Whether this phenomenon is exaggerated in Australian
patients due to the intensity and aspect of sunlight in Australia is not known.
Summary of the Personal Construct
Radiation has a damaging effect on normal tissue and inhibits the process of
tissue repair through damage to vasculoconnective tissue. The variation in
expression of radiation skin reactions may be attributed not only to the known
radiation factors but also to the genetic and personal factors that combine
differenUy for each individual.
Patients with cancer facing radiotherapy may be experiencing many of the
factors that impair healing: anorexia-cachexia, malnutrition, anaemia, some
metabolic alterations, impaired mobility, old age, disturbances in blood circulation,
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strass, anxiety and neurological disorders. These conditions have the potential to
be detrimental to the repair of the epithelium (Bruera & MacDonald, 1988;
Jacobson & Flowers, 1996; Taylor, Moran & Jackson, 1989). In addition, such
patients are likely to have been hospitalised for surgery and may have had, or are
having, chemotherapy. To date, the interplay of these factors and their effect on
radiation skin reactions has not been empirically tested.

Relationships Between the Constructs of the Conceptual Framework
To have a radiation skin reaction one element is essential, ionizing radiation.
The relationship between the Radiotherapeutic Construct and the severity of the
radiation reaction is undisputed, although the degree to which the patient-to-patient
variation can be explained by the radiation alone is not known. When the same
treatment protocol is used, such as in the treatment of early breast cancer, then the
radiation becomes more constant and investigation of individual variations can be
more clearly related to the presence of "other factors"
Events occurring in normal tissues following irradiation, as described in the
section on radiation histopathology, highlight the recovery or repair process as an
esset1tial component affecting the severity of the reaction. If the individual's ability
to repair damaged normal cells is poor, then it would be expected that the reaction
would be more severe. Therefore, the presence of factors known to have a
detrimental effect on wound healing such as smoking, poor nutrition, coexisting
chronic illnesses and some drugs, would also have a detrimental effect on radiation
reactions.
The role of the Genetic Construct in this conceptual framework is in the
genetic predisposition to factors which impair healing, such as chronic illness or
factors which potentiate the effects of radiation; for example, the genetic condition,
Ataxia Telangiectasia, known to produce a highly radiosensitive response.
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Theoretical relationships between the constructs and the resultant radiation
reactions formed the main hypothesis of the study: That the patient-to-patient
variation in radiation normal tissue reactions results from the combined effect of
some or all of the personal and genetic factors plus the radiation factors.
This can be illustrated in the formula:

Radiation Skin
Reactions

c:

Radiation
Factors

+

Genetic
Factors

+

Personal
Factors

Measurement Issues in Operationalising the Conceptual Framework
Dependent Variable - Radiation Skin Reactions
Previous studies investigating skin reactions have relied on highly technical
equipment that is not available in the average radiotherapy department; for
example, reflectance spectrometry for measurement of erythema (e.g. Denham et
al., 1995; Hamilton et al., 1996; Tucker et al., 1992; T1irreson & Notter, 1886;
Turreson & Thames, 1989). However these are not available on a day to day basis
and, more importantly, nurses are not skilled in their use. Therefore. to make the
final instrument useful in day-to-day practice the equipment must be available to
nurses at all times.
A number of scales have been devised for clinical use to assess the
progressive development of skin reactions. The most commonly used scales are
those devised by Yasko (1983), McNally, et al. (1985) and the Radiation Therapy
Oncology Group [RTOG] and the European Organisation for Research and
Treatment of Cancer [EORTC] (Cox, Stetz & Pajak, 1995). There are some
similarities in the scales in that the progression of increasing severity is
conceptualised as an ordinal scale and each level of the scale is given a brief
description.
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Yasko's (1983) system has four stages (1 - 4) and follows the pattern of the
acute skin reactions for the first three stages and then in the fourth level introduces
chronic reactions. McNally, et al's (1985) S)'stem also has only three stages with
each stage encompassing a broad range of possible reactions. The system is not
specific to the skin alone, but the lack of adequate description in the stages makes
its validity questionable.
The scoring criteria for acute radiation reac!ions were developed by the
RTOG/EORTC in 1985 to complement the long-standing scoring system for late
(chronic) reactions (Cox et al., 1995). The acute scale has six levels with

·o·

meaning an absence of radiation reaction and '5' meaning that the effects of the
radiation led to the death of the patient. The severity of reactions is graded from
one through four although in fact a grading of three is considered severe.
No psychometric testing has been reported for any of these scales. The
RTOG/EORTC, by the nature of its development by a group of expert radiation
oncologists (Perez & Brady, 1992) and its subsequent use in many research
studies (Dische. 1994), has established a measure of content validity. Only one
study was found that tested clinicians' scoring of skin reactions with the
RTOG/EORTC scale by comparing it with reflectance spectrometry. Denham et al.,
(1995) found that RTOG scores were lower than spectrometry readings in male

patients, melanin pigmented and sun-exposed anatomical sites. Other than this
discrepancy, the relationship between the two methods did not vary substantially
during the development of the reaction. However, whilst a reasonable correlation
was found between spectrometry readings and RTOG scoring, inter-rater reliability
among clinicians was poor. The article does not indicate how many clinicians were
involved in the observations, or if the conclusion was reached through statistical
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analysis. Reliability is, however, an important aspect to consider in controlling an
observational study based on visual assessment with the RTOG scoring system.
Independent Variables - Predictive Factors
Factors included in the Radiation Construct are objective items. The
collection of this data requires only an easy-to-use method of transferring data from
the medical record to the data collection form to ensure accuracy in documentation.
The measurement of factors included in the Genetic Construct was not within the
scope of this project. However, secondary measures such as a personal and/or
family history of cancer were included.
The Personal Construct includes the collection of some objective data, such
as age or type of chemotherapy and some measured phenomena such as
cumulative UV radiation exposure. Although factors which impair optimal healing
such as age, nutrition, medications and coexisting disease are well recognised, no
previous research in the wound care literature has attempted to quantify them. In
other words, there is no known effect size for any of these factors. Thus, despite
there being a logical theoretical relationship between the constructs, there is little or
no empirical evidence to assist in overcoming the pragmatics of testing the model.
Therefore, to determine which of the identified factors or combination of
factors best predict the individual differences in skin reactions, an inclusive
approach was considered appropriate. This means that as many factors as
possible were measured to explore individual and combined effects. Also,
wherever possible, similar characteristics (such as disease or treatment factors)
were grouped together to provide as much control as possible over the multitude of
potential extraneous variables. Details of the measures used to collect data for the
Personal Construct are presented in Chapter Three.
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Chapter Summary
The purpose of this chapter was to review and critique the literature to
construct a conceptual framework upon which the empirical study of factors
impacting on the severity of skin reactions to radiation therapy could be based. The
conceptual framework, draws together two bodies of knowledge, radiation oncology
and wound management. The scientific research and clinical knowledge presented
here shows that the interplay of radiation, genetic, and personal factors explains to
some degree, patient-to-patient variability in normal tissue responses encountered
in radiation oncology practice.
The complexity of conducting research that considers the impact of personal
factors on the severity of skin reactions is evident in the few studies that have been
published. To overcome some of the difficulties, Denham et al. (1995) recommend
that future research be confined to the study of one site and one gender.
Management of radiation skin reactions provides a daily challenge to the
interdisciplinary team in radiation oncology. For clinically utility it is not only
important to determine the influence of the aforementioned concepts on patient-topatient variability, but also find practical measures that can be used on a day-today basis.
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CHAPTER 3
THE RESEARCH PROCESS
This chapter presents the methods used to collect and analyse data for the
study. Details of the sample and setting, design, measures. procedures, analysis
and ethical considerations are described.

Sample
The sample was drawn from the population of patients com.--,encing
radiotherapy for cancer of the breast. A total of 128 women who met the following
selection criteria were approached to join the study:

e 18 years old)

o

Adult women

e

Able to verbally communicate sufficiently well in English to understand the
purpose and nature of the study in order to give consent, and complete the
interview.

e

Diagnosed with primary breast cancer at any stage who had undergone
surgical removal of the breast tumour (lumpectomy) with or without axillary
node clearance.

o

Commencing the standard post~lumpectomy radiotherapy protocol of 45 Gy to
the whole breast delivered by two tangential fields in daily fractions of 1.8 Gy
for 25 days, five days per week, followed by a 20 Gy electron boost (6MeV or 9
MeV) to the lumpectomy scar delivered by one field in daily fractions of 2 Gy for
1O days, five days per week.

Of the 128 women who were approached, 126 agreed to participate in the
study. One person refused because she was too busy and the other felt too weak.
There were no withdrawals from the study. Recruitment continued over a 12-month
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period. The entire data collection period including a follow-up of all cases was 14
months from May 1996 to June 1997 inclusively.

Setting
The setting for the study was the Radiation Oncology Department of a major
metropolitan, public teaching hospital located in Perth, Western Australia (WA),
hereafter known as the Department. During a 12-month period the Department
receives over 1200 new referrals and administers approximately 1350 treatment
courses. An average of 105 patients are treated each day.

Design
A prospective, descriptive correlational, repeated measures design was used
to detemiine predictors of skin reaction severity in patients being treated with
radiotherapy for breast cancer. This design facilitated the correlation of identified
factors with the development of radiation reactions experienced by participants.
The dependent variable was the severity of radiation skin reaction as measured by
the RTOG scoring system. The independent (predictive) variables were the factors
identified in the theoretical framework through review of the literature and clinical
knowledge.
Data were collected at weekly intervals over the seven weeks of treatment. In
addition to the observation of the skin reaction at each time point, a pain score was
recorded along with a description of the nursing interventions that had been
instigated. Comments from participants and observers were also recorded.

Instruments
Operationalisation of the conceptual framework is described in this section.
Figure 3.1 depicts the concepts and constructs that will be detailed subsequently.

CONSTRUCT RADIATION
LEVEL
SKIN
REACTION

RADIATION
FACTORS

GENTETIC
FACTORS

PERSONAL
FACTORS
(Disease related)

PERSONAL
FACTORS
(Treatment related)

PERSONAL
FACTORS
(General health)

PERSONAL
FACTORS
(Skin condition)

CONCEPT

a. Erythema

Dose

Previous
cancer

Tumour histology

a. Condition of scars

Age

Skin condition

a. itchiness

Fractionation

Stage of disease

b. Lymph drainage

Chronic illness

Skin allergies

a. Dry skin
loss

Treatment
length

c. Chemotherapy for
this cancer

Prescribed drugs

Family history
of allergies

a. Moist skin
loss

Energy

b&
c Chemotherapy
or radiotherapy for
previous cancer

Self-medication/
alternative drugs

LEVEL

Family history Time since diagnosis
of cancer
Recurrences

Reaction of skin
to UV radiation

Smoking history
b. Pain
Alcohol intake
Weight (kg)

Cumulative
UV exposure
Geographic
location

Height (cm)
Breast (bra) siza

::c

Nutritional intake
Alternative diet

MEASURE-

MENT
LEVEL

a. RTOG
scoring
system

Radiation
prescription

Participant
report

b. VAS- pain

Figure 3. 1 Operationalisation of the Conceptual Framework

Medical notes

a. Observation

Participant report

Participant report
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b. Participant report
c. Medical notes
I
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Dependent Variable - Severity of Radiation Skin Reactions
As shown in Figure 3. 1. the severity of radiation skin reactions was indexed
with two instruments, RTOG scoring system and a visual analogue scale (VAS) to
measure pain. The breast area was divided into eight anatomical sites and a score
recorded for each site at each observation. The sites were: midlinc chest
(sternum); axilla; inframammary fold: nipple; and the four quadrants of the breast,
upper outer quadrant (UOQ), upper inner quadrant (UIQ), lower outer quadrant
(LOO). and lower inner quadrant (LIQ). The data collection form for recording
weekly observations is presented in Appendix E.
The RTOG Scoring System
The RTOG Scoring System for Acute Radiation Morbidity was developed by
groups of expert physicians as part of the RTOG over some 25 years {Dische,

1994). The scoring has been used extensively in empirical studies {Dische) and is
used routinely in the Department as a standard measure for documenting skin
reactions.
Other scoring systems have been devised; however, they have fewer
categories and do not distinguish between acute and chronic reactions (see
literature review}. The RTOG, therefore, was judged to have more specificity, is
used extensively in clinical research and is accepted generally in the medical and
nursing communities. The validity of the scoring system is based on these
credentials as no formal psychometric testing of the RTOG has been published.
The current form of the scoring system was published in 1995 in a special issue of
the International Journal of Radiation Oncology Biology Physics (Cox, Stetz &
Pajak, 1995). Descriptors for skin reactions used in the study are detailed in Table
3.1.
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Table 3.1

BTOG Score System for Acute Radiation Skin Reactions

1

RTOG·

$CORES

2

3

Confluent, moist
Follicular, faint or Tender or bright
dull erythema.
erythema, patchy desquamation
epilation, dry
moist
other than skin
desquamation,
desquamation,
folds, pitting
oedema.
decreased
moderate
sweating.
oedema.
* RTOG Score of O = No change over baseline

4

Ulceration,
haemorrhage,
necrosis.

The RTOG system scores radiation reaction severity on an ordinal scale from
zero to four. Zero represents no change from the baseline observation with each
subsequent category depicting increasing severity as the score increases.
lnterrater Reliability
lnterrater reliability (IRR) in the use of the RTOG was tested at the
commencement of data collection and at random times throughout the data
collection period. Over the 14 months of data collection, 30 sets of observations
(observation of the eight anatomical areas made one set) were included in the IRR
testing, occurring approximately at fortnightly intervals.
Over the study period, three people were involved in the observation of skin
reactions, two research assistants and the researcher. All three observers were
experienced in radiation oncology nursing. IRR was tested between two observers
at a time because the use of three observers would have been practically difficult
and intrusive to the patient. The researcher was always one of the two observers.
The procedure for IRR testing was to examine a patient's skin together and then
record the observation on separate sheets.
IRR scores were generally high with an overall reliability of r = 0.85. The IRR
for each observation site of the breast are detailed in Table 3.2. Discrepancies
arose most often when the skin was changing from a RTOG 1 to RTOG 2 rating.
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Table 3.2
Overall lnterrater Reliability by Site on Breast over the Study Period.
Site

Average IRR Coefficients (range)

Sternum

r = 0.90 (0.80 - 1.00)

Axilla

r = 0.90 (0.80 - 1.00)

Upper Outer Quadrant

r = 0.90 (0.75 - 1.00)

Upper Inner Quadrant

r = 0.85 (0. 70 - 1.00)

Lower Outer Quadrant

r = 0.80 (0.70 - 1.00)

Lower Inner Quadrant

r = 0.80 (0. 70 - 1.00)

Nipple

r = 0. 75 (0.60 - 1.00)

lnframammary Fold

r = 0.90 (0.80 - 1.00)

Modifications to the RTOG Scoring System
After completing the data collection on the first 20 patients, a problem
emerged in the definition of RTOG 2. There was a clear difference in the
participant's perception of the skin reaction severity between "bright tender
erythema", and "patchy moist desquamation". That is, patients perceived loss of
even a small patch of skin worse than tender bright red skin. The decision was
made to differentiate between these two reactions recording bright tender
erythema as "2", and patchy moist desquamation as "2.5" as this would provide
more specific information for predicting outcomes.
A recent study (Denham et al., 1995) also found it necessary to modify the
RTOG scoring. They split RTOG 1 rather than RTOG 2. The decision in this study
to split RTOG 2 was based on what participants saw as a discrepancy in skin
reaction severity scores as described by the RTOG system.
Another modification was made due to the use of retention tape dressings to
prevent fragile skin from breaking down. The use of retention tape dressings, such
as Fixomull, Hypafix and Mefix) for thf' management of radiation skin reactions was
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developed by nursing staff in the Department and was a standard feature in the
skin care protocol (Downes, Porock & Upright, 1997). Retention tape is placed over
areas of moist desquamation to reduce pain and the risk of infection. However,
when the skin is assessed to be very fragile and breakdown is seen to be
imminent, the tape is used to prevent skin loss. Retention tapes, when used as
wound dressings, adhere to the skin and can remain intact for up to three weeks.
Radiotherapy can continue with the tape in situ, as it is thin enough not to create a
significant bolus effect (Downes et al.). This protocol could not be disrupted during
the course of the study. Thus, when a retention tape was recorded, a score of 2.5
was given to that site even when moist desquamation had not actually occurred as
it was anticipated that had the tape not been used, the skin would have broken
down.

Pain is an aspect of radiation reactions that is not included on the RTOG
scoring system other than by the term "tender" in RTOG 2. Pain was, therefore.
measured separately using a VAS where "zero" represented no pain and "ten"
represented the worst pain the patient could imagine. The VAS is a unidimensional
measure of the perception of pain based on the premise that pain is what the
patient describes it to be. Participants were asked to rate the worst pain they had
experienced with the skin reaction during the week preceding each observation.
The pain score was recorded on the data collection form for recording weekly
observations of skin reactions {Appendix E).
Independent Variables
As indicated in the conceptual framework, and illustrated in Figure 3.1. there
were many possible independent variables acting alone or in concert to increase
the severity of the radiation skin reactions. The data collected and tools used to
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measure factors from each construct are presented first, followed by a description
of content validity and reliability testing.
Radiotherapy Construct
The factors identified in the conceptual framework that comprise the
Radiotherapy Construct required careful documentation from the prescription for
radiotherapy. At the end of the treatment period, a treatment summary was written
by a radiation therapist from the planning section of the Department indicating the
total dose, dose per fraction, energy used for the electron boost and the total
number of days of treatment (including weekends and missed days).
Genetic Construct
The data collected for this construct were indirect indicators of personal or
familial genetic makeup. Other tests of radiosensitivity or cancer proneness were
beyond the scope and purpose of this study. The two items used were previous
personal history of cancer, and a family history of any type of cancer.
Personal Construct
The personal construct was the largest construct and the main focus of the
study. For ease of discussion the construct has been divided into four categories:
disease related factors, treatment related factors, general health factors and the
condition of the skin at commencement of radiotherapy.
Personal Construct- Disease-Related Factors
Data for disease-related factors were obtained from the medical record of
each participant. Specifically, the histology and staging of the tumour were
obtained from the pathology report after surgery. Time since diagnosis was
calculated from the date of surgery to the start of radiotherapy.
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Personal Construct - Treatment-Related Factors
The two main areas of data to be collected as treatment-related factors were
in relation to the surgical and chemotherapeutic effects of cancer treatment prior to
commencing radiation. In addition, data from treatment with radiation or
chemotherapy from any previous cancer treatment were documented.
The condition of the surgical scars at the lumpectomy site and from axillary
clearance was an important aspect in assessing the condition of the skin at the
commencement of treatment. In consultation with a microbiologist and a clinical
nurse consultant for wound care, an ordinal scale was developed. The scale was
reviewed informally for content validity by four experts in surgical wounds (two
surgical nurses and two wound care consultant nurses) and an agreement of r =
1.00 was achieved. The scar was observed during the first week of treatment and
recorded as follows.
The scar: (1) is fading; (2) is inflamed (3) has haemoserous discharge (4) has
purulent discharge
Details of concurrent and completed chemotherapy in relation to treatment of
the current breast cancer were taken from the participant's medical record.
Information regarding any previous chemotherapy or radiotherapy for the treatment
of any previous cancer was documented from the participant's self-report and
cross-checked in the medical record.
Personal Construct - General Health
Data for the general health section of the Personal Construct were primarily
collected by participant report or from the medical record (see Figure 3.1 ).
However, several factors required more measurement as described below.

Research Process

61

Nutritional intake.
Nutritional intake was measured using a subscale of the Braden Scale for
pressure ulcer risk prediction (Braden & Bergstrom, 1989). The Braden Scale is
comprised of six subscales developed from the aetiology of pressure ulcers
{Braden & Bergstrom, 1987). The nutritional intake subscale was chosen because
its underlying assumption was identical to this study: that poor nutritional intake
resulted in poor wound healing.
The scale has undergone a variety of psychometric tests. Content validity
was established by an expert panel and two studies of IRR were conducted in
extended care facilities; r = 0.99, and r = 0.83 - 0.87 (Bergstrom, Braden, Laguzza
& Holman, 1987).

The nutritional intake subscale is intended to measure a person's usual food
intake pattern rather than a temporary poor or negligible intake. If a person's intake
has been poor over a long period and food supplements have just been
commenced, then the rating would reflect the usual poor intak.e. Any change in
intake should be maintained for one week before it is considered usual (Braden &
Bergstrom, 1989).
Personal Construct - Skin Type and Condition
Measurement of the factors in the skin type and condition section of the
Personal Construct required the most development, as there was little published in
this area.

Severity of skin allergies.
A scale to measure the severity of skin allergies was developed with the help of
a microbiologist and clinical nurse consultant for wound care. Scale responses
were structured in the following manner: (1) Mild reaction {dry and peeling), (2)
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Moderate reaction (as above plus red and itchy), (3) Severe reaction (as above
plus blisters/oozing).
An expert panel of four nurses as described above, reviewed the scale for
content validity and the agreement achieved was r = 1.00. Study participants, who
had reported skin allergy as a problem, were asked to choose a response from the
scale that most closely fitted the severity of their skin to the presence of an
allergen.
Family history of skin allergies was measured using a simple "yes/no"
question to ascertain the presence of a family history. Participants were also asked
to record the number of family members with a skin allergy problem and their
relationship to the participant. Only first or second-degree blood relatives were
included in any analysis.

Skin type.
After review of the electronic data bases for references to non-invasive
measures of skin type, discussion with a Consultant Dermatologist revealed a wellknown dermatology clinical scale for skin type in relation to reaction to the sun; the
Fitzgerald scale (Harber & Bickers, 1981). The scale comprises six ordinal
descriptors as shown in Table 3.3. Patients are asked to report their skin reaction
to the sun following 30 to 45 minutes of unprotected sun exposure after the winter
season or a long period of no sun exposure.
The Fitzgerald scale correlates with more invasive measures of skin colour.
For example, the correlation between the Fitzgerald Scale and melanin density, as
measured by punch biopsy, is r = 0.49 (p = .001) (Dwyer, Blizzard & Ashbolt,
1996). The scale appears to be part of the tacit knowledge of dermatology, and no
record of its development or formal testing for validity and reliability was found.
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Table 3.3
The Fitzgerald Scale
Sunburn and Tanning History

Skin Type

I

Always bums easily, never tans (sensitive)

II

Always bums easily, tans minimally (sensitive)

111

Bums moderately, tans gradually (normal)

IV

Bums minimally, always tans well (normal)

V

Rarely bums, tans profusely (dark brown, insensitive)

VI

Never bums, deeply pigmented (insensitive)

Exposure to ultraviolet (UV} radiation
A non-invasive measurement of the cumulative effects of UV radiation was
not located. The factors involved in exposure to the sun relate to lifestyle, such as
sunbathing habits and use of protective measures. These are understandably
subject to a large degree of recall bias. A small qualitative study was conducted six
months prior to the main data collection to identify ways in which people described
their exposure to the sun. The purpose was to find a way to capture the effect of
lifestyle factors as potential predictive factors. The hypothesis was that a greater
cumulative exposure to the damaging effects of UV radiation was associated with
the development of more severe radiation skin reactions in sun exposed areas
such as the sternum.
After approval was gained from the hospital ethics committee, interviews with
six patients from the Department were undertaken. A further four healthy adults
were interviewed to identify if there were any additional factors not considered by
patients. Data were recorded as field notes and examined for themes. Three
themes emerged from the patient interviews and no new themes emerged from the
additional interviews with the healthy adults.
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The themes were:
1. Where free time was spent - indoors, outdoors or both
2. Where work occurfied - indoors, outdoors or both
3. How often sun protection was used - almost always, often, sometimes, almost
never.
The themes were further categorised by differences in their activities and
behaviours as children and as adults, and differences due to geographic location,
for example living in Australia versus Britain.
The developed scale was included in the content validity package sent to the
original five-member panel of experts in radiation oncology. The co-efficient of
expert agreement on content validity for this scale was r = 1.00. Study participants
were asked to choose a response from the scale that most closely matched their
history of sun exposure. The cut off point between childhood and adulthood at 15
years of age was based on tha skin cancer risk factors. The complete scale is
presented in the data collection form found on page 204, Appendix F.
Content Validity
The first step in developing the data collection methods was to assess the
content validity of the factors identified in the conceptual framework. The content
validity of the conceptual framework and tools for measuring variables was
assessed using Lynn's (1986) method of determining agreement between
members of an expert panel. In this method, each expert independently rates the
items of the instrument and indicates, in their opinion, to which of four set
categories the item belongs. The categories are: 1. Not relevant; 2. Unable to
assess without item revision; 3. Relevant but needs minor alteration; 4. Very
relevant and succinct.
When the responses have been collated, percent agreement among the
experts is calculated. The table of correlation coefficients formulated by Lynn
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{1986), indicates the number of experts from a panel who must agree to reach
significant agreement when oc = 0.05. The number of experts in a panel affects the
number required to achieve significant agreement. For example, to achieve
significance with a panel of two requires both experts to agree, whereas a panel of
five requires four experts to agree. If a particular item is rated as ca! .gory 3
(relevant but needs minor alteration) or 4 (very relevant and succinct), then it is
deemed to be a valid item. Lynn {1986) also suggests that an agreement
coefficient of over 0.80 is required before content validity is deemed established.
The procedure for assessing content validity of the predictive factors in this
study was as follows. Five expert radiotherapy practitioners, two nurses, two
consultant radiation oncologists and one radiation therapist were approached by
phone and all agreed to assist in the exercise. Each member of the panel was sent
a letter thanking them for their assistance and instructing them in the system to
check content validity. A copy of the abstract from the research proposal was also
sent for their information. A table was constructed for ease of assessment where
each item was alongside the categories as described above {Appendix G). All but
six items achieved a content validity coefficient of greater than or equal to 0.80,
which according to Lynn's {1986) criterion, is an acceptable level of agreement.
Four items, age, tumour histology, recurrences, and family history of cancer
attained a coefficient of 0.60. Two items had a coefficient of 0.40 {time since
diagnosis and stage of disease at diagnosis). According to Lynn {1996) these six
items should be modified or removed. However, panel experts offered no
recommendations for modification of the items. Given the exploratory nature of the
study, and the fact that the items were selected based on literature purporting
relationships between these and the severity of skin reactions, all items were
retained. Collection of data related to time since diagnosis and stage of disease
were justified as they would be useful descriptors of the sample.
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The expert panel was also asked to comment on the scoring of specific
items. Minimal changes were suggested and incorporated before proceeding to the
next phase of pilot testing. In addition to the expert panel's input, the consultant
statistician also reviewed the instrument and commented on the scoring. The
scoring system was found to be suitable for the analysis planned. Following this
initial assessment of content validity, operationalisation of the factors was
completed.
Reliability testing
The reliability of much of the data collection lay in the accuracy of recording.
Random checks were made, comparing the medical notes of about 20% (26) of the
sample and asking 5% (6) of participants to repeat the interview. No errors were
detected.
The process of asking six participants to repeat the interview made it possible
to assess the reliability of several of the scales used as listed below:
o

The subscale of the Braden Scale used for nutritional intake

o

The Cumulative UV Radiation Scale

•

The Fitzgerald Skin Condition Scale

o

The Skin Allergy Severity Scale

No differences in participants' responses to these scales were detected in this
small group.

Scar Condition Scale
lnterrater reliability for the Scar Condition Scale was conducted randomly
during the data collection period between the three observers. Approximately 10%
(12) of the sample was tested and reliability was found to be r = 1.00.
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Demographic Data
In addition to the factors described, the following demographic data were
cn!lected to test for representativeness of the sample: marital status, occupation,
and education level completed. In the pilot study socioeconomic status was
assessed through an item on annual family income. Participants were reluctant to
give this information so the item was removed and two other items replaced it,
usual accommodation, and postal area code. Socioeconomic status was then
assessed using the Australian Bureau of Statistics' (ABS) socioeconomic listing
developed from the National Census data (1996).
Pilot Testing of Measures
The final form of the data collection form can be found in Appendix F. The
instrument was piloted on the first five participants and modifications to the order of
the items were made. Participants reported verbally that they could understand all
items easily. No new items were added at this stage, so these participants were
included in the final sample.
Training of research assistants
Two research assistants were trained during the course of the data collection
period in the use of the preliminary instrument prior to commencing work on the
study to ensure that the explanations and instructions given to each participant did
not differ significantly. Where uncertainty arose (for example in assessing the
pathology reports) the Consultant Radiation Oncologist (adviser to the project) was
available to answer questions and make necessary clinical decisions.
All three observers were experienced in radiation oncology nursing and were
familiar with use of the RTOG scoring system in the Department. Thus training for
the measurement of the dependent variable comprised testing interrater reliability
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and ensuring that a second opinion would be obtained from another observer, or
the Consultant Radiation Oncologist in cases of uncertainty.

Procedures

Recruitment
Patients planned for standard protocol treatment of breast cancer were
identified from the list prepared each week by the planning section of the
Department. From this list the researcher/research assistant liaised with the
radiation therapists working on the linear accelerator units to ensure that identified
patients fitted the study criteria, and noted when treatment was to start.
Patients fitting the inclusion criteria of the study were approached to join the
study during the first week of their treatment. To avoid any unnecessary stress,
patients were not approached on the first day of their treatment. Prospective
participants were approached in the waiting area in the following way: The
researcher/research assistant introduced herself and asked if the patient had a few
moments to discuss a research study in which they might participate. If willing, the
patient was taken to a side room to provide the necessary privacy. The research
was explained fully and questions answered. Formal consenting procedures were
completed when the researcher/research assistant was sure that participants
understood both what was involved and their rights as voluntary research subjects.
Each participant was allocated a code number and each page of the questionm=tire
and follow-up schedule was numbered.
Interview - Completion of the Data Collection Form
The interview to complete the preliminary instrument was conducted at the
same time as consent. An interview format was used, as the preliminary instrument
was not designed for independent completion. On a very small number of
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occasions the interview was completed at the first follow-up. It was essential
however, that the condition of the skin was assessed and documented on the first
occasion to establish a baseline.
Most items on the questionnaire were answered by patient report in the
interview and no corroboration was sought. Information for items 1 - 5 on the
questionnaire and the treatment details were obtained from the medical notes and
the prescription for radiotherapy.
Follow-up
The follow-up procedure was facilitated by the good working relationship
between the researcher/research assistants and the radiation therapists working on
the linear accelerators. Once a week during the treatment period, each participant
was examined immediately prior to or after the daily treatment so that they did not
have to undress again for the research protocol. A list of current participants'
names was given to the radiation therapists working on the linear accelerators who
would then call the researcher/research assistant to the machine to see
participants. Consent was verified verbally with the participant before the
observation took place at each follow-up.
Participants' data were name identified on the front page only. All the
research documents were kept in a lever arch file and secured along with the
medical notes in the Department. Completed consent forms were kept in a locked
filing cabinet in the nursing office in the Department for the duration of the data
collection period and then transferred to the research office and kept in a secured
place.
Closure of Study Participants
At the end of the treatment period the participant's questionnaire and followup schedule ware removed from the lever-arch file. The section at the top of the

Research Process

70

first page on which was the hospital label with the name of the participant was
removed and placed with the consent forms in the filing cabinet. The questionnaire
and follow-up schedule, now only identified by a code number, was removed from
the Department, taken to the research office and secured in a locked cabinet.

Analysis Plan
The data were analysed using the Statistical Package for the Social Sciences
version 7.0. Data were cleaned and data entry checked by random sample of 10%
of the questionnaires. The process of data analysis was completed in the steps set
out below.
1. Sample characteristics and all potential predictive factors (independent
variables) were explored using descriptive statistics. Normality of continuous
variables was tested graphically using a probability plot and box plot and onesample Kolmogarov-Smimov nonparametric test.
2. The RTOG score {dependent variable) was explored and found to have a nonnormal distribution. Therefore the RTOG score was re-coded into a
dichotomous variable for all eight anatomical sites and for each week thus
{refer to Table 3.1 for definitions of RTOG scores):
•

RTOG score of O or 1, representing no reaction or a mild reaction
became 0-RTOGO

e

RTOG score of 2 or more, representing a less manageable reaction
became D-RTOG1.

3. The independent variables were explored and collapsed where necessary to
ensure the validity of chi-square testing.
4. Chi-square testing was conducted between the dependent site-specific DRTOG score and each categorical independent variable.
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5. Independent sample t-tests were conducted on the dependent site-specific 0RTOG score and each continuous independent variable.
6. Nursing interventions with creams and topical ointments were tested as
possible co-variants.
7. On the basis of the univariate results, any relationship with a p-value of< 0.10
was noted for inclusion in the logistic regression analysis.
8. Stepwise logistic regression was performed on the results for week five first
This week was the last of the radiation to the whole breast area and if a more
severe reaction was going to occur it would most likely have occurred by week
five. The alpha level for entry of a predictor was set at 0. 10 and removal at

0.15 to allow for a more complete exploration of the predictors. Categorical
variables were treated as indicator (dummy} variables with the reference group
being the "zero" group e.g. for smoking, the never smoked group was the
reference group with which the ex-smoker and current smoker groups were
compared.
9. Stepwise logistic regression was performed in the same manner on the DRTOG scores for weeks four and three to determine what variables might
predict those at risk of an early reaction.

10. The RTOG scores were described from data recording the skin reactions
during the electron boost treatment in weeks six and seven.
11. Univariate level relationships were tested using chi-square analysis for
categorical variables and t-tests for continuous variables for weeks six and
seven.
12. Stepwise logistic regression analysis was then performed between the DRTOG scores in week six and seven. RTOG scores for weeks six and seven
record the effect of the electron boost to the lumpectomy scar and the
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diminishing skin reaction effect of the remainder of the breast following
completion of the whole breast protocol.
13. A prediction model for each anatomical site by week was developed providing
an estimate of the relative risk for each predictive factor in the model. The
Exp(B) column in the table constructed as part of the computer output is the
logistic regression equivalent of the odds ratio or relative risk. The probability
or likelihood that an individual may enter the more severe reaction group was
calculated from the following formula:
Probability (event)

=

ez
1 + e2

14. The results of the Pain VAS were described and compared with the results of
the RTOG and D-RTOG scores.

Ethical Considerations
Permission to conduct this study was given by Edith Cowan University
Committee for the Conduct of Ethical Research on July 28, 1995 and the
Institutional Ethics Committee of the study hospital on March 22, 1996 (Appendix
H).
Consent
Each participant was given an information letter detailing the purpose and
nature of the study and informing them of their rights as research participants.
Telephone numbers were included to provide ongoing opportunity for participants

to ask questions or exercise their right to withdraw (Appendix I). Fully informed,
written consent was obtained from all participants before proceeding. Consent was
affirmed verbally at each follow-up observation.
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The research assistants were made aware of the vulnerability of patients as
research participants particularly as one of the research assistants was a nurse in
the Department. The issue of ensuring participants knew their rights to ask
questions or to withdraw from the study was specifically targeted during training
Confidentiality and Security of the Data
Th"! issue of confidentiality was particularly important in this study as the data
were name identified for follow-up over seven weeks and because the research
office was not at the study site, necessitating transportation of confidential data.
Particular care was taken in the design of the data collection forms to make it
possible to facilitate follow-up by name as well as to be able to completely remove
name-identification before removing forms from the Department. This was
achieved by making the patient identification label removable as can be seen in
Appendix F. Once in the research office the data collection forms were stored in a
locked area, separate from the consent forms and master-list of participants' code
numbers.
Risks and Benefits
The risks to participants in the study were minimal, as there was no change
to the care given from nursing, medical or radiation therapy staff and the weekly
observations were timed to coincide with treatment on the linear accelerators. The
only difference was the extra time necessary to complete the consenting
procedures and the interview. Only one person, approached to join the study,
refused on the grounds of time.
Many participants commented that being in the study had reassured them.
They felt that having their skin observed so closely meant that any adverse affect
would be detected ear1y and they would receive the help they needed straight
away.
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Another serendipitous benefit from participation was the opportunity for
participants to talk to someone who was not directly involved with the hospital
processes, but who was knowledgeable of them. Several times the interview time
was extendea due to the participant needing to tell the story of their diagnosis and
other related events. Two women were referred, with their permission, to
professional counsellors due to the distress they were suffering related to their
diagnosis and other problems.
The fact that there were no withdrawals from the study suggests that any
inconvenience involved in the research process were balanced by the benefits
perceived by participants.
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CHAPTER FOUR
RESULTS
This chapter presents the results of the two principal research objectives:
Firstly, to test the theoretical relationships between factors that may impair healing
and the severity of radiation skin reactions; and second, to develop a model to
predict radiation skin reactions in women being treated for breast cancer.
The chapter is organised by these objectives following the description of the
sample and each variable.

Descriptive Analysis

Demographic Variables
The sample comprised 126 wcmen commencing the standard protocol of
radiotherapy following surgical lumpectomy of breast cancer. The age variable was
nonnally distributed with a mean of 53.22 years (SD = 10.64, Range= 30- 78
years).
Sample statistics of demographic variables are shown in Table 4.1 with
comparative figures for the female population in Western Australia fl/'/A) from the
1996 census (Australian Bureau of Statistics [ABS], 1997). A typical participant in
the study would be 53 years old, married (or in a long term de facto relationship),
with

at least a high school education although their current occupation would be

classified as home duties. The participant would own or be purchasing her
residence and have a weekly income of $311.
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Table 4.1
Percent Distribution of Participants According to Sample Demographics for
Comparison with General Population Statistics
Demographic Item

Sample (n = 126)

WA Population

Marital Status
2.4

*8.4

79.4

*67.9

Separated

0.8

4.8

Widowed

7.1

8.7

Divorced

10.3

10.1

Never married
Married/de facto

Education/qualification
Primary school

3.2

Lower secondary

31.8

Trade/secretarial

24.6

Upper secondary

13.5

Degree/diploma

20.6

Higher degree

4.8

}

42.9
23.2

}

8.6

Accommodation
Own home/flat

87.3

66.7

Rent home/flat

10.3

29.0

Other e.g. Nursing
home
Mean weekly income

4.3
$311

$307

* The ABS figures do not include de facto relationships as a separate category. Therefore,
some people in de facto relationships would respond as "never married"

Occupational status was not reported in the census data in a fom, comparable

with the study and does not appear in the table. The largest occ1.1pational group was
"home duties' (34.1%} followed by clerical (19.8%), retired (16.7%} and professional
(14.3%). The remaining participants classified themselves as unemployed, unskilled
workers, students or skilled tradespeople.
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Postal codes were used to determine the socioeconomic status of the sample
using the 1996 census results (ABS, 1997). Results showed the sample had a mean
weekly household income of $311 . In comparing the demographic data from the
sample with the population statistics from WA (ABS, 1997), the sample was
reasonably representative of the general female population on most items, including
income.

Radiation Construct
The organisation of the remainder of this section is based on the conceptual
framework. The radiation factors: dose, doses per fraction. number of fields and
treatment techniques were identical for all participants (see Chapter Three for
details). It was possible for only two radiation factors to vary: overall length of time
taken to complete the course of radiotherapy and the energy used for the treatment.
The mean number of days taken was 38 days (SD= 2.84, range= 34- 57 days).
The mean number of days for the electron boost was 14.7 days (SD= 1.54, range=
10 - 20 days).
The other variation was the energy used for the treatment; 114 (95%)
participants received their photon dose at an energy of 6MV and the remainder at
4MV. The majority received an electron boost to the scar of 9- 16 12Meve· (Table

4.2).

Results 78

Table 4.2
Percent Distribution of Participants According to Radiation Energy Levels Used for
Electron Boost Treatment
Percentage of Participants

Energy (MeVe}

6

5.1

9

28.0

12

41.5

16

18.6

20

6.8
100.0

Total

Genetic Construct
Two items, a personal and/or a family history of cancer, represented
secondary measures of genetic disposition to cancer and radiosensitivity.
Personal History of Cancer
The majority of the sample (82.5%} had not had cancer before; 15% had one
previous epi.:-J:ide of cancer and 2.5% had more than one previous episode. The
types of cancer reported are summarised in Table 4.3.

Table4.3
Frequency and Percent Distribution of Participants According to Types of Previous
Cancer (N = 126).
Cancer Type

Frequency of Participants(%)

Skin C<:1ncers (including melanoma)

13 (52%}

GynaecologiC<:11 (cervix, uterus)

7 (28%)

Breast C<:1ncer

3 (12%)

Other

2 ( 8%)

Total

25 (100%)
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Overall, 21 participants reported 25 cancers. Of these, 13 participants
reported having skin cancer including two cases of melanoma. A history of skin
cancer was a particularly important variable on the basis that the development of
skin cancers indicated significant sun damage to the skin. The criterion used to
detennine a history of skin cancer was a confinned medical diagnosis and
treatment. All of these had received treatment for skin cancer including liquid
nitrogen, laser treatment, surgical removal and 5-Fluorouracil cream. Given the fact
that medical treatment had been given, the diagnosis of skin cancer was taken as
positive. There was no significant difference in age between participants with a
history of skin cancer and those without a history of skin cancer as tested by an
independent sample t-test.
Family History of Cancer
Overall, 69% of p....1rticipants reported having one or more first or second
degree relatives with a history of cancer. More than one quarter (26.4%) reported
having one relative with cancer and a further 25.6% reported they had two. The
remaining 10% had had between three and ten relatives with cancer.
Just over one third (39%) of participants reported a family history of breast
cancer. The majority of these (67%) had one relative affected. Two participants
reported four and five family members refipectively.

Personal Construct - Disease-Related Factors
All participants had undergone lumpectomy for breast cancer. Histology
reports revealed that the majority of tumours were Infiltrating Ductal Carcinoma
(66%). The next largest group was Lobular Carcinoma (15.9%) with two participants
{1.6%) having both Infiltrating Ductal and Lobular Carcinoma. The remaining
tumours were classified as Adenocarcinoma (3.1 %}, Infiltrating Cribifonn Carcinoma
(1.6%), Medullary Carcinoma (0.8%) and Mucinous Carcinoma (0.8%). In 10.3% of

Results 80

pathology reports specific histology typing was not reported. The recommended
practice for the classification of histology type states that the tumour is ductal unless
otherwise specified (Australian Cancer Network, 1997). Also, adenocarcinoma is
listed as ductal meaning that a total of 79.4% of the tumours were ductal. Published
figures. such as the European study of 861 describing early stage breast cancers in
Kurtz et al (1989), suggest that 82% of breast cancers are ductal, suggesting that
this sample was relatively typical of the breast cancer population.
Almost three-quarters (73%) of tumours were staged at surgery as Stage I,
and one participant was classified as tumour in-situ. The next largest group was
Stage II with 21.4% of participants.
Most participants (79%) began their radiotherapy within eight weeks of
surgery. The remaining 21% were delayed in starting by: chemotherapy (13%);
infection (1.6%); lymphocele (4.8%); one participant (0.8%) was being treated tor
recurrence 12 months following surgery; and one (0.8%) delayed by choice.

Personal Construct- Treatment-Related Factors
Variables in the treatment-related factors' section of the Personal Construct
focused on the condition of the surgical scars, axillary lymph node clearance, tr,..
development of a lymphocele, and chemotherapy treatment.
Scar Condition Scale
The condition of the lumpectomy scars of the majority of participants (97.6%)
was classified as good with the scar healing and fading. The remaining 2.4% of
lumpectomy scars were still inflamed. Almost one third of participants (31%) did not
have a separate scar in the axilla from clearance of axillary lymph nodes. Of the
remaining 87 participants, 97. 7% of the axillary scars were healing well and fading.
The scar was still inflamed in one particioant and there was a haemoserous
discharge from the scar of another.
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Axillary Lymph Node Clearance
The majority of participants (84.9%) had one or more axillary lymph node
removed for pathology with a mean of 9.38 nodes (SD= 5.96 nodes, Range= 039). Of the 104 participants with nodes removed 20 (19.2%) had one or more nodes
affected by cancer with a mean of 2.75 nodes affected (SD= 2.43, Range 1 - fl).
Lymphocele Drainage
Over half of the participants (55.6%) did not develop a lymphocele that
required draining by needle aspiration following surgery. Table 4.4 details the
frequency of needle aspirations. Seven participants required that straight drainage
be re-commenced after going home due to the build-up of lymph fluid.

Table 4.4
Perc.ent Distribution of Participants According to the Number of Needle Aspirations
for Lymphocele (N = 126)
Number of Aspirations
None

Percentage of Participants
55.6

1

9.5

2

7.1

3

6.3

4

4.8

5

5.6

~

11 .1

6 (including those recommenced on
straight drainage)
Total

100.0%

Chemotherapy for Breast Cancer
Participants receiving chemotherapy were classified into two groups.
1. those who had four cycles of Etoposide and Cyclophosphamide (EC) over
three months prior to radiotherapy and a further three cycles of
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Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) concurrently
with radiotherapy; and
2. those who had six cycles of CMF beginning at approximately the same
time as their radiotherapy.

An independent sample t-test analysis revaaled that those participants
receiving chemotherapy were significantly younger than those not receiving
chemotherapy for breast cancer (t (124) = 2.10, p = 0.038).

Personal Construct- General Health Factors
The variables included in the general health section of the Personal Construct
were those specifically relating to factors known to impair wound healing.
Chronic Illness
More than half of the participants (52.4%) reported having current chronic
illness with 22% reporting two or more diagnoses. In total, 21 diagnoses were
reported but none were classified as radiosensitive conditions. The most commonly
occurring chronic illness was osteoarthritis (16.7%) followed by hypertension
(15.2%), followed by asthma and cardiac conditions an equal third (10.6%).
An independent sample t-test analysis revealed, as expected, that participants
with chronic illness were significantly older than those reporting no chronic illness (t
(124)

=-4.62, p =0.000). An independent sample t-test analysis also revealed that

participants with a current chronic illness were significantly higher in weight than
those reporting no chronic illness (t (123) = -2.66, p = 0.009).
Prescribed drugs, Self medication and Complementary medicines
The majority of participants (62.7%) were taking prescribed medications on a
regular basis. However, none of these drugs had a possible side effect of
photosensitivity. Only two participants were taking drugs that could impair healing;
these were steroids taken regularly for asthma. One fifth of participants were taking
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Tamoxifen as part of their treatment for breast cancer. This group were significantly
older than participants not taking Tamoxifen as tested by an indepenrtent sample ttest (t (124) = -4.66, p= 0.000)
Participants were asked an open-ended question to report their use of overthe-counter pharmaceuticals and complementary medicines. To assist data
collection. three categories were given to determine the purpose or effect of the
medicine; for general health, to aid healing, and as an anticancer treatment
Participants could nominate to which of these categories the medicine belonged or
explain its use in their own words. No new categories were formed. In total, 74
(58.7%) of participants were self-medicating or taking complementary medicines
prescribed by a naturopath. Of these, 58 (78.4%) were taking these medicines to
improve their general health, 15 (20.3%) were taking them to aid healing and 16
(21.6%) were taking them as complementary anticancer treatments.
Participants classified the reason for taking complementary medicines
differently. For example for some taking antioxidants was for their general health
and for others it was an anticancer treatment. Details of the complementary
medicines taken by participants can be found in Appendix J. In addition to taking
complementary medicines two participants were receiving acupuncture as an
anticancer treatment concurrently with radiotherapy.
The Relationship between Chronic Illness and Medication Use
Chi-square analysis revealea a significant association between the chronic
illness and the use of prescribed medications, with both the dichotomous prescribed
medication variable

(x.2 (1) =142.48, p =.000) and the three level prescribed

medication variable

(x2 (2) =184.32, p =.000). There was no association between

reporting a chronic illness and taking complementary medicines, which is confirmed
by the finding that the majority of participants were taking these medications to
improve general health. There was, however, a significant association between
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taking prescribed medications and complementary medicines(/ (1) = 9.52, p-=
.002).
Smoking History
Just over half of the participants (521 % ) had a history of smoking. For the
analysis, smoking history was collapsed into a three-level variable, with 45 (47.9%)
in the never smoked group, 36 (38.3%) in the ex-smoker group, and 13 (13.8%) in
the current smoker group. All the ex-smokers. except one, had quit more than 12
months prior to commencing radiotherapy. Of the current smokers nine (69.2%)
smoked 15 or less cigarettes per day, two (15.4%) smoked 20 cigarettes per day,
and two (15.4%) smoked 40 cigarettes per day.
Alcohol Intake
The majority of participants (64.3%) reported that they consumed alcohol.
However, just over half of all participants (55.6%) indicated they had decided not to
drink during treatment
Nutritional Status
Nutritional status was indexed by body weight in kilograms, height in
centimetres and by intake as assessed by the nutrition subscale of the Braden Scale
(1992). The mean weight of the sample at commencement of radiotherapy was
66.9kg (SD= 13.4, range= 42 -112kg). The weight variable was normally
distributed.
Measurement of height was taken to establish the body mass index (BMI) of
participants. BMI was then classified into three groups for further analysis, 9.6% of
participants were underweight (BMI < 20), 69.1% were of normal weight (BMI 20 25), and 21.3% were overweight (BMI > 25).

Results 85

Important to nutritional status is any recent change in weight. The range of
reported weight change in the sample was from -13 kg to+ 12kg although 57 4%
had not changed their weight since diagnosis
The majority of participants had an "excellent" intake of food (81 4 % )
according to the Braden Scale assessment of nutritional intake. Of the remainder.
17% reported an "adequate" intake and only 1.6% had a "probably inadequate"
intake. No participants were assessed as having a ·very poor" intake
In addition to nutritional intake, participants were asked if they had changed
their diet since being diagnosed with breast cancer. Only 9.6% reported a change in
diet. The changes consisted of a reduced intake of fats and red meat, and an
increased intake of fibre through fresh fruit and vegetables.
Breast Size
Breast size was indexed by the brassiere size and cup size. The range of
brassiere size was size 10 to 22 with almost two thirds of the sample being size 12
or 14. The frequencies for cup size are shown in Table 4.5.

Table4 5
Percent Distribution of Participants According to Brassiere Cup Size and the
Dichotomous Breast Size Variable (N = 124)
Cup Size

Percentage of Participants

A

13.0

B

31.7

C

30.1

D

17.1

.:: DD

8.1

Total

100.0%
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Personal Construct - Skin Condition Factors
Skin Condition and Allergies
Participants rated the skin condition in the treatment ar~a as oily. normal or
dry. The majority (78.6%) rated their skin as normal, 19% rated it as dry and the
remainder (2.4%) rated their skin as oily.
Le~.s than half the sample (42.1 %) reported having skin allergies Most
avoided contact with the allergen but rated the severity of the reaction if it did occur
to be mild (31%), moderate (41.1%) or severe (27.7%). Participants reported allergic
reactions to a variety of substances including foods, plants. make-up, detergents
and jewellery. In addition. 36.5% reported a family history of skin allergies.
Skin Reaction to UV Radiation.
Results of participants' reports of their skin reaction to UV radiation as
measured by the Fitzgerald Scale are shown in Table 4.6.

Table 4.6
Percent D1strip_ution of Participants According to Skin Reaction to UV Radiation (N =
126).
Fitzgerald Scale

Percentage of Participants

1

12.7

2

18.3

3

35.7

4

29.4

5

4.0

6

0.0

Total

100.0%

Results 87

Cumulative UV Radiation Exposure
This variable was first analysed by examining frequencies for each item of the
scale (see Table 4.7) Scores of the two items of the child exposure subscale
(possible score range 2 - 7) and three items of the adult subscale (possible score
range 3 - 10) were calculated and combined into a total score being the sum of the
five items (possible score range 5 - 17). The mean of the child exposure subs ca le
was 5.6 (SD= 1.4 range= 2 - 7) The mean of the adult exposure subscale was 5.5
(SD= 1.5 range= 3 - 9). The mean of the total UV exposure scale was 11.2 (SD=
2.4 range= 6 - 16).

Table 4.7
Percent Distribution of Participants According to Individual Items on the Cumulative
UV Radiation Exposure Scale (N = 126)
Item

Percentage of Participants

Free time as a child spent in:
1. Indoor activities
2. Indoor and outdoor activities
3. Outdoor activities

12.7
42.9
44.4

Sun protection as a child used
1. Almost always
2. Often
3. Sometimes
4. Almost never

4.0
16.7
65.9

Work as an adult was {or is) mainly
1. Indoors
2. Both indoors and outdoors
3. Outdoors

81.7
16.7
2.0

Free time as an adult spent in:
1. Indoor activities
2. Indoor and outdoor activities
3. Outdoor activities

18.3
55.6
26.3

Sun protection as an adult used
1. Almost always
2. Often
3. Sometimes
4. Almost never

36.5
23.8
19.8
19.8

13.5
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The impact of the sun on the skin is dependent on the geographic location and
residents of Australia are known to come from a wide range of countries. Therefore.
participants were asked the predominant place they lived as a child and an adult
More than half of the participants (52 4%) had lived in Perth as a child and as an
adult. The next largest group were those who lived in the UK and Europe (34.3%) as
a child, but spent most of their adult life in Australia. The mean length of time lived in
Australia was 41 years (SD= 18 years, range= 2 - 76 years)

Analysis of Whole Breast Radiation Treatment (Weeks One to Five)

Description cf the RTOG Scores Weeks One to Five
KTOG scores for the dependent variable for each anatomical area are shown
in the following figures by week of treatment One week of treatment is equivalent to
five daily fractions of radiation. For the first five weeks the daily dose is 1.8 Gy.
Thus, the doses for week one were 1.8 Gy to 9 Gy; week two were 10.8 Gy to 18
Gy; week three are 19.8 Gy to 27 Gy; week four are 28.8 Gy to 36 Gy; week five

were 37.8 Gy to 45 Gy. Results for weeks six and seven, which are the 10 days of
electron boost to the scar, are presented later in the chapter.
RTOG Scores for Weeks One and Two
In week one, no participants scored RTOG 2 or more with the vast majority
scoring "O" for all anatomical sites except the nipple. One participant scored RTOG 2
in week one; this was related to inflammation of the lumpectomy scar that was
located v'9ry close to the nipple. In week two, three participants scored RTOG 2 on
the nipple; two participants had more severe reactions on the sternum, two in the
inframammary fold; and one in the axilla, UOQ and LIQ areas.
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RTOG Scores for Week Three
In week three, as expected, a number of participants showed signs of a more
severe skin reaction Figure 4 I illustrates the RTOG scores over the eight sites for
the third week of treatment. The more severe reactions categorised as a RTOG 2
score or higher, were not common The site with the most frequent severe reactions
was the sternum (17 participants). The description in the comments accompanying
the data colle'"'tion report the sternum reactions to be follicular rashes with some
blistering noted. The second most frequent site for severe reactions was the axilla
with 13 participants demonstrating more severe reactions at this location.

-

Site of Reaction
IDRTOGO fil!RTOG 1 DRTOG2

I

lnfram = lnframammary Fold
Figure 4.1 Frequency Distribution of Participants According to RTOG Scores by
Anatomical Site for Week Three of Treatment
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RTOG Scores for Week Four
The frequency of more severe radiation skin reactions increased

in

week four

as expected Figure 4 2 illustrates the distribution of RTOG scores. Patchy moist
desquamation, indicated by scores of RTOG 2.5, began to appear during week four
of treatment The areas affected were the axilla, UOQ and the inframammary fold
areas. Skin loss on the sternum was different to the other areas, as the blistering
reaction, noted in week three, broke down and oozed serous fluid The reactions in
the axilla, UOQ and inframammary fold were typical radiation moist desquamation
reactions.
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RTOG Scores for Week Five
The frequency of patchy moist desquamation (RTOG 2.5) increased again
during week five of treatment. In addition, confluent moist desquamat,on (RTOG 3)

was recorded for the first time in the ax1lla and UOQ reactions. Figure 4.3 illustrates
the distribution of RTOG scores for week five.
Patchy moist desquamation in the sternum area continued to be the result of
the blister reaction noted in earlier weeks. The number of participants with patchy
moist desquamation and confluent moist desquamation also increased in the axilla
and inframammary reactions.
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Frequency of Moist Desguamation
Patchy moist desquamation (RTOG 2.5) occurred n four sites during the
course of treatment: the sternum. axilla, UOQ and inframammary fold. Two of these
sites, the axilla and UOQ. recorded the occurrence of confluent moist desquamatton
(RTOG 3). Figure 4.4 illustrates the time trends for the development of moist
desquamation in this sampl6 for the four sites. The figure includes the weeks of the
electron boost to consider the pattern of moist desquamatinn over the full treatment
time.
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14 +---------------------,,...C..---""~-----1
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8

+----------------+-7"i::....c..---:;....;._~'"'""'=:~---I
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4 +-------------~;.L----------:::,,,..-=.:.........:::::__---1
2

+-----------::;,,.-,,,:;;;._ _;_:____--=_~=-------I

0

+-----,------,-----,,..----,-----,-----,----week 1

week2

!

week 3

-<)- Sternum

week 4

week 5

---§-Axilla -i&- UOQ

week 6

week 7

"""*- Infram j

Figure 4.4 Time Trends for the Development of Patchy or Confluent Moist
Desquamation in the Four Most Affected Sites

The pattern that emerged was as expected with skir loss reported in all four
sites by week four. Skin loss in the sternum began in week three, but healed by
week seven, an understandable pattern, as electron boosts were not administered
to the sternum.
The axilla had the highest frequency of moist desquamation, peaking in week
six and falling slightly in week seven. Although the axilla was a site for electron
boost treatment, most participants had no treatment to this area in weeks six and
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seven. TJ.,e peak. of the axilla reaction in week six probably indicates a car,y-over
effect from the end of the whole breast treatment completed in week five.
The frequency of moist desquamation in the UOQ showed a steaciy increase
through weeks six and seven. This was expected given the fact that most of the
electron boost treatments in this sample were in the UOQ.
The development of moist desquamation in the inframammary fold site
followed a similar pattern to that of the axilla. Again healing was noted as the
severity of the reaction decreases during week. seven.

Testing the Theoretical Relationships of the Conceptual Framework in Radiation
Skin Reactions during Whole Breast Treatment
To ensure the validity of univariate and multivariate testing, several predictor
variables were re-coded to overcome the problem of empty cells. A standard
approach was taken. First, a dichotomous variable was created with "O" indicating
no and "1" indicating yes. For example if the participant did not have a history of skin
cancer they would score "O", if they did, the score would be 'T. Further subdivision
was tested, however, in all cases this did not reveal any further significant detail.
Table 4.10 details the proportion of scores in re-coded variables.
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Table 4.8
Percent Distribution of Participants According to Re-coded Predictor Variables
--------------------------~----·------------

--

Percentage of Part1c1pants
Predictor Variable

No

Yes

History of Cancer (not skin cancer)

82 5

17 5

History of Skin Cancer

89.7

103

Tumour Stage~ II

73.8

26.2

Aspiration of Lymphocele

55.6

444

Chemotherapy for breast cancer (overall)

87.3

12 7

Chemotherapy commenced concurrently
with radiation

89.7

10.3

Chemotherapy before radiation (part or all
of chemotherapy treatment)

96.8

3.2

74.8

25.2

31.0

69.0

Breast s;ze

~

D cup

Skin ty~ - Fitzgerald scale > 3

Univariate Testing of Potential Predictive Factors during Whole Breast Treatment
The distributions of the RTOG scores were not normal for any of the
anatomical sites in any week. The RTOG scores were re-coded into dichotomous
variable values (D-RTOG). A score of "O" or "1" became 0-RTOG 0, (a mild or no
reaction) and a score of "2" or more became D-RTOG 1, (a severe reaction). Weeks
one and two had extremely few scores in D-RTOG 1. Participants who scored DRTOG 1 in weeks one and two were ali found to have developed a breast infectjon.
Therefore, the univariate testing focussed on weeks three to five only.
For continuous variables, independent sample t-tests were performed to test
relationships between potential predictor variables and skin raactions (D-R TOG
scores). Table 4.9 presents the significant t-test results (ex= 0.10) for weeks three,
four and five. Each predictive factor was tested for association with the 0-RTOG

-
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scores for each anatomical site for each week of treatment. Chi-square analysis was
performed on categorical variables (a= 0.10) (see Tables 410,411and412)

Table 4.9
Significant Relationships between Site and Continuous Predictor Variables for
Weeks Three, Four and Five as Measured by t-test (p-value).
Anatomical Site

Current

Dose

Weight
Week 3 Sternum
Week 3 Axilla

UV child

Total UV

sub-score

score

-1.95 (.053)
-3.06 (.003)

Week3 UOQ

, .96 ( 053)

Week3 UIQ

2.46 (.015)

Week3 LOQ

-1.74 (.085)

Week 3 Nipple

-1,92 (.057)

Week 3 lnframammary
Fold
Week4Axilla

2.52 (.013)
-2,93 (.004)

Week4 UOQ

-2.13 (.035)

Week 5 Axilla

-4.05 (.000)

Week5 UOQ

-2.35 (.021)

-3.11 (.002)

Week5 UIQ

-1.81 (.073)

-4.07 (.000)

Weeks LOQ

-2.22 (.028)

-3.38 (.001)

Week5 LIQ

-2.22 (.028)

-3. 13 {. 002)

Week 5 Nipple
Week 5 lnframammary
Fold

3.09 (.002)

-2.46 (.015)
-3.93 (.000)

Table4.10
Significant Relationships in Dichotomous RTOG Scores for Week Three According to Site as Tested by Chi-square (p-value)
Site

Breast
size

Lymphocele

Condition
of breast
scar

Chemotherapy
befora
radiation

Concurrent
chemothsrapy

r-amily
history of
cancer

Chronic
illness

Smoke

Stage~ II

Tamoxifen

6.33 (.01)

3.61 (.08)

5.94 ( 01)

UOQ

2.79 (.09)

10.88 (.00)

3.76 (.05)

UIQ

5.75 (.02)

7.88 (.00)

5.53 (.02)

3 73 (.05)

LOQ

4.02 (.04)

9.26 (.00)

4.52 (.03)

2.98 (.08)

LIQ

2.79 (.09)

10.68 (.05)

3.76 (.00)

Inframamma!Y_

3.35 (.07)

History of
skin
cancer

444 ( 04)

7.74100)

-

Sternum

Axilla

Skin-type

3.50 (.06)

5.39 (.07)

2.99 (.08)

3.59 ( 06)

3.61 (.06)

11.19 ( 00)

;:o
(T)
Cl)

C
;:::;
(/1

tO

CJ)

Tabla4.11
Significant Relationshi(,!s in Dichotomous RTOG Scores for Week Four According to Site as Tested b~ Chi-sguare (Q-value)
Site

Alcohol
intake

Breast size

Chemotherapy

Concurrent
chemotherapy

Chemotherapy
before
radiation

Condition
of breast
scar

Sternum

Skin-type

Family
history of
skin
allergies

3.70 (.05)

Axilla

15.48 (.00)

uoa

8.74 (.00)

4.91 (.03)

History of
skin cancer

Smoke

15.80 ( 00)

4.80 (.03)

599( 01)
2. 79 (.09)

4.83 (.03)

UIQ

6.23 (.04)

5.16 (.02)

3.74(05)

LOQ

6.52 (.04)

5.53 (.02)

2.74 (09)

4.96 ( 03)

6.00 ( 05)

LIQ

6.52 (.04)

4.96 (.02)

5.53 (.02)

2.73 ( 09)

4 96 (03)

6.00 ( 05)

Nipple

5.52 (.06)

4.29 (.04)

Inframamm

3.07 (.08)

Tamoxifen

2.81 ( 09)
5.42 (.02)

5.26 (.02)

6.32 ( 04)

::0
<l)

1/)

C:
;:::;:
1/)

<.O
-..j

Table4.12
§igniflQ:.@nt Relatlonshlgs in Dichotomous RTOG Scores for Week Five According to Site as Tested b~ Chi-sguare {12-value}
Site

Breast size

Smoke

History of
cancer-not
skin

Lymphocele

History of
skin
allergies

Tamoxifen

11.24 ( 00)

Sternum
Axllla

5.46 (.02)

3.18 (.07)

3.21 (07)

uoo

9.14 (.00)

4.81 (.09)

3.22 (.07)

UIQ

5.68 (.02)

UV
protection
used as an
adult

6 85 ( 08)

3.16 (.08)
3.30 (.07)

LOQ

7.89 (.00)

5.25 (.04)

LIQ

3.02 (.08)

8.95 (.01)

Nipple

3.02 (.08)

8.70 (.01)

4.51 (.03)

17.34 (.00}

14.10(00)

5.57 ~.01)

lnframammary

History of
skin cancer

2 86 ( 09)

3.67 ( 06)

::0
(1)

C/l

C:

cii
U)

OJ
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Testing for Potential Covanates
A potential source of covariance was the nursing interventions used as
standard practice dunng the course of radiation therapy Particularly 1mport~nt was
the use of creams and emollients The premise for using these products was to
promote patient comfort. There is no empirical evidence to date that suggests that
creams used have a significant impact on reducing the severity of the skin reaction.
In addition. the governing principle for deciding which cream is used and how often.
is patient preference.
The null hypothesis that there was no significant association between using
cream and the severity of skin reaction was tested by Chi-square analysis for weeks
three, four and five at each site. No significant associations were detected for any of
these tests, indicating that cream use was not associated with the severity of the
skin reaction.

Development of Predictive Models for Radiation Skin Reactions during Whole
Breast Treatment
Logistic regression analyses were conducted on the D-RTOG scores for each
anatomical site for weeks three to five. The predictive value of all independent
variables, identified from the conceptual framework, was tested by stepwise logistic
regression analysis on the D-RTOG score for each site. Due to the exploratory
nature of the study a variable entry level was set at ex: = 0.10 and removal level was
set at ex:= 0.15 (Tabachnick and F1d8II, 1996). This prevented the premature
deletion of variables that may be clinically significant even if not reaching the usually
accepted oc = 0.05 level for statistical significance. This decision increased the
likelihood of Type II errors in hypothesis testing, meaning that there could be an
increased chance of false positive results. This is an acceptable clinical error in the
case of radiation skin reactions as it represents a cautious approach.
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Results from the week five reactions are presented first as week five
represents the main effect of radiation on the skin in the treatment area during whole
breast irradiation The results for the sternum reaction are used as a full example of
the method of interpreting logistic regression analysis including the calculation of
relative risk and the interpretation of confidence intervals.
Week Five Prediction Models
The D-RTOG scores recorded during week five represent the reactions
experienced during the last five doses of whole breast treatment (Dose range= 28.8
Gy - 45 Gy). In most cases, these reactions will not become any more severe
following the last dose, except for the site of the electron boost treatment. Thus. the
results of the stepwise logistic regression analysis for the radiation skin reactions
observed at each site in week five represents the prediction of the worst radiation
skin reaction experienced during whole breast irradiation.
Week five sternum reaction results.
Data from all 126 women were available for analysis: 74 (58.7%) had a score
of D-RTOGO and 52 (41.3%) scored D-RTOG1. Of the variables tested, two entered
the model: history of skin cancer and age. These two factors correctly predicted
97.3% of cases with mild or no reactions, and 26.92% of cases with severe
reactions giving an overall accuracy of 68.25% for the model.
The use of a Chi-square test (Tabachnick & Fidell, 1996) determines whether
the model is a significant improvement over the observed frequencies alone. This is
expressed as a significantly reliable model. The model for the week five sternum
reaction was significantly reliable when compared with the constant only model,
x.2{2)

=14.407, p =0.000, indicating that the predictors, as a set, reliably

distinguished between the 0-RTOGO and 0-RTOG 1 scores. Table 4 .13 shows
details of the regression analysis for each of the two predictors.
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Table 4.13
Logistic Regression Results for the Week Five Sternum Reaction
Variables

B

SE

Wald

OF

Sig

R

Exp{B)

95%CI

History of
skin cancer

2.462

.808

9.272

1

.002

.206

11.723

2.404 57.170

Age (per
year)

-.030

.018

2.713

1

.099

-.064

{Constant2

1.020

.973

1.099

1

.294

.970

.9381.006

From these results, the relative risk of developing a more severe sternum
reaction in week five is 11. 7 times greater in an individual with a history of skin
cancer when compared with an individual with no history of skin cancer.
Relative risk calculation.
The regr ~ssion equation for calculating the probability of experiencing a more
severe skin reaction in the sternum is:

where

Using the week five data, estimates of model parameters give the regression
equation:
z = 1.0202 + 2.4616(skin cancer) -0.0303(age)

For example, consider an individual who has a history of skin cancer and who
is 60 years of age. The calculation for the probability of developing a severe skin
reaction on the sternum during week five of treatment is as follows:
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As the individual has a history of cancer, the value of X, (where O = no history
of cancer and 1 = history of cancer) is 1 and the.· value of X2 (age in years) 1s 60,
then:

z = 1.020 + (.461(1) -0 030(60)

= 1 6638

The probability of a S.£!vere skin reaction is then

e' 6638

ez
=

1 + ez

=

~~16683

= 0.8407

In other words this individual r.as an 84% likelihood of developing a score of
D-PTOG = 1, that is a standard RTOG score of ::: 2, in week five of treatment.
If the probability of me individual developing a severe reaction is 0. 841, then
the probability of not developing a severe skin reaction is therefore:

1 - 0.8407 = 0.1593

Comparing these probabilities, the odds ratio (or risk) of developing a severe
skin reaction is:

0.8407: 0.1593 = 5.227: 1

Therefore, this 60-year-old individual with a history of skin cancer is 5.227
times more likely to develop a severe skin reaction than not to develop a severe skin
reaction.
Consider now an individual of the same age who does not have a history of
skin cancer. The calculation for the probability of developing a severe skin reaction
on the sternum during week five of treatment is as follows:
As the individual has no history of cancer, the value of X, (where O = no
history of cancer and 1 = history of cancer) Is O and the value of X 2 (age In years) is

60, then:

z = 1.020 + 2.461(0) -0.030(60) = -.7978
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e· 1g10

ez
=

1+e

1

=

1 + e·

19e

= 0.3105

In other words. this individual has only a 31% likelihood of developing a score

of D-RTOG = 1, that is a standarti RTOG score of ::: .'"_2, ir.

·P ~k

five of treatment

The probability of the individual not developing a severe skin reaction is,
therefore:
1 - 0.3105 = 0.6895

Comparing these probabilities, the odds ratio of the individual developing a
severe skin reaction, or not developing a severe reaction, is:
0.3105 : 0.6895 = 0.4503 : 1

Therefore, a 60-year-old individual who does not have a history of skin cancer
is only 0.4503 times more likely (meaning the individual is less than half as likely) to
develop a severe skin reaction, than not to develop a severe skin reaction.
The effect of the history of skin cancer is to increase the odds, or risk, of a
severe skin reaction from 0.4503 : 1, to 5.227 : 1
thus:
5.227 I 0.4503 = 11.7233

= exp (2.4616)

The relative risk of a severe skin reaction, therefore, is 11.7233 times greater
for an individual with a history of skin cancer. The relative risk is calculated
automatically by the computer and can be found in the Exp(B) column of Table 4.13.
As the stepwise logistic regression resulted in a regression equation with no
significant interaction term, the relative risk of a history of skin cancer on developing
a severe reaction is constant for all ages. Thus, the relative risk of 11 .7233 applies
for individuals of all ages, not just a 60-year-old.
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The process is the same for calculating the impact of age on the seventy of
the skin reaction. In this case, the inverse relationship between age and the sternum
reaction. shown by t.'le negative B result. means that as age increases the relative
risk of a severe skin reaction reduces.
For example, consider an individual with no history of skin cancer who 1s 30
years of age. The calculation for the probability of developing a severe skin reaction
on the sternum during week five of whole breast treatment is as follows:
As the individual has no history of cancer. the value X, (History of skin cancer)

= 0 and the value of X2 (age)= 30,
then:

z = 1.0202 + 2.4616(0) - 0.0303(30) = 0.1112

The probability of a severe skin reaction is:
eo 1112

=

1+

=

eo1112

05277

In other words this individual has a 52.7% likelihood of developing a severe
skin reaction.
If the probability of the individual developing a severe reaction is 0.5277, then
the probability of not developing a severe reaction is:

1 -0.5277

=

0.4723

Comparing these probabilities, the odds ratio or risk of devel0ping a severe
skin reaction is:

0.5277 : 0.4723 =

1.1173 : 1

Consider then the individual in the previous example who was 60 years of age
and had no history of skin cancer. Recall that the risk of developing a severe
reaction for this individual was 0.4503: 1.
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To compare the effect of agr between a 60-year-old and a 30-year-old the
odds ratio, or risk. of a severe skin reaction 1s
0 4503 I 1 1173 = 0 4030

In the example calculating the relative risk of a severe skin reaction due to
having a history of skin cancer, this final result would represent the relative risk, or
Exp(B). as listed on the table (11 723). However, the calculation of the relative risk
with a continuous variable differs from the calculation of 2n indicator (dummy)
variable in that the relative risk accounts for the effect of one year only. This means
that the relative risk for a specific age difference is the relative risk per year raised to
the appropriate power. Thus to calculate the relative risk of an age difference of 30
years (60 - 30 years) the Exp(B) must be raised to the power of 30.
then,
0.9701 30

=

0.4030

This means that when no history of skin cancer is reported, the 60 year old
individual is less than half as likely to develop a severe skin reaction in week five
than a 30-year-old individual.
In a similar way, each logistic regression table lists the estimates of model
parameters specifying the regression equation enabling the ca!culation of the
probability of a severe skin reaction for any individual. In addition, each listed value

of the relative risk (Exp(B)) enables us to summarise the effect of each factor on the
likelihood of developing a severe skin reaction.
Confidence intervals.
Confidence intervals for logistic regression analysis are calculated for the
estimated exponential B values (Exp(B)) or relative risk. It must be remembered that
Exp(B) values and the limits of confidence intervals are in an exponential scale
therefore the Exp{B) value does not fall in the middle of the interval but closer to the
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lower limit. Also. when the estimated Exp(B) value is large, then consequently the
confidence interval will be large. In the sternum reaction model for week five, history
of skin cancer has a large estimated Exp(B) value and this is reflected in the wide
range for the confidence interval.
Other than these points, the usual rules for interpretation stand. The
coniidence interval is testing that:
B

~

1

Therefore, 1.he confidence interval should not include "1". Occasionally the
lower limit of the confidence interval is less than 1.00 as in the case of "age" in the
week five sternum reaction model. The,e are three potential explanations for this
finding. A lower confidence interval limit of < 1.0·J can result from:
1. A small estimated Exp(B) value{< 1.00).
2. Accepting a significance level of 0.10 for entry of predictors to the model
has weakened the statistical power for testing that predictor.
3. The predictive factor being represented by a small number of participants
resulting in a loss of statistical power to detect the effect of the predictor.

The first two of these explanations apply to "age" in the sternum reaction
model; the Exp(B) value is less than 1.00 and the significance level for age is 0.099.
Week five axilla reaction results.
After deletion of one case due to missing values, data from 125 women were
available for analysis: 63 (50.4%) had a score of D-RTOGO and 62 (49.6%) scored
D-RTOG1. Two variables entered the model: lymphocele aspirated and current
weight. These two variables correctly predicted 76.19% of cases with mild or no ski: 1
reactions and 69.35% of severe reactions, giving ari overall accuracy of 72.80% of
cases overall. The model was signfficantly reliable when compared with the constant
only model,

x2(2) =19.872, p =0.0000, indicating that the predictors, as a set,
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- - - - - - - - - - - - - - - - - - - - - · · - - - · · - - - - - ~ ~ - ~ - - -"--~-reliably distinguished between the D-RTOGO and D-RTOG1 scores Table 4 14
shews details of the regression analysis for each of the two predictors
Table 4.14
Logistic Regression Results for the Week Five Axilla Reaction
Variables

B

SE

Wald

DF

Sig

R

Exp(B)

95%CI

Lymphocele
aspirated

.788

.395

3.984

1

.046

.107

2.199

9324.322

Weight (per
kilogram)

063

.017

13.189

1

.000

.254

1 065

1.028 1.098

{Constant}

-4.530

1.194

14.384

1

.000

Those participants who had developed a lymphocele requiring drainage had a
relative risk c,f developing a more severe skin reaction 2.2 times greater than those
who did not. The relative risk is based on the weight of the participant in kilograms,
therefore the relative risk of developing a more severe reaction increases 1.065
times per kilogram increase in weight. Thus the magnitude of the impact of weight
on severity of skin reaction becomes more apparent.
The equauon for calculating the probability of experiencing a more severe skin
reaction in the axilla then, is:
e -4.5301 •. 1sa2(lymphocels> • o.0626(weighl>

1 + e -4.5301 •. 1aa2(lymphocels> •

o.DE26(welQht)

It is possible to compare the impact of these two predictors despite one being
an indicator variable {lymphocele aspiration) and the other being continuous {weight
in kgs), to answer the question: what weight difference corresponds with the risk
associated with having had a lymphocele aspirated?
The process illustrated in the calculation of relative risk for an age difference is
also used in this example. The relative risk of a severe skin reaction is ExpB =
1.0648 which means that the relative risk of severe skin reaction for a weight

Results 108

difference of dkg (where d = difference in weight) 1s 1 0646d To calculate the impact
of weight compared with the impact of lymph drainage, then the value of d must be
calculated when
2.1995
That is when
d = *In 2, 1995 / In 1 0464

=

12.6
*In = natural log

The effect of an increase in weight of 12.6 kg is equivalent, in risk, to an
indh ::::ual who has had a lymphocele aspirated. That is an individual who is 72.6 kg
in weight, but has not had a lymphocele aspirated, has the same risk of developing
a severe skin reaction as an individual who is 60 kg in weight but has had a
lymphocele aspirated. This calculation illustrates the magnitude of the weight
variable on the development of severe skin reactions.
Week five upper outer quadrant (UOQ) reaction results.
After deletion of three cases due to missing values, data from 126 women
were available for analysis: 86 (68.2%) had a score of D-RTOGO and 37 (31.8%)
scored D-RTOG1. Five variables entered the model: breast size, dose group,
lymphocele aspirated, smoking and stage. Dose was re-coded (dose group) into
dichotomous variable values with 37.8 Gy to 43.2 Gy (fractions 1-4 in the Slh week of
treatment)

=0, and 45 Gy (5th fraction in the 5th week of treatment) =1. This was

done to account for a non-normal frequency distribution for dose and the need to
estimate risk for the highest dose received in the whole breast treatment.
These five variables correctly predicted 88.24% of mild ~r no skin reactions
and 42.11 % of severe skin reactions giving an accuracy of 73. 98% overall. The
model VJas significantly reliable when compared with the constant only model, x2(6)

=24.463, p =0.0004, indicating that the predictors, as a set, reliably distinguished

Results 109

between the D-RTOGO and D-RTOG1 scores Table 4 15 shows details of the
regression analysis for each of the five predictors
Table 4.15
Logistic Regression Results for the Week Five

uoq Reaction
Exp(B)

95%CI

131

2.788

1.0937.112

.047

.113

2.856

1.0158.042

1

.026

.140

2.840

1.1357.105

3.000

1

.083

.081

2.343

.8946.150

6.670

2

.036

.133

OF

Sig

4.610

1

.032

.528

3.949

1

1.044

.468

4.974

.852

.492

Variables

B

SE

Breast size

1.025

.478

Dose group

1.050

Lymphocele
aspirated
Stage group

*Smoking

Wald

R

Ex-smoker

0.480

.481

0.994

1

.320

.000

1.620

.6304.150

Current
smoker

1.780

.692

6.615

1

.010

.174

5.930

1.53023.019

25.122 1
-2.491 .500
.0000
{Constant}
*Reference group for smoking is the "never smoked" group

For breast size, where the cup size is "D" or more, the risk of having a more
severe reaction is almost three times greater than if the cup size is "A, 8 or C". The
last fraction of the whole breast treatment (45 Gy), increases the risk of severity by
almost three times. For women who have had a lymphocele aspirated one or more
times, the relative risk of a more severe reaction is almost three times greater than if
no drainage was performed. For those participants whose tumour was stage II or
greater at surgery, the relative risk of developing a more severe reaction in week
five is over twice as great than for participants who were stage I or tumour in situ.
This result must be considered with cautioun as the confidence includes 1. The
smoking predictor reveals a slight increase in risk for ex-smokers but a high relative
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risk six times greater for those smoking through treatment than for those who have
never smoked. The confidence interval includes 1 for the ex-smokers, however the
ex-smoker group was not at significant nsk
The lower limits of the confidence intervals for stage group and ex-smokers
are both less than 1.00. In the case of these two predictors the explanation lies in
the significance level being> 0.05 for entry into the model. In the case of exsmokers the significance level is 0.320 and is included in the model only as a level
of the smoking variable.
The equation for calculating the probability of experiencing a more severe skin
reaction in the

uoa is:
e -2 .491 •

1 025{Breast :...tu) • 1 050{Dose gcoup) • 1 044 (Lymphocele)

• 0.48Q(Ex-smoker) • 1 78Q(Current smdwr) • 0.0521Staqe)

1+ e -2.491

+

1 025{Breasl size)

+

1 050(Dos8 oroup) • , 044 (Lymphooole)

• 0.480(fa-smolcer) • 1 780(Curref11 smelter)• 0.052(S1.lge)

Week five upper inner quadrant (UIQ) reaction results.
After deleting three cases due to missing values, data from 123 women were
available for analysis: 86 (68.2%) had a score of D-RTOGO and 37 (31.8%) scored
D-RTOG1. Three variables entered the model: breast size, dose group, and
lymphocele aspirated. These variables correctly predicted 97.70% of mild or no
reactions, and 25.00% of severe rractions giving an accuracy of 76.42% of cases
overall. The model was significantly reliable when compared with the constant only
model, x2(4)

=13.100, p =0.0108

indicating that the predictors, as a set, reliably

distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.16 shows
details of the regression analysis for each of the three predictors.
The prediction model for the radiation skin reaction in the UIQ is similar to that
of the UOQ except the factors smoking and stage did not enter the model. The
relative risks indicate that the larger breast size is over twice as likely to have a
more severe reaction; receiving the last fraction of treatment (45 Gy) has a relative
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- - - - - - - - - - - - - - - - - - - - - · - - - - · - · · · · · · - ··--------------risk two times greater than the fractions given on the other four days of week five
{i.e. 37.8 - 43.2 Gy). Lymphocele aspiration increases the relal!ve risk for this site
by two times The confidence intervals for all three variables include 1. and
therefore. must be viewed with caution The significance level for all three variables
was> 0.05 and this probably explains the lower limit of the confidence levels

Table 4.16
Logistic Regression Results for the Week Five UIQ Reaction
Variables

SE

B

Wald

OF

Sig

R

Exp(B)

95%CI
.9435.655

Breast size

.837

.457

3.357

1

.067

.096

2 310

Dose group

.875

.501

3.050

1

.081

.084

2.398

.8996.399

Lymphocele
aspirated

(Constant}

.772

.421

3.367

1

.067

-1.853

.379

23.888

1

.000

.096

2.166

.9494.944

The equation for calculating the probability of experiencing a more severe skin
reaction in the UIQ is:

e -1.eso. o.837(Bmaat sizaJ • o.s75(l)ose groupJ • o 1n<Lymphocelo>
+
1 e ·t.650• 011Ji<Brmst sizoJ • o.87S(l)osegroupJ. o.in(LJTTll)hoc:elaJ
Week five lower outer quadrant (LOO) reaction results.
Tnree cases ware deleted due to missing values, therefore data from 123
women were availab:S for analysis: 91 (73.9%) had a score of 0-HTOGO and 32
(27.1%) scored D-RTOG1. Two variables entered the model: breast size and
smoking. These variables correctly predicted 96.67% of mild or no reactions and
6.06% of severe reactions, giving an accuracy of 72.38% overall. The model was

significantly reliable when compared with the constant only model, x.2(3)

= 0.0076, indicating that the predictors, as a

= 11.942. p

set, reliably distinguished between the
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D-RTOGO and D-RTOG1 scores. Table 4.17 shows details of the regression
analysis for each of the two predictors
The relative risk associated with a large breast size is similar to that seen 1n
both UOO and UIQ reactions The results for smoke group indicate that there is little
additional risk of severe reaction for ex-smokers but over four times the risk for
current smokers. The lower limit of the confidence interval for ex-smokers is < 1
probably because the ex-smoker group did not have a significant level of risk.

Table 4.17
Logistic Regression Results for the Week Five LOO Reaction
Vanables

8

SE

Breast size

1.092

.460

*Smoking
Ex-smoker
Current
smoker

OF

Sig

R

Exp(B)

95%CI

5.642

1

.018

.160

2.981

1.210 7.343

5.327

2

.070

.097

Wald

.282

.477

.350

1

.554

.000

1.325

.5513.372

1.427

.621

5.286

1

.022

.152

4.165

1.23414.058

23.107 1
-1.641 .341
.000
{Constant)
*Reference group for smoking is the "never smoked" group

The equation for calculating the probability of experiencing a more severe skin
reaction in the

LOO is:
e -1.641 + 1.092(Breast size) + 0.282(Ex-smokar) + 1 427(Cummt smoker)
1 + e-1.641 + 1.&ri(ffuimiiiilze) + oiii2(Eic-cmolier) + 1.427(Currenhmoker)

Week five lower inner quadrant (LIQ) reaction results
Three cases were deleted due to missing values therefore data from 123
women ware available for anat ·sis: 90 (73.2%) had a score of D-RTOGO and 33
(27.8%) scored D-RTOG1. Three variables entered the model: breast size,
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lymphocele aspirated and smoking. These variables correctly predicted 93.26% of
mild or no reactions. and 20.59% of severe reactions, g1v1ng an accuracy of 73 17%
overall. The model was significantly reliable when compared with the constant only
model, x2(4) = 19.667. p = 0.0006, indicating that the predictors. as a set, reliably
distinguished between the D-RTOG1 and D-RTOG2 scores. Table 4.18 shows
details of the regression analysis for each of the three predictors.

Table 4.18
Logistic Regression Results for the Week Five LIQ Reaction
Variables

B

SE

Breast size

1.191

.471

.886

.476

Lymphocele
aspirated

*Smoking
Ex-smoker

.192

.487

OF

Sig

R

Exp(B}

95%CI

6.389

1

.012

.174

3.289

1.307 8.278

3.468

1

.063

.101

2.426

.9556.168

9.569

2

.008

.196

.155

1

.694

.000

1.211

.466-

Wald

3.146
Current
smoker

2.067

.679

9.284

1

.002

.224

7.904

2.091 29.881

22.693 1
-2.117 .445
.000
{Constant~
*Reference group for smoking is the "never smoked" group

The model is similar to the LOO reaction, with a relative risk over three times
greater for those with a larger breast size. The lymphocele group had a relative risk
of over twice that of the no lymphocele group. It should be noted that the lower limit
of the confidence interval < 1. Again, the ex-smokers have a small but nonsignificant increase in risk of severe skin reaction, but the current smoker's risk is
eight times that of the never smoked group.
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The regression equation for calculating the probability of experiencing a more
severe skin reaction in the LIQ is

e

1

-2 117 • I 191{Broasl Silo) • 0

886(Lymphocekl) • 0

192(Ex-smoker) • 2 067(Cuttem smolcm)

+ e -2 117 • I 191(B<oast sue) • 0 886{lymphocelo) • 0 192/Ex-imoker) • 2 067/Curu,nt amolu,,j

Week five nipple reaction results.
Data from 126 women were available for analysis: 86 (68.2%) had a score of
0-RTOGO and 40 {32.8%) scored D-RTOG1. Only one variable entered the model:
smoking. This model correctly predicted 92.86% of mild or no reactions and 23.81 %
of severe reactions, giving an accuracy of 69.84% overall. The model was
significantly reliable when compared with the constant only model, /(2) = 7.461, p =
0_0240, indicating that the predictor ;eliably distinguished between the 0-RTOGO
and D-RTOG1 scores. Table 4.19 shows details of the regression analysis for the
single predictor.

Table4.19
1,_Q£istic Regression Results for the Week Five Nipple Reaction
Variables

B

SE

*Smoking
Ex-smoker
Current
smoker

Wald

OF

Sig

R

7.131

2

.028

.140

Exp{B)

95%CI

.399

.425

.884

1

.347

.000

1.491

.6493.427

1.569

.588

7.121

1

.008

.179

4.804

1.51715.213

-1_059 .282
14.144 1
.000
{Constant}
*Reference group for smoking is the "never smoked" group

The model for predicting the nipple reaction differs fmm the reactions of the
four quadrants of the breast, in particular, in that the size of the breast did not
predict the severity of the reaction. The ex-smokers had a slightly increa:,ed relative
risk although again, not significant, of one and a half times that of never smokers.
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The confidence interval reflects this. as the lower limit is < 1 The nsk is significantly
increased for current smokers who had an almost five times greater risk of a more
severe reaction.
The regression equation for calculating the probability of experiencing a more
severe skin reaction in the nipple is:
e .f 059 • 0 399(Ex-smoker) • 1 S69(Curren1 smoker)
1 + e -1 059 • 0 399(Ex-w>Olwr) • 1 S69(Curren1 smoker)

Week five inframammary fold reaction results.
Three cases were removed due to missing values therefore data from 123
women w~re available for analysis: "'8 (63.4%) had a score of D-RTOGO and 45
:6.6%) scored D-RTOG1. Two variables entered the model: breast size and

smoking. This model correctly predicted 90.91% of mild or no reactions and 47.83%
of severe reactions giving an accuracy of 74.80% overall. The model was

significantly reliable when compared with the constant only model, /(3) = 31.080, p

= 0.0000, ind:cating that the predictors, as a set, reliably distinguished between the
D-RTOGO and D-RTOG1 scores. Table 4.20 shows details of the regression
analysis for each of the two predictors.
The relative risk of developing a more severe skin reaction in the
inframammary fold was increased over five times with a large breast size. It is
notable that for skin reactions in the inframammary fold, ex-smokers showed a
significantly increased risk of severe reaction of three times over the never smoked
group. Those participants smoking through treatment had over ten times the risk of
the never smokers.
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Table 4.20
Logistic Regression Results for the Week Five lnframammary Fold Reaction
Variables

B

SE

Wald

DF

Sig

R

Breast size

1.687

.482

12.282

1

.001

.252

13.479

2

.001

.241

Smoke
group

Exp(B)

95%CI

5.406

2.104 13.890

Ex-smoker

1.142

.458

6.233

1

.013

.161

3.134

1.2787.681

Current
smoker

2.316

.690

11.261

1

.001

.239

10.139

2.621 39.223

.000
-1.715 .351
23.907 1
{Constant~
*Reference group for smoking is the "never smoked" group

The equation for calculating the probability of experiencing a more severe skin
reaction in the inframammary fold in week five is:

e -1.715 + 1.687(Breast size)+

U42(Ex-$1'10ker) + 2.316{Cumml smolal<)

1 .,.. e -1.ns + 1.M?(8i'east &IZS). 1.142(Ei-srnofuirj. 2.316(Cuiren1 smoiaiij

Week Four Prediction Models
The reactions recorded for week four represent the dose range of 28.8 Gy 36 Gy. A score of 0-RTOG 1 (standard RTOG > 2) during week four represents an
early severe reaction. Thus the prediction models developed by stepwise logistic
regression produce factors that indicate the likelihood of an earlier reaction
occurring in an individual. Dose group was categorised in a simUar way as week
five with 28.8 Gy - 34.2 Gy as the reference group (0) and the last dose of the
week, 36 Gy being grouped as 1.
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Week four sternum reaction results.
Data from 126 women were available for analysis: 89 (70.6%) had a score of
0-RTOGO and 37 (29 4%) scored D-RTOG1. Two variables entered the model
dose group and history of skin cancer. These variables correctly predicted 96.63%
of mild or no reactions and 27.03% of severe reactions, giving an accuracy of
76.19% overall. Dose group in week four represents the last fraction of week four of
the whole breast treatment (36 Gy). The model was significantly reliable when
compared with the constant only model, /(2) = 18.212, p = 0.0001, indicating that
the predictors, as a set, reliably distinguished between the 0-RTOGO and 0-RTOG 1
scores. Table 4.21 shows details of the regression analysis for each of the two
predictors.

Table 4.21
Logistic Regression Results for the Week Four Sternum Reaction
Variables

8

SE

Wald

OF

Sig

R

Exp(B)

95%CI

Dose group

.994

.493

4.068

1

.044

.116

2.701

1.0287.092

History of
skin cancer

2.334

.705

10.960

1

.001

.242

10.322

2.59241.110

{Constant}

-1.379

.257

28.750

1

.000

A history of skin cancer is an important predictor in the model for week four
sternum reactions. The relative risk for a history of skin cancer is 10.3, which is very
similar to the week five model. The difference seen here is that the dose factor,
rather than age, entered the model in week four. The last fraction of treatment in
week four more than doubles the relative risk of a severe skin reaction.
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The equation for calculating the probability of experiencing a severe skin
reaction in the sternum in week four is

e ·1 4o56 • 0 8410{Do,w, group) • 2 4514/Slun cancer)
1 + e -l 4656 • o8410(Dos.o group) • 2 4514(Skln cance1>

Week four rucilla reaction results.
Three cases were deleted due to missing values, therefore data from 123
women were available for analysis: 95 (77.2%) had a score of D-RTOGO and 28
(22.8%) scored D-RTOG1. Three variables entered the model: breast size,
chemotherapy, and lymphocele aspirated. These variables correctly predicted
92.55% of mild or no reactions and 41.38% of severe reactions, giving an accuracy
of 80.49% overall. The model was significantly reliable when compared with the
constant only model, x2(3)

=18.726, p =0.0003, indicating that the predictors, as a

set, reliably distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.22
shows details of the regression analysis for each of the three predictors.

Table4.22
Logistic Regression Results for the Week Four Axilla Reaction
Variables

B

SE

Wald

OF

Sig

R

Exp(B)

95%CI

Breast size

1.553

.477

10.614

1

.001

.253

4.726

1.85712.032

Chemotherapy

1.101

.619

3.160

1

.075

.093

3.008

.89310.125

.766

.466

2.702

1

.100

.072

2.150

.8635.356

-2.222

.402

30.482

1

.000

Lymphocele
aspirated

(Constant}

The model differs slightly from the week five model in that breast size has
replaced weight a larger breast size increases the relative risk of a more severe
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skin reaction by three times. Chemotherapy also entered the model, indicating that
when having chemotherapy for breast cancer the relative risk of having a severe
radiation skin reaction is three times as great. This result must be viewed with
caution, as the lower limit of the confidence interval is < 1. The impact of lymphocele
aspiration is very similar to that in the week five model at just over two times the
relative risk. Again, it should be noted that the lower limit of the confidence interval is
< 1.

The equation for calculating the probability of experiencing a more severe skin
reaction in the axilla in week four is:
e·2.222 + 1.553(Broast size)+ 1 101(Chemolherapy) • 706{Lymphocele)

1 + e·2.222 + 1.S53{8reasl size)+ 1 101(Chemolherapy) +

706(Lymphocele)

Week four UOQ reaction results.
Three cases were deleted due to missing values therefore data from 123
women were available for analysis: 100 (81.3%) had a score of D-RTOGO and 23

(18.7%) scored D-RTOG1. Two variables entered the model: breast size, condition
of the breast scar. These variables correctly predicted 99.00% of mild or no
reactions and 8. 70% of severe reaction, giving an accuracy of 82.11 % overall. The
model was significantly reliable when compared with the constant only model,

x2(2)

=10.315, ,) =0.0058, indicating that the predictors, as a set, reliably distinguished
between the D-RTOGO and D-RTOG1 scores. Table 4.23 shows details of the
regression analysis for each of the two predictors.
The model is quite different for UOQ reactions in week four compared with
week five. Breast size is the only predictor that is the same; interestingly the relative
risk also remains similar. The condition of the breast scar as a predictor indicates
that if the lumpectomy scar is inflamed or discharging at the commencement of
treatment, then the risk of a severe skin reaction in week four is over 1O times

greater.
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The lower limit of the confidence interval for "Condition of the breast scar" is
less than 1. 00 and is probably due to there being only three participants with
inflammation or infection in the scar at the commencement of radiation The high
upper limit of the confidence interval for this predictor reflects the high relative risk

Table 4.23
Logistic Regression Results for the Week Four UOQ Reaction
Exp(B)

95%CI

.206

3.741

1.4129.911

.100

10.122

.799128.144

Wald

OF

Sig

R

.497

7.046

1

.008

2.315

1.295

3.194

1

.074

-1.988

.322

38.104

1

.000

Variables

B

Breast size

1.319

Condition of
breast scar

{Constant}

SE

The equation for calculating the probability of experiencing a more severe skin
reaction in the UOQ in week four is:

e· 1.988 + 1.319(Breasl size)+ 2.315{Condition of br82st scar)
1 + e· 1.988 + 1.319(8,easl size)+ 2.315{Condition of bmasl scar)

Week four UIQ reaction results.
Three cases were deleted due to missing values therefore data from 123
women were available for analysis: 101 (82.1%) had a score of D-RTOGO and 22
(17.9%) scored D-RTOG1. Two variables entered the model: breast size and
condition of the breast scar. These variables correctly predicted 99.01% of mild or
no reactions and 9.09% of severe reactions, giving an accuracy of 82.93% overall.
The model was significantly reliable when compared with the constant only model,
x2{2) = 8.809, p = 0.012, indicating that the predictors, as a set, reliably
distinguished between the 0-RTOGO and D-RTOG1 scores. Table 4.24 shows
details of the regression analysis for each of the four predictors.
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Table 4.24
Logistic Regression Results for the Week Four UIQ Reaction
Wald

DF

Sig

R

.504

5.386

1

.020

3.350

1.287

3.333

1

.068

-1.990

.322

38.144

1

.000

Variables

B

Breast size

1.171

Condition of
breast scar

(Constant)

SE

Exp(B)

95%CI

.171

3.225

1.2008.669

.107

10.483

.841130.615

The predictors entering the model for the UIQ: breast size and condition of the
breast scar, are the same as for the UOQ in week four. The levels of relative risk
associated with the predictors are also very similar. Again, the confidence interval
includes 1 for "condition of the breast scar".
The regression equation for calculating the probability of experiencing a
severe skin reaction in the UIQ in week four is:

e·1.990 + 1.171(Bnlast size)+ 3.3SO(Condilion al broa$1 scar)

1 + 0 -i .990 •

1.111{8roasl size) + J.350(Condllion a1 breast s.car>

Week four LOQ and LIQ reaction results.
Please note that the results for LOQ and LIQ reactions are identical. They are
therefore presented together. Three cases were deleted due to missing values,
therefore data from 123 women were available for analysis: 103 (83.7%) had a
score of 0-RTOGO and 20 (16.3%) scored D-RTOG1. Three variables included in
the model: breast size, condition of the breast scar, and smoking. These variables
correctly predicted 96.08% of mild or no reactions and 14.29% of severe reactions,
giving an accuracy of 82.11 % overall. The model was significantly reliable when
compared with the constant only model,

x.2(4) =12.874, p =0.012, indicating that

the predictors, as a set, reliably distinguished between the 0-RTOGO and 0-RTOG 1
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scores. Table 4.25 shows details of the regression analysis for each of the three
predictors.

Table 4.25
Logistic Regression R.3sults for Week Four LOQ and LIQ Reactions
Variables
Breast size

SE

B

.900

Wald

OF

Sig

R

2.709

1

.095

.084

2.460

3.506

1

.0611

.115

13.727

5.457

2

.065

.114

Exp(B)

.5390
Condition of
breast scar

2.619

1.399

Smoking

95%CI
.8567.077
.885212.962

.665

.593

1.258

1

.262

.000

1.944

.6096.214

Current
smoker

1.490

.706

5.447

1

.019

.175

5.190

1.30220.691

(Constant)

-2.490

.464

28.869

1

.000

Ex-smoker

The equation for calculating the probability of experiencing a more severe skin
reaction in the LOO and the LIQ in week four is:

e-2.490 + .900(broozt size) + 2.61S{condition of lifcaSI &ear) + .665(ox-smoker) + 1.490(currenl smok.er)

1 + e-2.400 + llOO(bri,ssi sizo) + 2.619(c:ondlilon of breast scar) +

.66S(ox~ + 1.490(curmnl smoker)

Week four nipple reaction results.
Data from 126 women were available for analysis: 98 (79. 7%) had a score of

D-RTOGO and 25 (20.3%) scored D-RTOG1. With the standardised approach to the
logistic regression, a model that significant1y improved the prediction of severe skin
reactions to the nipple was not found.
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Week four inframammary fold reaction results.
Data from 126 women were available for analysis: 98 (77 7%) had a score of
D-RTOGO and 28 (22.3%) scored D-RTOG1. Two variables entered the model,
chemotherapy and smoking. These variables correctly predicted 96.94% of mild or
no reactions and 14.29% of severe reactions, giving an accuracy of 7, 57% overall
The model was significantly reliable when compared with the constant only model.
x.2(3) = 10.709, p = 0.0134, indicating that the predictors, as a set, reliably
distinguished between the 0-RTOGO and D-RTOG1 scores Table 4.26 shows
details of the regression analysis for each of the two predictors.

Table4.26
Logistic Regres.. ,on Results for the Week Four lnframammary Fold Reaction
Variables

B

SE

Chemotherapy

1.306

.584

Smoking

OF

Sig

R

Exp(B}

95%CI

5.006

1

.025

.150

3.692

1.17611.593

6.349

2

.042

.133

Wald

.692

.503

1.8SS

1

.169

.000

1.998

.7465.323

Current
smoker

1.563

.629

6.182

~

'

.~13

.177

4.773

1.39216.363

(Constant)

-1.974

.380

27.033

1

.000

Ex-smoker

The regression equa!ion for calculating the prcl:!.9C'ility of experiencing a more
severe skin reaction in the lnframammary Fold in week four is:
Ef1.974 +1 ~+ 0.692(Ex-cmokef)

1 + 8 -1.s1.o •

+

1.563(CUmm1 smoker)

i.306(C1lemalfuipy). o.002cex-<11t101mr>. 1.563(Current iimoimr>
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Week Three Prediction Models
Although very few participants scored D-RTOG 1 during week three. a logistic
regression analysis was attempted in order to determine if any predictors could be
proposed to identify very early reactions. The reactions recorded for week three
represent the dose range of 19.8 Gy- 27 Gy.
Week three sternum reaction results.
Data from 126 women were available for analysis: 109 (86 5%) had a score of
0-RTOGO and 17 (22.4%) scored D-RTOG1. One variable was included in the
model: history of skin cancer, and correctly predicted 100.00% of mild or no
reactions and 0.00% of severe reactions predicted 86.51% of cases overall. The
model was significantly reliable vlhen compared with the constant only model, /(1)

=5.879, p =0.0153, indicating that this predictor reliably distinguished between the
0-RTOGO and D-RTOG1 scores. Table 4.27 shows details of the regression
analysis.

Table4.27
Logistic Regression Results for the Week Three Sternum Reaction
Variables

B

SE

Wald

OF

Sig

R

Exp(B)

95% Cl

History of

1.660

.647

6.590

1

.010

.215

5.260

1.481 -

skin cancer

(Constant)

18.685

-2.130

.305

48.671

1

.000

A history of skin cancer entered the model as it did in the models of both
weeks four and five. The relative risk is noticeably lower in this model, indicating that

the relative risk of a severe reaction is just over six times greater in those with a
history of skin cancer. The relative risk was calculated at 10 and 11 times greater in

the models for weeks four and five respectively.
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The equation for calcuiating the probability of experiencing a more severe skin
reaction in the sternum in week three is

e -2 130 • , 660!~ o1 •kin canoot>
+
1 e·2 1Jb. 1 •6So(Ai5tiiv a aJn cance<1
Week Three Results for the Remainder of the Sites
The frequency of D-RTOG 1 scores were small in week three, therefore the
predictive models produced through logistic regression were not significantly reliable
when compared with the constant only model for each site.
One variable, lymphocele group, consistently appeared in the models as
significantly related to the severity of skin reactions in week three, as detennined by
the Wald statistic. The lymphocele group appeared in the model for reactions in the
axilla, and all four quadrants of the breast The size of the breast variable was also
significantly related to the severity of the skin reaction in the UIQ and LOO sites.

Analysis of Electron Boost Treatment

Description of RTOG Scores in Weeks during Electron Boost Treatment

The results of the RTOG scores for weeks six and seven are displayed in
Figures 4.5 and 4.6 respectively.
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The highest frequency of moist desquamation (RTOG ~ 2) occurred in week
six. 'Mlen comparing Figure 4.4 and 4.5, it can be seen that the frequency of RTOG

O scores increase and the frequency of RTOG 1 scores decrease concurrently m
week seven indicating that overall there was healing and recovery during the last
week of the boost treatment
Over half of the participants (55.6%) had their lumpectomy scar, and thus their
boost, in the UOQ of the breast. The frequency distribution for lumpectomy scars is
detailed in Table 4.28.

Table4.28
Frequency and Percent Distribution of Participants According to the Site of
Lumpectomy Scar
Site of Lumpectomy Scar

Frequency(%) of Participants

UOQ

70 (55.6%)

UIQ

19 (15.1%)

LOO

10 ( 7.9%)

Central scars (including the nipple)

1O { 7. 9%)

Across both UOQ & axilla

9 ( 7 .1 % )

LIQ

6 ( 4.8%)

Axilla

3 ( 2.4%)

_ln_fra_ma_m_m_a_ry....._F_o_ld_ _ _ _ _ _ _ _ _1_{...__0_.S_o/c~o).___ _ _ _ _ _ _ _ __

The severity of the reaction only continues to increase at the site of the
lumpectomy scar, where the electron boost is delivered. At the remainder of sites

the reaction diminishes as healing progresses. Given this fact, it was not logical to
include all sites in the analysis, as the diminishing reactions in most cases would

confound the results. Therefore, for the purposes of analysis, only participants
whose lumpectomy site was located in the UOQ, the UOQ and axilla, or the axilla

were inciudad (N = 82, 65.1% of total sample).
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Univariate Testing of Potential Predictive Factors Related to Severe Skil" Reactions
during the Boost Treatment
Chi-square analysis was performed on dichotomous and categorical predictor
vanables and the D-RTOG scores for week six and seven. The analysis was
confined to those participants with the boost treatment in the axilla and/or the UOQ
of the breast Tables 4.29 and 4.30 present the results of the Chi-square analysis for
weeks six and seven respectively.
For continuous variables, t-tests were performed to test relationships between
potential predictor variables and skin reactions {D-RTOG scores). In week six.
participants with a more severe axilla reaction had a significantly higher mean

=-3.96, p =.000). as did participants with a more severe UOQ
reaction (t (72) =-2.17, p =.033).

weight (t (72)

In week seven, participants with a more severe axilla reaction had a
significantly higher mean weight (t (75) = -2.64, p = .010). Participants with a more
severe UOQ reaction had both a significantly higher mean weight {t (74.91)
p

= .002), and a significantly higher mean age {t (75) = -2.40,

counterparts with a mild skin reaction.

= -3.22,

p = .019) than their

Tabla4.29
Sigaifi~nt Rel~tionshlRS in Qichotomous RTOG Scores for Week Six According to Site as Testeg by Chi-~uare (g:value}
Site

Alcohol

intake
(p-value)

Breast
Size
(p-value)

Boost
energy
(p-value)

Family
history of
breast
cancer
(p-value)

Family
history of
cancer
(p-value)

Lymphocele
group
(p-value)

History
of
previous
cancer
<e-value)

6.86
(.009)

5.11

4.49

(.024)

(.034)

3.13
(.077)

Smoker
current
or ex(p-value)

Smoke
group
(p-value}

D-RTOG
Axilla
weeks
(p-value)

0-RTOG
UOQ
week 5
(p-value)

Week6
Axilla

UOQ

11.17
(.001)
6.81
(.033)

4.09

(.043)

12.68
(.013)

2.71
(.099)

10.66)
(.001)

3.46

(.063)
9.76
(.002)

11.51
(.003)

20.83
(.000)

Table4.30
Significant RelationshlQs in Dichotomous RTOG Scores for Week Seven According to Site as Tested by Chi-§Quare (~-value}
Age
group

Breast
size

Boost
energy

3.35
(.067)

Axilla

Chronic
Illness

Alcohol
intake

Hypertension

Smoker
current
or ex-value

Smoke
group
(p-value)

Skin
condition

D-RTOG
Axilla
week6

0-RTOG
UOQ
week6

14.01
( 000)

4.10
(.043)

::0
t1)

fl)

UOQ

7.164
(.028)

9.27
(.056)

5.55
(.062)

3.36
(.067)

6.93
(.008)

7.69
(.021)

5.63
(.060)

5.64
{.018)

C
;:;
fl)

.....
I'.)

co
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Development of Prediction Models for Radiation Skin Reactions during Electron
Boost Treatment
Week Six Prediction Models
Week six represents the first week of electron boost treatment following the
completion of 45 Gy to the whole breast The electron boost is delivered to the
tumour bed located under the lumpectomy scar plus a small margin of tissue
surrounding the area. As can be seen from the description of the RTOG scores,
those areas not included in the boost site begin to heal.
Week six axilla reaction.
Following the deletion of eight cases due to missing values, data from 74
women were available for analysis: 37 (50%) had a score of D-RTOGO and 37
(50%) scored D-RTOG1. Two variables were included in the model: lymphocele
aspirated and current weight. These variables correctly predicted 83.78% of mild or
no reactions and 75.68% of severe reactions, giving an accuracy of 79. 73% overall.
The model was significantJy reliable when compared with the constant only model,
x2(2)

=22.066, p =0.0000, indicating that the predictors, as a set, reliably

distinguished between the D-RTOGO and D-RTOG1 scores. Table 4.31 shows
details of the regression analysis for each of the two predictors.

Table4.31
Logistic Regression Results for the Week Six Axilla Reaction
Variables

B

SE

Wald

DF

Sig

R

Exp(B)

95%CI

Lymphocele
aspirated

1.531

.584

6.885

1

.009

.218

4.623

1.47314.506

Current
weight

.105

.029

12.906

1

.000

.326

1.111

1.0491.176

(Constant)

-7.487 2.010

13.880

1

.000
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Those participants who had developed a lymphocete requiring drainage had a
relative risk of developing a more severe skin reaction 4.6 times greater than those
who did not. The relative risk is based on the weight of the participant in kilograms
The relative risk value appears small but it represents an increase per kilogram
increase. Thus the magnitude of the relative risk is quite large.
The equation for calculating the probability of experiencing a more severe skin
reaction in the axilla is:
e·7.4873 + I 5130{1ymphocele) + 01050(weigh1)

1 + e·1 asn. 1.s13b(F,,nphocele). o 1056(we1111J1>
Week six UOQ reaction.
Following the deletion of 8 cases due to missing values, data from 74 women
were available for analysis: 41 (59.4%) had a score of 0-RTOGO and 28 (40.6%)
scored D-RTOG1. Two variables entered the model: boost energy and skin-type.
This model correctly predicted 90.91% of mild or no reactions and 43.33% of severe
reactions, giving an accuracy of 71.62% overall. The model was significantly reliable
when compared with the constant only model, x2(2)

=19.008, p =0.0001, indicating

that the predictors, as a set, reliably distinguished between the 0-RTOGO and DRTOG1 scores. The lower energy levels of the electron boost treatment (6 - 12
MeVel were not associated with a severe reaction so "boost energy" was re-coded
into a dichotomous variable where 6 - 12 Meve·

=O and 16 -

20 Meve·

=1. Table

4.34 shows details of the regression analysis for each of the two predictors.
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Table 4.32
Logistic Regression Results for the Week Six UOQ Reaction
Variables

B

SE

Wald

OF

Sig

R

Exp(B)

95%CI

Boost
energy

2.822

.848

11.059

1

.001

.301

16.802

3.18688.621

·Skin-type

1.858

.814

5.209

1

.023

.179

6.414

1 30031.645

9.108 1
.003
-2.398 .795
Constant
*Reference group was sensitive response to the sun
The relative risk of a severe reactions was over 16 times greater if the boost
was at the higher energy levels. The skin-type variable predicted that those with a
nom,al or insensitive response to UV (Fitzgerald scale = 4 - 6) had a relative risk of
almost six times greater than participants with sun-sensitive skin (Fitzgerald scale =

1 -2).
The equation for calculating the probability of experiencing a more severe skin
reaction in the axilla is:

e· 2.398 • 2.S22(boosl enerov>. 1.s58(s1on4ype)
1 + e· 2.398 + 2.822(boOSI energy)+

1 858(slan-type)

Week Seven Prediction Models
Week seven axilla reaction.
Following the deletion of five cases due to missing values, data from 77
women were available for analysis: 45 (58.4%) had a score of D-RTOGO and 32
(41.6%) scored D-RTOG1. Two variables were included in the model: lymphocele
group and current weight This model correctly predicted 77. 78% of mild or no
reactions and 50.00% of severe reactions, giving an accuracy of 66.23% overall.
The model was significantly reliable when compared with the constant only model.
x2(2) = 9.455, p = 0.0088, indicating that the predictors, as a set, reliably
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distinguished between the 0-RTOGO and D-RTOG1 scores. Table 4.33 shows
details of the regression analysis for each of the two predictors.

Table 4.33
Logistic Regression Results for the Week Seven Axilla Reaction
Variables

B

SE

Wald

OF

Sig

R

Exp(B)

95%CI

Lymphocele
aspirated

.832

.510

2.668

1

.102

.080

2.298

.8476.239

Current
weight

.061

.023

6.941

1

.008

.217

1.063

1.0161.112

1.608

8.487

1

.004

{Constant}

-4.685

Those participants who had developed a lymphocele requiring drainage had a
relative risk of developing a more severe skin reaction over two times greater than
those who did not. It should be noted that the confidence interval includes 1 for this
predictor. The relative risk is based on the weight of the participant in kilograms,
therefore the relative risk of developing a more severe reaction increases slightJy per
kilogram increase in weight
The equation for calculating the probability of experiencing a more severe skin
reaction in the axilla is:

e-4.6850 + .roz2(lymphocela aspiralod) + o.0608{weigh1>

1 + e-4.6850 + .83ti(lympfucelc aiip/raied) + o.~>

Week seven UOQ reaction.
Following the deletion of five cases due to missing values, data from 77
women were available for analysis: 33 (42.8%) had a score of D-RTOGO and 44
(57.2%) scored D-RTOG1. Only one variable was included in the model: current
weight This model correctly predicted 51.52% of mild or no reactions and 72.73% of
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severe reactions, giving an accuracy of 63.64% overall. The model was significantly
reliable when compared with the constant only model, /(1) = 9.378, p = 0.0022,
indicating that the predictor reliably distinguished between the D-RTOGO and DRTOG1 scores. Table 4.37 shows details of the regression analysis for the single
predictor.

Table 4.34
Logistic Regression Results for the Week Seven UOQ Reaction
Variables

B

SE

Wald

DF

Sig

R

Exp(B)

95% Cl

Current
Weight

.067

.024

7.876

1

.005

.236

1.070

1.021 1.121

Constant

-4.042

1.543

6.862

1

.009

The relative risk is based on the weight of the participant in kilograms.
Therefore, the relative risk for developing a severe skin reaction in the UOQ during
the boost treatment in week seven increases 1.070 times per kilogram increase in

weight.
The equation for calculating the probability of experiencing a more severe skin
reaction in the axilla is:

8

• 4.042 + o.001cweighl)

1 + e· 4.642 + o.ost<wolght>

Pain and Discomfort with Radiation Skin Reactions: Results of the VAS Pain
Scale
Pain was not as great a problem as anticipated during the course of the
radiotherapy. Many participants said that what they felt was discomfort and not real
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pain and chose to report zero on the VAS scale Table 4 35 details the frequencies
of scores on the VAS over the seven weeks of treatment

Table 4.35
Percent Distribution of Participants According to VAS Pain Scores over Seven
Weeks of Treatment
Pain VAS
Week

0

1

1

99.2%

0.8%

2

98.4%

0.8%

3

96.8%

4

92.8%

5

6*

2

3

4

5

6

9

0.8%
2.4%

0.8%

0.8%

0.8%

1.6%

3.2%

87.3%

1.6%

2.4%

3.2%

1.6%

2.4%

0.8%

83.2%

2.7%

6.0%

0.9%

1.8%

1.8%

2.7%

4.4%

0.9%

1.8%

1.8%

2.7%

88.6%
7**
*N=115 **N=114

8

0.8%
0.8%
0.9%

Moderate to severe pain (VAS= 4 -10) appeared in week four with one
participant reporting a score of eight. Week six represents the highest number of
participants reporting pain with 16.5% (19) scoring between one and nine on the
VAS. Figure 4.6 illustrates the similarity in pattern between the pain score over the
weeks of treatment, and the development of radiation skin reaction and moist
desquamation in the axilla.
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Figure 4.7 Comparison of Pain Scores with A>cilla D-RTOG Reactions and Moist
Desquamation over the Seven Weeks of Treatment.

Cross Validation of Predictive Models
To test the validity of the predictive models two random samples of about 40%
of the sample were taken and stepwise logistic regression perfonned using the
same criteria as in the main analysis. A sample of cases was selected randomly by
SPSS using the select cases facility. Random sample 1 had 54 cases and random
sample 2 had 50 cases. The details of the logistic regression analysis for predicting
the severity of radiation reactions in weeks four and five, for these samples, can be
found in Appendix K. Table 4.36 lists the significant predictors from the analysis of

the full sample and the two random samples by site for reactions in week five. Only
week five prediction models were cross validated because with the small numbers in
the random samples, the proportion of severe reactions would be too small to
interpret the predictive models in a meaningful way.

Results 137

The models developed for cross validation were very similar in the predictor
variables to enter the models for each site. This provides an indication of the
trustworthiness of the predictive models developed with the full sample

Table4.36
Comparison of Significant Factors between Analysis of Full Sample and Two
Random Samples for Week Five Reactions

=54)

=126)

Random Sample 1 (N

Sternum
History of skin cancer
Age

Sternum
History of skin cancer
Age

Sternum
History of skin cancer

Axilla
Lymphocele aspirated
Weight

Axilla
Lymphocele aspirated

Axilla
Lymphocele aspirated

UOQ
Breast size
Dose
Lymphocele aspirated
Stage of tumour
Smoking

UOQ
Breast size

UOQ

Lymphocele aspirated

Lymphocele aspirated
Stage of tumour

Smoking

!JJ.Q

!JJ.Q

Full Sample (N

Breast size
Dose
Lymphocele aspirated

Random Sample 2 (N

UIQ

Lymphocele aspirated
Stage of tumour

LOQ
Breast size
Lymphocele aspirated
Smoking

LOQ

LOQ

Smoking

Smoking

!JQ

!JQ

!JQ

Breast size
Lymphocele aspirated
Smoking

Breast size

Breast size

Smoking

Smoking

~
Smoking

Nipple
Smoking

Nipple
Smoking

lnframammaiY Fold
Breast size
Smoking

lnframammarv Fold

lnframammarv Fold
Smoking

=50)
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Summary of Chapter
This chapter has documented the analysis and findings of data collected on
the development of skin reactions in 126 women being treated for breast cancer with
a standard protocol of post lumpectomy radiation. The results show that the
theoretical relationships posed in the conceptual model could be demonstrated
empirically on univariate and multivariate levels. Prediction models for each of eight
anatomical areas of the breast exposed to radiation were wnstructed for skin
reactions during the weeks of treatment to the whole breast area supporting the
proposition that it is possible to estimate the risk of skin reactions for individual
women facing radiotherapy. Prediction models were also constructed for the
electron boost treatment phase for the UOQ and axilla sites.
The validity of the prediction models for week five reactions was tested by
cross validation with two random samples. Comparison between the predictive
models from the full sample and the two random samples indicated a satisfactory
level of validity.
Pain associated with radiation skin reactions was not as severe as expected

with many participants pl'flferring to describe the reaction as discomfort. When pain
was reported it followed a very similar pattern to that of moist desquamation. That is,
when skin loss had occurred, then pain, rather than discomfort, is reported.
The findings reveal that radiation factors alone cannot predict the severity of
radiation skin reactions. The addition of factors from the Personal Construct of the
Conceptual Framework, particularly the impact of smoking, breast size and
lymphocele aspiration, make the prediction model more complete.
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CHAPTER FIVE
DISCUSSION AND CONCLUSION

The principle hypothesis developed and tested in this study is that knowledge
of factors that impair wound healing will contribute to creating a more complete
understanding of radiation skin reactions and make the prediction of individual risk
possible. The ultimate purpose of this study was to develop an instrument for
clinical and research use that would enable nurses to predict the severity of
radiation skl11 reactions on an individual basis. The research focussed on women
with breast cancer as they represented a reasonably homogenous group for

studying such a complex and multifactorial issue.
The development of the prediction instrument was reported in detail in this
thesis, as follows. Chapter One presented an argument for obtaining empirically
based knowledge about the importance of radiation skin reactions in relation to the
preparation of women for treatment. Chapter Two traced the theoretical
relationships between the effects of ionizing radiation on normal skin and the
impact of factors that impair the processes of tissue healing. A model supporting
the following hypothesis was offered: that the severity of radiation skin reactions is
a function of radiation, genetic and personal factors. Chapter Three detailed the
methods and procedures developed to test the hypothesis and Chapter Four
detailed the findings of the research process.
This chapter discussed the study findings in relation to the conceptual
framework and identifies practice implications through the development of a
msttlod of risk prediction for women commencing standard radiotherapy post
lumpectomy. In addition, the chapter includes a critical reflection on measurement
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issues arising from the study and study limitations. A summary of the findings 1s
presented first.

Summary of Findings
Data from a sample of 126 women commencing standard post-lumpectomy
radiation protocol were collected on factors that were potentially predictive of
radiation skin reaction severity. Skin reactions of these women were documented
over the seven weeks of treatment to detennine the relationship between the
predictive factors and the severity of the skin reaction that developed. The sample
was representative of the general population of women in Western Australia on a
range of socio-demographic items. The sample was also similar to the breast
cancer population in disease related factors such as histology of the tumour when
compared with published figures (Kurtz et al., 1989).
Predictive Factors
A review of treatment-related factors revealed that at the time radiation
therapy commenced, the women's surgical incisions at the lumpectomy and axillary
clearance sites were in good condiiion with less than 3% having any inflammation
or haemoserous discharge. Almost half of the sample had required the aspiration
of a lymphocele on one or more occasions post axillary clearance. Indications for
aspiration were: discomfort due to the collection of lymph fluid, and/or a change in
contour of the lateral chest wall due to the accumulation of fluid thus changing the
measurements for accurate administration of ionizing radiation. Only 16
participants were receiving or had received chemotherapy for their breast cancer.
In tenns of general health, over half of the sample had one or more
concurrent diagnoses of chronic illness. None of these illnesses were
radiosensitive and the majority were not identified as illnesses that would impair
healing. Almost two-thirds of the sample were taking prescribed medications, this
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being significantly related to the presence of a chronic illness. In addition, over half
of the sample were self-medicating or taking medicines prescribed by a naturopath
Over three-quarters of these self-medications were vitamin and mineral
supplements and just over one fifth of the sample were taking alternative
medicines for their anticancer properties.
Just over half of the sample had smoked at some time. but only 13 reported
smoking throughout treatment. Alcohol consumption during treatment was reported
by just over half of the sample.
The nutritional status of the participants, as assessed by the nutrition
subscale of the Braden Scale, showed that intake was adequate or excellent in
98% of cases. There was a considerable range in the weight of participants from
42 to 112kg, but the majority had a body mass index in the normal range. The size
of the breast was significantly related to weight as would be expected. The majority
of participants had smaller breast size as defined by brassiere

·c~ cup or smaller.

The condition of the skin was normal ir. almost 80% of cases and less than
half reported problems with skin allergies. In relation to participants' skin responses
to UV radiation, as measured by the Fitzgerald Scale, almost 70% reported a
normal or insensitive response. The mid to high level scores on the Cumulative UV
Scale showed that the sample as a whole had spent their time in the sun
unprotected with a hat, clothing or sunscreen in both childhood and adulthood. The
majority of participants had lived in Perth thus being exposed to the high-intensity
UV radiation for which this area is known.
RTOG Scores
The patterns of skin reaction development followed the expected course, as
described in Chapter Two, with dull erythema with or without dry desquamation
(RTOG = 1) appearing about two weeks after the commencement of radiation. This
was followed by a steady increase with the intensity of erythema becoming bright
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and/or tender with or without moist desquamation (RTOG

~

142

2). The reactions

during electron boost treatment reflected the anticipated change in protocol, with
reactions remaining high or increasing at the boost site and receding elsewhere.
Also as anticipated, the three sites with the most severe skin reactions
(RTOG

~

2) were the axilla, the upper outer quadrant and the inframammary fold.

The severity of the sternum reaction with the blister reaction was not unexpected.
but required less nursing intervention with creams and/or dressings. The blister
reaction is not uncommon with patients treated in the Department. but has not
been reported in the literature. It is this type of variance to the usually reported
reactions that suggests that the chronic sun-exposure of the sternum is
responsible. This phenomenon requires comparison with other geographic areas.
Also as expected, the most severe reactions were recorded during week five
of treatment with confluent moist desquamation being noted in the axilla and upper
outer quadrants. During the two weeks of boost treatment, the reactions generally
began to heal in the areas that were not in the vicinity of the boost. RTOG scores
of two or more were recorded most frequently in week six. Unless actual skin loss
had occurred, skin reactions were not reported to be painful, but rather there was a
heightened awareness of the breast and some discomfort.
Similarities between Prediction Models.
Some clear patterns emerge in the prediction models between the sites of the
breast Table 5.1 summarises the predictors. Most notable is the similarity between
the breast quadrants. The two lower quadrants had identical prediction models in
week four and the same predictors with only slight variation in relative risk values in
week five. In the two upper quadrants. the predictors that entered the models in
week five were similar with the exception of smoking and tumour stage, which were
not predictive in the UIQ. The small number of smokers may explain the anomaly of
smoking not being a predictor in only one quadrant in week five.

Table 5.1
Patt~ms of Predictors between Sites and Over Time
Week six

Week Seven

Lymphocele aspirated*

Lymphocele aspirated

Lymphocele aspirated*

Weight

Weight

Weight

Breast size

Breast size

Boost energy

Weight

Condition of breast scar•

Current smoker

Skin type

Site

Week.Three

Week Four

Week Five

Sternum

History of skin cancer

History of skin cancer

Dose

History of skin cancer
Age•

Lymphocele aspirated*
Breast size

Axilla

Chemotherapy•

UOQ

Lymphocele aspirated
Stage*
Dose

UIQ

Breast size
Condition of breast scar•

Breast size*
Lymphocele aspirated*
Dose*

LOO

LIQ

Breast size*

Breast size

Current smoker
Condition of breast scar·

Current smoker
Lymphocele aspirated

Breast size*

Breast size

Current smoker
Condition of breast scar•

Current smoker
Lymphocele aspirated*
Current smoker

Nipple
lnframammary Fold

Chemotherapy

Breast size

Current smoker

Ex-smoker
Current smoker

• indicates that the confidence interval included "1".

0

~-
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g
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J:,.

w
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In week five, predictive factors included in the models for all breast quadrants
were: a larger breast size; receiving the last fraction of whole breast treatment; and
having had a lymphocele aspirated. In week four, breast size and the condition of
the breast scar were µredictors in all quadrants. This is of interest given that the
majority of scars were in the upper quadrants suggesting that the impact of
increased inflammatory response along the scar line affects the overall healing of
the whole breast. However, this finding must be viewed with caution as the
confidence interval included 1.
The similarities between the models suggest that with further development, it
may be possible to group the sites, thus making the assessment simpler for daily
clinical practice and more practcal for educational purposes.

Mechanisms Underlying the Relationships between Predictors and the
Severity of Radiation Skin Reactions
The development of models to predict the severity of radiation skin reactions
in women with breast cancer was undertaken systematically and rigorously to
ensure the final product would be statistically sound and clinically useful. Selection
of potential predictors for entry into the stepwise logistic regression was based on
the conceptual model and results of the univariate testing. In interpreting the
findings in terms of the theoretical basis for the predictive relationships, it was clear
that the conceptual framework could be modified to represent the findings more
closely. The discussion that follows develops hypotheses for each predictive factor
suggesting possible mechanisms underlying the predictive relationships. Factors
are presented in order of frequency of occurrence in the prediction models.
Breast Size and Weight
Breast size was a significant predictor of severe radiation skin reactions in all
quadrants of the breast and the inframammary fold in week five, and the axilla, all
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quadrants of the breast and the nipple, in week four. The participant's weight was a
significant predictor in the axilla reaction models in weeks five, six and seven.
Breast size and weight were closely related variables as indicated by the finding of
a significant moderate correlation between the two measures and a significantly
higher mean weight for participants in the larger breast size group. The hypotheses
presented to support these two factors are the same; thus the discussion is
combined.
There are two possible hypotheses that probably combine to explain the
influence of the participant's breast size/weight on the severity of the radiation skin
reaction. From a wound management perspective, increasing breast size/weight is
an indicator of several mechanisms that may impair healing. The negative impact
on the efficiency of healing caused by excess layers of adipose tissue or obesity
was discussed in Chapter Two. One mechanism suggested was that the poor
vascularity of adipose tissue compromises healing (Carville, 1995; Dealey, 1994).
Obesity can also cause excessive wear and tear on skin through increased friction

cm movement, causing abrasion. In surgical patients, obesity is also a factor in
increased risk of postoperative infection. A larger breast size, even when a woman
is not obese, can increase the risk of friction particularly if a brassiere is always
needed for support.
Areas such as the axilla where there is appositional skin are also more prone
to severe skin reactions due to the increased moisture, warmth and friction along
with poor aeration. It is well recognised that these elements can contribute to a
'llOre severe radiation skin reaction through increasing the rate at which the

stratum comeum sloughs (Sitton, 1992). A mainstay of radiation skin care protocols
has lJeen to artificially maintain the stratum comeum through actions aimed at
reducing possible friction for example by patting the skin dry rather than rubbing;
wearing loose cotton clothing; and moisturising the skin.
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From a radiation therapy perspective, weight can be viewed as an indication
of increasing size of the chest area, i.e. as weight increases the area included in
the treatment field increases. A skin-sparing effect occurs as the higher energies
produced by megavoltage linear accelerators result in the accumulation of the dose
deeper in the tissues. A larger (heavier) person would, therefore, require a higher
dose of radiation to the skin surface to ensure that the tumour receives the full
dose required for eradication. Based on the hypothesis that the heavier the person,
or the larger the breast size, the higher is the dose required relative to the skin
surface, then a better measure of size might be a caliper reading between the
sternum to the lateral aspect of the torso taken for treatment planning. Another
alternative would be to develop a method of calculating skin dose for each of the
observations sites that could be used on a practical level by nurses. In addition, a
larger breast size is an indication of increased tissue volume being treated. A larger
treatment volume has been implicated as increasing the severity of reactions
(Maciejewski et al., 1990; Perez & Brady, 1992).
Smoking
Smoking during treatment was a significant predictor in all models in week
five except for the sternum and upper inner quadrant. It was also a significant
predictor in the two lower quadrants, nipple and inframammary fold reactions in
week four. The impact of smoking on the development of more severe skin
reactions was an extremely interesting finding. Wound healing literature suggests
that smoking, and nicotine in particular, delays or impairs healing through a number
of mechanisms. These mechanisms, as presented in Chapter Two, are:
•

Cutaneous vasoconstriction as a result of one or more of the constituents of
cigarette smoke {Cohen, et al., 1992)

e

The negative impact on the nutritional status of the patient, in particular vitamin
and mineral depletion (Cohen, et al., 1992; Dealey, 1994)
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Changes to the endothelium, increased platelet stickiness, high levels of carbon
monoxide in the blood of smokers limiting the oxygen-carrying capacity of
haemoglobin (Cohen, et al., 1992)

•

Reduction in macrophage activity and epithelialisation (Siana, Frankild &
Gottrup, 1992)
The effects of smoking on mucosal reactions in the mouth and throat have

been described on several occasions in the radiation therapy literature. The
mechanism hypothesised to explain the increased severity in mucosa! reactions
has been the direct contact of an irritant (cigarette smoke) with the mucosa
{Bentzen & Overgaard, 1994b; Browman et. al., 1993; Des-Rochers, Dische &
Saunders, 1998; Rugg, Saunders & Dische, 1990). These fi;:dings suggest that
adverse effects result not only in relation to direct contact, but also from the
systemic effects of smoking that have been described and tested in the wound
management literature.
The relative risk of the ex-smoker group was not significantly higher than the
group who had never smoked, suggesting the possibility that encouraging patients
to quit smoking may positively impact on the severity of the skin reaction. This
suggestion must be tempered by the knowledge that all except one of the exsmokers had quit more that one year prior to diagnosis. The efficacy of a quit
smoking intervention on reducing the severity of skin reaction would require further
testing.
The significant impact on the severity of the skin reaction by smoking whilst
on treatment cannot be ignored and may help identify new patients who may be at
particular risk for severe skin reaction. The finding also underscores the importance
of health promotion activities, such as smoking cessation, in cancer nursing
practice. From the findings presented here it is clear that encouraging patients to
quit smoking during treatment is an area of research that requires further attention.
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Aspiration of a Lymphocele
Having had a lymphocele aspirated was predictive of a more severe skin
reaction in the axilla and all quadrants of the breast in week five and in the axilla
reaction in week four. Entry into the models occur.-.Jd in some instances because of
the broader entry criteria of p = .1O; where the significance level was greater that
.50 but less than .10, then the confidence interval included 1. Despite these
qualifications on the interpretation of lymphocele aspiration as a predictor, there
are significant clinical implications which support the inclusion of the variable in the
prediction models.
The theoretical explanation for lymphocele aspiration exacerbating the skin
reaction is related to the role the lymphatic system plays in the physiology of
healing. It is logical to assume that participants who required aspiration of a
lymphocele experienced more damage to the lymphatic system in the axilla due to
clearance of axillary lymph nodes. The mean number of lymph nodes removed was
not significantly different between participants who had a lymphocele aspirated and
those who did not.
As lymph oedema of the breast increases due to an inflammatory response
to the ionizing radiation, the congestion resulting from axillary clearance increases,
exacerbating the skin reaction and compromising the normal healing processes.
Those women, who have demonstrated more damage to the lymph drainage
channels by requiring aspiration of a lymphocele, are therefore at greater risk of
breast lymph oedema and of compromised healing.
It is possible that as a result of having the additional trauma to the axillary
tissue from needle aspiration, a more marked inflammatory response would follow,
further compromising the already weakened lymphatic system in the axilla. In
addition, the possibility that the normal flora of the skin could be introduced into
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tissue during the procedure would suggest further heightening of the inflammatory
response or even a low-grade infection.
The usual channel for drainage of lymph fluid for the breast is via the axillary
nodes. The fact that aspiration of a lymphocele was not predictive in the
inframammary fold reaction in either week four or five supports the hypothesis of
increased tissue damage due to impaired lymphatic drainage in the upper breast.
as there are alternative lymph node stations to channel lymph fluid from the lower
aspect of the breast.
Condition of the Breast Scar
Less than 3% of lumpectomy scars were inflamed or discharging
haemoserous fluids. The condition of the breast scar was predictive of severe skin
reactions in three of the breast quadrants (not upper outer quadrant) in week four.
Although the effects of scar condition are no longer predictive in week five
reactions, it does appear to be an important indicator of risk for early onset
reactions. The confidence intervals indicate that these findings should be viewed
with caution and therefore further research is required before accepting the
condition of the breast scar as a predictor in clinical assessment.
The theoretical explanation for the predictive influence of scar condition lies
in the delay in the healing processes due to inflammation and/or infection. The
presence of infection or immunosuppression may affect the normal tissue response
to radiation as described by Bentzen and Overgaard (1994b) and Chak et al.,
(1988). As discussed in Chapter Two, immunosuppression may well be part of the
causal chain in the development of infection in radiation reactions where the
integrity of the skin has been compromised.
Clinical infection delays healing by prolonging the inflammatory phase and
inhibiting the ability of fibroblasts to produce collagen (Senter & Pringle, 1985). In
addition, there is competition for white cells and nutrients; therefore, healing may
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be delayed until the body has overcome the infection. Furthermore. systemic
infection causes fever, raising the metabolic rate, thus increasing catabolism and
tissue breakdown. Pain, also produced by infection, may further increase the
metabolic rate.
The small group size and the interpretation of confidence intervals indicate
that this finding musi be viewed with caution.
History of Skin Cancer and Skin Type
Having a history of skin cancer was significantly related to a more severe skin
reaction to the sternum on a univariate level and as a significant predictor in weeks
three, four and five. Skin type (as measured by the Fitzgerald scale) was
significantly related to the severity of the sternum reaction in weeks three and four,
and entered the prediction model for the UOQ in week six, during the first week of
electron boost treatment.
History of Skin Cancer
The most likely explanation for a history of skin cancer being a significant
predictor is that skin cancer is a measure of skin damage from chronic UV radiation
exposure. The effects of chronic exposure to the sun were described in Chapter
Two. It is interesting to note that other variables indicative of sun damage were
significantly related to the severity of the skin reaction on a univariate level. These
were skin-type in weeks three and four and the level of protection from UV
radiation used as an adult (as measured by the Cumulative UV Radiation Scale) in
week five.

Of the variables associated with sun damage, only a history of skin cancer
remained in the predictive model for the sternum. Given that only participants with
a confirmed medical diagnosis of skin cancer were included in the analysis, this
factor was a very conservative measurement of damage due to UV radiation. It
also may suggest that a more discriminating measure of cumulative sun damage
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could provide a better understanding of the impact of sun damage to areas of
chronic exposure.
Another interpretation of the theoretical basis for a history of skm cancer
predicting the severity of the skin reaction would be that an individual who
demonstrated sensitivity to the carcinogenic effects of UV radiation may also have
a propensity to be generally more radiosensitive. In addition, the general immune
depletion effects of chronic exposure to UV radiation as described by Santucci
(1996), may have resulted in some impairment of the inflammatory phase of the

normal process of wound healing. Although logical, these two hypotheses would be
more credible if a history of skin cancer had featured in the prediction models in the
reactions in other areas of the breast. It should be noted however, that on a
univariate level, a history of skin cancer was significantly related to more severe
reactions in the two lower quadrants and the nipple in week four. Thus, it would be
premature to disregard the alternative hypotheses of radiosensitivity or immune
depletion.
Skin type
The Fitzgerald scale, used to measure skin-type, incorporates sunburn and
tanning history in a six point ordinal scale, to indicate the individual's sensitivity to
the effects of UV radiation from the sun. Due to missing values, the variable was
re-coded to two levels representing participants who were sensitive to the sun and
those who had a normal or insensitive reaction to the sun. The finding that a high
risk was associated with participants who had a normal or insensitive reaction to
the sun would seem initially illogical. However, experience in the sun would lead
those with sun-sensitive skin to prevent sunburn by using a hat, clothing and/or
sunscreen. Those with skin that tans and is classed as either normal or insensitive

to the sun, would be more likely to spend time in the sun unprotected, thus leading
to a greater risk for chronic UV radiation damage.
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The Cumulative UV Radiation Scale
The two factors. history of skin cancer and skin-type, clearly suggest the
probability of a relationship between the cumulative effects of chronic exposure to
UV radiation. The Cumulative UV Radiation Scale was developed from a need to
find a non-invasive method of estimating the impact of exposure to UV radiation
over time. Initial development was through interviewing patients in the Department
and healthy adults to determine a 1<1eaningful way of collecting information on
exposure to the sun. The reliability and validity testing conducted were adequate to
continue with the scale in the research. Although it was disappointing to find that
the scores for this scale were not significantly related to the severity of skin
reactions, the finding that a history of skin cancer and skin type were related to the
radiation skin reactions in the sternum and UOQ shows that there is probably merit
in pursuing some measure of UV radiation damage. The Cumulated UV Radiation
may provide the basis for future development in this area.
Radiation Dose
Dose of radiation was a significant predictor in severe reactions in all
quadrants of the breast and the nipple in week five; the sternum, upper outer
quadrant and inframammary fold in week four and the sternum in week three. The
significance of dose as a predictor is obvious and certainly expected, thus the fact
that several models do not include dose as a predictor is, in fact, a more interesting
finding.
For example, the dose factor, although significantly related to the sternum
reaction on a univariate level in weeks three, four and five, and on a multivariate
level in weeks three and four, was not included in the prediction model in week five.
This is a noteworthy finding, as it appears to indicate that the influence of a history
of skin cancer is greater by week five than dose of radiation alone. The relative risk
of dose is 3.5 in the week three model and 2.8 in the week four model. It would

Discussion

153

seem that the influence of dose diminishes over the weeks of treatment to be
replaced by an increasing relative risk for a history of skin cancer of 6 1 1n week
three, and almost 12 in weeks four and five.
The finding that dose does not appear in the axilla predictions is interesting
given that it is an area prone to more severe reactions, including moist
desquamation. These results suggest that wound healing factors have a significant
influence in predicting the risk of a severe skin reaction in the axilla. The influence
of having a lymphocele aspirated, having chemotherapy and the size of the breast
were better predictors than radiation dose. Both a radiation enhancement
mechanism and a healing mechanism can explain the influence of breast size and
chemotherapy. On balance, however, it seems that in the axilla. at least, the
influence of impaired healing is greater than that of dose or other direct radiation
factors.
Chemotherapy
It is noteworthy that chemotherapy is included in models predicting earty
onset reactions {week four) in the axilla and the inframammary fold. These sites
are prone to moist desquamation as indicated in the descriptive results; supporting
clinical experience. The well established theoretical basis for chemotherapy
exacerbating radiation skin reactions was presented in Chapter Two and centres
on the cytotoxic properties of chemotherapy and the potential for enhancing
radiosensitivity {Bentzen & Overgaard, 1993; Fu, 19B5; Hirshfieid-Bartek. 1992;
O'Rourke, 1987; von der Maase, 1994).
In addition to their damaging effect on normal cells, cytotoxic drugs also have
a suppressing effect on the immune system and thus wound healing. The principle
risks of immune suppression are infection and bleeding. Healing is specifically
impaired by the delay in clearance of debns through reduced white ceH activity
(Laurence & Bennett, 1987). As a result, patients receiving chemotherapy are
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expected to be at risk of infection. This would be extended to patients receiving
chemotherapy as an adjuvant to radiotherapy, thereby increasing the risk of
infection in any skin reaction particularly where moist desquamation has occurred
From a clinical perspective it was surprising to find that chemotherapy did not
significantly influence the prediction of week five reactions. It is possible that the
impact of chemotherapy occurs earlier; but overall the reaction may not be worse
during the treatment period. This study was limited to observations of skin reactions
during the seven weeks of treatment only. It would be useful to follow those who
developed moist desquamation after treatment to measure the healing time
required and determine the variables that influence healing time.
Pedersen, Bentzen and Overgaard (1994) discussed the notion of the
"burden of side effects" suggesting the score for the reaction at the end of
treatment alone does not supply sufficient information to comprehend the impact of
side effects on the patient. This suggests that the length of time a patient
experiences the side effect, as well as the severity, is important to note. Certainly in
preparing an individual for radiotherapy the ability to determine the likelihood of
earlier onset side effects would be reassuring to women facing radiation therapy
and assist in coping with the experience.
Age
Age is frequently cited as being a probable risk factor in the development of
radiation skin reactions (Ber.tzen & Overgaard, 1994b; Holmes, 1988; Perez &
Brady, 1992). However, in this r:search, age was found to be a predictor only in
the week five sternum reaction. Furthermore, an inverse relationship was revealed.
As age increased the probability of a more severe reaction in the sternum
decre~sed. This finding was not anticipated as the radiation literature had indicated
a belief, at least, that increasing age would have impacted negatively on the
development of skin reactions. From the wound management literature, the
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diminishing capacity of the body to heal as age increases is due to a multitude of
physiological and social reasons that suggests recovery from ionizing radiation
would be at least delayed if not impaired. Data from this study was contrary to the
expected view.
Possible explanations for this finding may lie in three areas. Firstly, it is an
accepted practice that chemotherapy is not used as frequently with older women.
In this study the small group of participants receiving chemotherapy were
significantly younger than those not receiving chemotherapy. Further testing of the
potential relationship between chemotherapy and age determined that there was
no significant interaction, suggesting that in this sample chemotherapy was not a
covariant in the model. However, a larger sample with a greater proportion of
participants receiving chemotherapy may shed light on this hypothesis.
The second explanation is that as the rate of mitosis in normal skin cells
reduces as age increases then the cells directly and indirectly affected by ionizing
radiation would reduce. The effect on the tumour would not be the same, as the
rate of mitosis is higher than that of normal cells. Jacobson and Flowers (1996)

state that there is a notable decrease in the turnover rate of the epidermis by up to
50% in the elderly. This decrease may be sufficient to provide some protection
against the effects of ionizing radiation in the skin.
The third possible explanation is one of difference in lifestyle of older
participants in relation to chronic exposure to UV radiation. It is possible that the
older generation was more likely to have been fully clothed when in the sun both in
their youth and even in recent years. Although this is speculation, the data did
indicate a significant iiiverse relationship between age and the protection used as a
child as reported in the Cumulative UV Radiation Scale.
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Boost Energy
The results of the logistic regression for the skin reactions recorded dunng
the two weeks boost treatment found that boost energy was a significant predictor
of severe reactions in UOQ reaction di iring week six of treatment (first week of the
electron boost). The relationship between the boost energy levels and the relative
risk was demonstrated by higher energy levels(> 16MeVe') increasing the risk of a
more severe reaction 011~r 16 times in the UOQ. However, boost energy did not
predict the reactions in week seven. This was a somewhat unexpected finding as it
could have been anticipated that as more skin-sparing effect occurs as higher
energy levels increase, the relationship should have been inverse.
Nevertheless, boost energy, as a predictor of severe skin reactions in week
six, is a straightforward factor for use in clinical practice as the nurse can easily

check the energy prescribed for the electron boost. The patient can then be
prepared appropriately and be identified for close monitoring.
Stage of the Tumour
The inclusion of the stage of the tumour in the predictive model for the upper
outer quadrant was an interesting finding. The model indicated that having a stage
II or higher more than doubled the risk of a severe skin reaction. Inclusion of stage
in the prediction models for the upper outer quadrant of the breast only was
probably due the majority of tumours being located in the upper breast in this
sample. The wound management literature identifies advanced cancer as a risk for
wound !i&aling but, only one participant was classified as stage IV. The more
probable explanation is that more participants classified at stage 11 or higher had
larger tumours. Thus, the surgical bed would be larger, generally resulting in more
trauma to the surrounding tissue and increasing the risk of haematoma, entrapped
air, infection and/or abscess.
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Comparing the Conceptual Framework with the Empirical Evidence
After critical reflection on the predictive factors identified in this research,
there is substantive evidence to support the original conceptual framework
developed theoretically in comparison with the framework that emerged empirically.
Figure 5.1 reproduces the original framework, introduced in Chapter Two.
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Figure 5.1 Conceptual Framework of Potential Predictors of Radiation Skin
Reactions

In considering the hypotheses generated to explain the relationships between
predictors and the severity of the radiation skin reaction, there appears to be
evidence for two main constructs to represent the empirical findings of this
research. Figure 5.2 illustrates these factors.
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Healing Factors

Radiation Factors

current smoking
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Genetic Factors

Figure 5.2 Empirically Based Framework Developed from the Findings

The factors that entered the predictive models during the analysis are listed
in Figure 5.2. This empirical evidence supports the theoretical relationships with the
severity of radiation skin reactions, but they do not represent an exclusive list.
Replication of this work must include all factors from the original conceptual
framework until the limitations of this sample have been addressed. Furthermore,
development of measures for concepts such as nutritional status and exposure to
UV radiation may contribute to understanding this phenomenon.

Measurement Issues
The research process included a number of measures in order to
operationalise the conceptual framework. The complexity of the framework
required the development of new measures for some factors. These were
combined with data from review of medical notes and reasonably concrete
measures such as age and weight. Furthermore, another consideration in selecting
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and developing measures was the ease with which nurses could make
assessments on a routine basis in the clinical setting. No measure was either too
difficult or too expensive, either in time or equipment, to prohibit its use in practice.
The process of establishing rudimentary psychometric properties of the new
measures was a focal point of the development work. The results of content validity
and interrater reliability testing, as discussed in Chapter Three, indicate that the
instruments were able to measure reliably the concepts under investigation.
RTOG Scoring System for Skin Reactions
Measuring the severity of skin reactions has been an important focus in
radiation oncology since the inception of ionizing radiation as a therapeutic
modality. The RTOG Scoring System used in this study was developed from clinical
practice for clinical assessment rather than research. Denham et al. (1995)
criticised the use of the system for research asserting that reflectance spectrometry
has more specificity and reliability when compared with the RTOG as assessed by
a number of radiation oncologists. The study by Denham et al. Revealed, however,
that the pattern of skin reaction development was the same using the two methods.
In the current research, reliability was ensured through careful training of research
assistants and regular IRR testing. The results of the IRR testing, as described in
Chapter Three, showed a high degree of correlation between all data collectors,
certainly within acceptable ranges.
The RTOG scoring system was modified early in the data collection period by
the introduction of a score to separate "tender or bright erythema~ from "patchy
moist desquamation". Where patchy moist desquamation occurred, a score of 2.5
instead of 2 was recorded. In the final analysis, only a few participants experienced
any moist desquamation and even fewer experienced "confluent moist
desquamation" (RTOG = 3). Despite this finding, there may be merit in retaining the
differentiation between a score of 2 or 2. 5 to increase the specificity of the RTOG
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system. Denham et al. (1995) suggested separating the RTOG = 1 category into
two with "follicular or dull erythema" as "1" and "dry desquamation" as "1 S. It is
likely that these modifications will improve the specificity of the RTOG particularly
for research. Further validity testing of the modifications is essential.

Limitations
The limitations of the study relate to three issues. Firstly there is the
acknowledgement that other factors may increase the explanatory power of the
prediction models. Despite this, the prediction models were able to predict the
severity of radiation skin reactions with an overall accuracy of between 68% and
82%. Other factors, such as the oxygenation of the skin or its temperature, specific
nutritional deficiencies, or the impact of psychological state, could be tested in
future research.
Secondly, the limitations in measurement of the independent and dependent
variables must be considered. Measures adapted or developed for use in the study
were subject to content validity testing and to interrater and test-retest reliability
testing. Refinement and further testing of this exploratory work will determine the
utility of these measures for risk assessment in clinical practice.
Thirdly, attention should be given to the limitations of the sample. The
recruitment of participants continued over a 12 month period. Despite the
extremely high response rate, the final sample size was 126. The sample did show
significant similarity on socio-demographic data and on tumour histology
suggesting that the data from the sample is trustworthy and further research with
larger samples would be worthwhile.
These limitations are tempered by the strengths of the study. The study
developed a strong theoretical foundation and considerable effort was spent on
ensuring that the measurements and protocols conducted frequently over a long
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period of time remained accurate so that quality data were collected. Also, the
sampling criteria were restricted as Denham (1996) cautioned that the investigation
of predictive factors for skin reactions was subject to considerable extraneous
variation particularly in relation to radiation factors and gender. The use of a
sample drawn from women only, all of whom were receiving a standard post
lumpectomy radiation protocol for breast cancer minimised the variation so that the
focus of the analysis could be on the influence of factors from the Personal
Construct.

Application of the Predictive Models of Radiation Skin Reactions to Clinical
Practice
Underpinning this research was the aim of developing an empirical base for
assessing patients' risk of a more severe radiation skin reaction. This study has
developed and presented both theoretical and empirical evidence to support this
aim. The application of this knowledge lies not just in improving clinical assessment
in radiation oncology, but provides the theoretical basis for introducing
interventions to support the patient physically and psychologically throughout the
treatment period.
As discussed in Chapter Two, Hendry (1994) suggested the possibility of
moderating normal tissue damage through modifying individual character.sties such
as diet and supporting the individual's resistance to infection with prophyla<..iic
antibiotics. Hendry recognised the impact of surgery and chemotherapy on the
promotion of cell proliferation and suggests that appropriate supportive therapy in
the form of fluids, electrolytes and antibiotics may positively affect morbidity,
ultimately resulting in an ability to give higher doses of radiation. This study
supports Hendry's conclusion that not only can "other factors" affect the individual
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expression of radiation reactions, but that the modification of these factors may
moderate the impact of genetically determined radiosensitivity.
Despite this research being exploratory and further research being required
to confirm the psychometric properties of the assessment tool, specific knowledge
arises from these findings that can be used in practice as a result of the findings.
For example, a practicing nurse can incorporate the knowledge that smoking during
treatment increases the likelihood of a more severe reaction; that a patient
receiving chemotherapy will probably manifest a severe skin reaction earlier; and
that patients with large breast sizes are at an increased risk of severe skin reaction
and skin loss.
Results also indicate that the models, as they have been developed with this
sample, are extremely accurate in predicting patients who will develop only a mild
(RTOG = 1) reaction or no reaction (RTOG = 0). Knowing who will not have a
severe reaction is as important in clinical practice as knowing who will. If, when
preparing a patient for radiation at the commencement of treatment, the •1urse can
tell the patient that she/he is 90% sure that there will be no more than a mild
reaction, the patient is likely to be reassured and experience a reduction in anxiety
(Poroch, 1995).
The lower level of accuracy in predicting those who can expect a severe
reaction means that fewer patients than predicted will have a severe reaction; a
greater risk of making a Type II error. This is a cautious and safe approach
because the pre1iction of a false positive will initiate close monitoring by both the
nurse and the patient. Logically, a reaction that is not as severe as predicted would
be better received by the patient than one that is worse.
The potential to assess risk on an individual basis has several benefits. For
the patient it means knowing what to expect, and when. For the nurse, it provides
an empirical base for prioritising care and developing individualised skin
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management. Risk assessment may also provide additional information for
determining the effectiveness of different skin care and dressing products on a
day-to-day basis.
A Rudimentary Assessment Tool
It is possible, using the formula described in detail in Chapter Four, to
calculate the probability of an individual's risk for developing a radiation skin
reaction of RTOG

~

2 in women commencing a standard protocol of post

lumpectomy radiation for breast cancer. Appendix L presents a series of tables
constructed for each of the eight sites observed in this study that can be used to
estimate individual risk. These tables are rudimentary and are not intended for
immediate clinical use, but rather to indicate a useful form through which the
findings of the study may be applied to practice in the future.

Future Research Directions
This study has explored and tested the relationships between the severity of
radiation skin reactions and radiation, genetic and personal factors. Although
described and hypothesised in texts and other publications, these relationships had
not been tested before in a prospective study. The benefits of applying this
knowledge to practice have been presented. Taking into consideration the
limitations and strengths of the research it would be worthwhile to continue to
develop this programme of research to develop a trustworthy method of risk
assessment in radiation skin reactions.
The first line of future research is in the development or modification of the
measures used for the independent variables. For example, further development of
the non-invasive measure of sun damage, and the addition of other predictors such
as psychological state, skin oxygenation and skin temperature. Larger samples
from more diverse populations will confirm and clarify the prediction models found
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thus far. The process of validation studies would also require trials of prediction
models where the person assessing the developing skin reaction would be blinded
to the prediction.
The second line of future research would extend the methodology developed
here and apply it to skin sites other than the breast area and then to other normal
tissue damage such as gastrointestinal tract mucosae. The skin has been used as
the model for understanding the adverse effects of ionizing radiation on normal
tissue (Denham et al., 1996). The application of this methodology to other radiation
side effects is a logical trajectory to follow.
The empirical basis for decision making in radiation skin management has
been quite limited. One of the reasons for this has been that due to the problem of
patient-to-patient variation, large random samples are required. The findings of this
study provide support for stratification of samples based on known predictors, for
example, smoking, breast size and lymphocele aspiration. For example. in testing
the effectiveness of a topical ointment or cream, sample recruitment would be
stratified by current smoking, breast size and lymphocele aspiration.
Finally, it may be possible to use the predictions in the process of testing the
effectiveness of topical medications and dressing materials. Earlier work by
Downes, Porock and Upright (1997) indicated that using retention dressing tapes,
such as Fixomull or Hypafix, may minimise skin loss through creating an artificial

stratum comeum.

By predicting who is most likely to develop a severe skin

reaction, selection criteria for research in this area can be more appropriately
structured, avoiding the exposure of patients to an unnecessary intervention when
they are unlikely to develop a severe reaction.
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Summary and Conclusions
This research was conducted in three stages reflecting the overall aims of the
research. Two assumptions underscored the research process: firstly that in
addition to the effects of ionizing radiation, factors and mechanisms known to
impair wound healing also affect the development of radiation skin reactions
through impainnent of the nonnal process of tissue healing; and secondly that
these factors were measurable.
The first stage involved identification of factors from both wound healing and
radiation literature along with clinical knowledge and development of a conceptual
framework that could be tested. From this framework it was hypothesised that the
severity of radiation skin reactions was a function of some or all of the genetic and
personal factors plus the radiation factors.
Development of the research protocol and completion of data collection
fanned the second stage. All measures were subject to testing for content validity.
The research protocol was piloted which included testing for stability over time,
using test-retest reliability. During the data collection, the three, trained observers
were rigorously tested for interrater reliability and accuracy of transferring
infonnation from the medical record. The psychometric properties of the tool used
exceeded the pre-set criteria.
The sample of 126 women, recruited over a 12-month period, was
representative of the WA general female population on socio-demographic criteria
and representative of the breast cancer population in tenns of histology type.
The third phase involved testing of the theoretical relationships on a
univariate level with chi-square and t-test statistics, and on a multivariate level
through stepwise logistic regression analysis. Through this analytical process, a
predictive model was developed for each of the eight sites observed for the
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reactions recorded in weeks three to seven of standard post lumpectomy radiation
for breast cancer.
The final aspect of the third phase was the critical reflection on the research
process and findings. The purpose was threefold: Firstly, to form hypotheses
explaining the mechanisms underpinning the significant predictors; secondly, to
interpret the findings for nurses practising in radiation oncology and; thirdly, to map
out the logical next steps for continuing the research work in this important area.
Despite the limitations of this exploratory study, the findings contribute to both
the knowledge and practice of radiation oncology nursing. The theory base has
been developed through bringing together the radiation literature and the wound
healing literature. Testing the theoretical relationships between the severity of
radiation skin reactions and radiation factors and personal healing factors, provides
the empirical foundation for the creation of a tool for individualising the assessment
of risk for a severe radiation skin reaction. A trustworthy assessment tool will
evolve with further research and development, adding to the repertoire of skills
used by the radiation oncology nurse to promote optimal, individualised pa+i~nt
care.
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Normal Skin
The skin is the largest organ of the body accounting for approximately 15% of
body weight and along with its appendages, hair, nails, sebaceous and sweat
glands, forms the integumentary system. Carville (1995) describes the integument
as a complex system that performs five major functions: protection of underlying
structures; sensation; communication; thermoregulation and metabolic synthesis.
The skin is di11ided i11to two layers, the epidermis and the dermis, each with a
distinct structure and function. The epidermis is further divided into five layers and
the dermis into two.
Epidermis
The innermost of the five epidermal layers is the stratum germinativum or
basal layer where constant mitotic reproduction of squamous cells occurs. The
second layer is the stratum spinosum and the third, the stratum granulosum. These
three layers together are also known as the Malphygian layer. The thickness of the
Malphygian layer varies throughout the body and is related to the amount of friction
occurring in each area. The fourth layer, stratum lucidum, is only present in the
thick skin of the soles and palms. The cells of the fifth and outermost layer, the

stratum comeum, are dead, having been converted to a water-repellent protein
called keratin. This layer sheds (desquamates) continually.
The epidermis is avascular; the capillary beds in the upper layer of the dermis
supply nutrition through the thin basement membrane between the dermis and the
epidermis. Interstitial fluid infiltrates the intercellular spaces of the stratum

genninativum from the capillaries in the underlying dermis.
About 10% of the human epidermis undergoes mitosis daily (Breathnach &
Wolff, 1979) and it has been estimated that the basal cells of the skin take eight
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hours to replicate (Withers, Peters, Thames & Fletcher, 1992). Frequency of
mitosis in the stratum germinativum varies directly with the rate of desquamation at
the epidermal surface. Under normal conditions the rate of mitosis in the basal
layer is able to maintain the supply of these overlying non-dividing squamous cells.
The cells of the stratum germinativum are vegetative intermitotic cells relatively
sensitive to radiation (Casarett, 1980).
Cells other than those in the germinal layer are primarily fixed postmitotic
squamous cells. These are first cylindrical, and subsequently polyhedral. They then
differentiate to become flattened, anucleated, keratinised. superficial skin layers
that are extremely refractory to radiation and are highly radioresistant (Casarett,
1980; McDonald, 1992).
Other structures found in the epidermis are melanocytes. hair, and
sebaceous and sweat glands all of which are composed of specialised epithelial
cells continuou~ with the stratum germinat,vum of the epidermis.
Melanocytes
Melanocytes are found at the junction of the pigmented basal layer of the
stratum germinativum and the dermis. Melanocytes determine the colour of the skin

along with the inherent yellow colour of the skin and the vasculature of the dermis.
Melanin production is stimulated by ultraviolet radiation (UV) as a fine granular
substance that is passed through the cell layers of the epidermis showing at the
surface as hyperpigmentation. Melanocytes are probably reverting postmitotic cells
and are relatively radiosensitive (Casarett, 1980; McDonald, 1992).
Hair.
The hair consists of the visible hair shaft and the root situated in the hair
follicle which is a continuation of the stratum germinativum. Approximately 85-90%
of hair follicles on the scalp are in the active growing (anagen) phase at any one
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time. The root of the hair divides rapidly, pushing the previously produced cells up
the shaft After the talogen (resting) phase. the hair 1s shed as the new growth
starts in the hair follicle.
Due to its active reproduction the hair 1s relatively rajiosensit1ve with more
rapidly growing hair having higher radiosensitivity. Lacassagne and Gncouroff
( 1956, cited in McDonald. 1992) ranked the radiosensit1vity of hair

in

decreasing

order thus: scalp hair. male beard, eyebrows, axilla. pubis and last. fine body hair
Sebaceous glands.
Sebaceous glands secrete oil for the hair and skin as a natural moisturiser
preventing excessive water evaporation from the skin and water absorption through
the skin. The presence of sebum on the surface of the skin conserves heat loss
from the body. Sebaceous glands are classified as holocrine glands. Secretions
produced by holocrine glands consist of the disintegrated cells of the gland.
Secretion of sebum is followed by mitotic regeneration of the secretory cells. These
regenerating cells are vegetative intermitotic cells and are relatively radiosensitive.
The epithelial cells not involved in secretion. are fixed postmitotic cells and are
relatively radioresistant (Casarett, 1980; McDonald, 1992).
The radiosensitivity of sebaceous glands is approximately equivalent to hair
follicles (Casarett, 1980). After a dose of radiation high enough to cause depilation,
a reduction in secretion of sebaceous glands begins within a week. After a month.
few glands persist and in those that do, degenerative changes are apparent.
Sweat glands.
Sweat glands are small but numerous in the body performing an important
part in maintaining homeostasis of fluid and electrolytes and body temperature.
Sweat glands are classified as merocrine glands. Merocrine glands produce their
secretion within the cells and are not destroyed in the process. This makes them
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less vulnerable to damage as the frequency of mitosis required to repair or replace
sweat glands is less than for sebaceous glands The epithelial cells that hne this
simple, coiled tubular gland are reverting postmitot1c cells and are. therefore.
relatively radioresistant (Casarett.

·1

980: McDonald. 1992)
Dermis

The dermis ,s divided into two layers. the dermis and the hypoderrms or
subcutaneous layer. The dermis is a very vascular layer also containing nerve
endings, lymphatics. connective tissue and collagen fibres (Bryant. 1987). The
components of the dermis are principally responsible for tissue repair. The
hypodermis is a layer of loose connective tissue with variable amounts of adipose
tissue. Its principal function is in connecting the dermis to underlying fascia or
periosteum.
In radiation skin reactions, damage to the dermis. either in the acute or
chronic phases, is rarely seen with modern radiotherapy techniques, therefore. the
epidermal layer is of primary concern (McDonald, 1992) .

•

Appendix 8

Appendix B

Normal Tissue Repair

183

Appendix B

184

Repair of Normal Tissue
A background to radiotherapy and the effects of ionizing radiation on
normal tissues would not be complete without some information on the
mechanisms involved and the factors affecting the repair of epithelial tissue. Many
factors influence the progress of healing, whether the cause of the tissue damage
is from ionizing radiation or any other trauma. These factors are essential to
understanding the theoretical underpinnings of the proposed model The factors
are described and discussed in the second section of this chapter in relation to
their potential impact on the severity of radiation reactions. Although the
mechanism by which radiation causes trauma to normal tissue is different from
other injury, meaning that radiation reactions cannot be strictly defined as a wound,
the process and mechanisms of healing are the same in principle. The differences.
due to the permanent damage caused by radiation, are described in detail in the
section on radiohistopathology.
The healing process of damaged tissue is usually described as occurring by
first or second intention. Healing by primary intention is the union of the edges of a
wound, progressing to complete healing without scar formation or granulation.
Healing by secondary intention is wound closure in which the edges are separated,
granulation tissue develops to fill the gap and epithelium grows over the
granulations, producing a scar (Mosby, 1990).

Phases of Tissue Repair

Inflammatory phase.
Tissue damage initiates the inflammatory response where a cascade effect
leads to the release of histamine along with other vasoactive chemicals causing
vasodilation in surrounding tissue. As more blood flows to the area, erythema,
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oedema. heat and discomfort ensue. The inflammatory response includes the
arrival of polymorphonuclear leucocytes (polymorphs/neutrophtls), to protect the
wound from bacterial invasion, and macrophages. to clear the wound of debris
Reconstruction phase.
A primary mechanism in the reconstruction phase occurs through the
attraction of fibroblasts to the wound as a result of growth factors produced by
macrop~·.ages. Growth factors stimulate fibroblasts to produce collagen and to form
new blood vessels {angiogenesis) which are then capable of bringing oxygen to the
wound.
Epithelialisation phase.
Epithelialisation is an important phase in the healing of radiation skin ar
mucosal reactions and is the phase where skin loss is repaired by renewal of
epithelial cells. Squamous cells at wound margins and around hair follicle remnants
proliferate and migrate over the wound surface in a leap-frog fashion {Dealey,
1994). Migration stops when cells meet. either in the centre of the wound forming
islets of cells, or at the edges. This is known as contact inhibition. Epithelial cells
can only migrate where the tissue is viable and the wound environment is moist
(Winter, 1962).
Maturation phase.
Maturation occurs over a long period often taking more than a year. The
mechanisms involved are reduction in vascularity, re-organisation of collagen fibres
and remodelling of scar tissue. During the maturation phase, tensile strength
increases and the ability of the wound to resist friction and breakdown increases
commensurately.
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Mechanism of Cytotoxicity and Possible Mechanism of Enhancement of Radiation Effects in 15 Commonly Used Chemotherapeutic Drugs

Drug

Mechanism of Cytotoxicity

Po...,sible mechanism of radiation enhancement

Dactinomycin

Intercalates DNA and inhibits DNA and RNA synthesis;
causes single-strand breaks in DNA

i slope of radiation dose response curves . .J.. SLD and PLO
repair

Adriamycin
(doxorubicin)

lntercalcates DNA and inhibits DNA. RNA, and protein
synthesis

Additive cytotoxicity, ,.. accumulation of SLD. " PLO repair

Bleomycin

Causes single- and double-strand breaks in DNA. inhibits
DNA synthesis, preferencially kills cells in G2 and M phases.

? .J. of repair of drig damage by radiation. ? perturbations 1n
cell kinetics

BCNU,CCNU

Causes DNA strand breaks and crosslinks by alkylation and
inhibits DNA. RNA, and protein synthesis

Additive cytotoxicity. ? .J.. of SLD repair.
cell kinetics

Cisplatin

Causes DNA intrastrand crosslinks and changes in DNA
conformation and inhibits DNA. RNA. and protien synthesis

,i. SLD and PLO repair.

Cyclophosphamide

Causes DNA crosslinks by alkylation and inhibits DNA
synthesis

Additive cytotoxicity

Cytosine arabinoside

Inhibits DNA synthesis, selectively kills cells in the S phase

,i.

5-Fluorouracil

Binds and inhibits thymidylate synthetase and inhibits RNA
processing and function

? perturbations in cell kinetics

Hydroxyurea

Inhibits ribonucleoside diphosphate reductase and DNA
synthesis, selectively kills cells in the S pha~_ ~~-

i

?

perturbations in

slope of hypoxic cell radiation dose

response curves

PLO repair. ? ... SLD repair. perturbations in cell kinetics

t slope of radiation dose response curve postdrug exposure.
Perturbations in cell kinetics

}>
"C

~
:::,

C.

x·

0

_.
0:,

-...J

Drug

Mechanism of Cytotoxicity

Possible mechanism of radiation enhancement

Methotrexate

Inhibits dihydrofolate reductase and synthesis of thymidylate
and purine nucleotide

7 perturbations in cell kinetics

Mitomycin C

Causes intrastrand and interstrand crosslinks in DNA by
alkylation and inhibits DNA synthesis

Additive cytotoxicity

Nitrogen mustard

Causes single-strand breaks and crosslinks in DNA by
alkylation and inhibits DNA, RNA, and protein synthesis

Additive cytotoxicity

Vin~stine; vinblastine

Binds tubulin. poisons the mitotic spindle and causes mitotic
arrest

?perturbations in cell kinetics

SLD

=sublethal damage; PLO =potentially lethal damage

From Fu, K (1985). Biological basis for the interaction of chemotherapeutic agents and radiation therapy. Cancer (Suppl). May 12. p 2127.
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Agents That May Cause Photosensitivity Reactions
Chemotherapy
• Decarbazine
Fluorouracil
Methotrexate
Procarbazine
Vinblastine
Adiamycin
Antidepressants
lmipramine
Amitryptyline
Amoxapine
Desiprarnine
Doxepin
Maprotiline
lsocarboxazid
Nortriptyline
Protriptyline
Trimipramine

Antlpsychotic Drugs
Chlorpromazine
Chlorprothixine
Fluphenazine
Haloperidol
Perphenazine
Promethazine
Piµer ::icetazine
Promethazine
fhioridazine
Trifluoperazine
Thiothixene
Triflupromazine
Trimeprazine
Diuretics
Acetazolamide
Ch loroth iazide
Furosemide
Hydrochlorothiazide

Antihistamines
Cyproheptadine
Diphenhydramine

Hypoglycemics
Chloropropamide
Glyburide

Antimicrobials
Demeclocycline
Doxycycline
Griseofulvin
Methacycline
Minocycline
*Nalidizic
Oxytetracycline
Sulfacytine
Sulfamethazine
Sulfamethazole
Sulfamethoxazole-trimethoprim
Sulfasalazine
Sulfathiazole
Sulfisoxazole
Tetracycline

Nonsteroidal Anti-inflammatory
Ketoprofen
Naproxen
Phenylbutazone
Piroxicam
Sulindac

Antiparasitic Drugs
*Bithionol
Pyrvinium pamoate
Quinine

Sunscreens
Benzophenones (Aramis. Clinique)
Cinnamates (Aramis, Estee Lauder)
Oxybenzone (Eclipse, PreSun)
PABA and PABA esters (Block Out.
Sea & Ski)
Miscellaneous Drugs
*Amiodarone

*Bergarnot oil, oils of citron, lavender,
lime, sandalwood, cedar
Carbamazapine
Contraceptives
Disopyramine

* Reactions occur frequently {McDonald, 1992).
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Weekly Skin Reaction Observation Record

"

weeklv skin reaction observation record
DATE
WEEK
week l

week2

week 3

SITE
R/L
midline chest wall
ax.ilia
upper outer quadrant
upper inner quadrant
lower outer quadrant
lower inner quadrant
nioole
inframammary fold
midline chest wall
axilla
upper outer quadrant
upper inner quadrant
lower outer quadrant
lower inner quadrant
nioole
inframammart' fold
midline chest wall
axilla
upper outer quadrant
upper inner quadrant
lower outer quadrant
lower inner quadrant
nioole
inframammary fold

RTOG
SCORE

I[)

DOSE

TOPICAL Rx
DATE

DRESSING

PAIN
SCORE

COMMENl~

-

)>

ia.
:,

x

m

....

U)

N

klv sk·
DATE
SITE
WEEK R/L
week4

r

b

t'

d
RTOG
SCORE

. ed
DOSE

ID

TOPICAL Rx
DATE

DRESSING

PAIN
SCORE

COMMENTS

midline chest wall

axilla

weeks

week6

uooer outer quadrant
uooer inner quadrant
lower outer quadrant
lower inner quadrant
nipple
inframammary fold
midline chest wall
axilla
uooer outer quadrant
upper inner quadrant
lower outer quadrant
lower inner quadrant
nioole
inframammary fold
midline chest wall
axilla
upper outer quadrant
upper inner quadrant
lower outer quadrant
lower inner quadrant
nipple
inframammary fold

·-

)>
"O

1il:,
a.
x

m

~

m
w

kly sk
DATE
WEEK
week 7

Spare

Spare

SITE
R/L
midline chest wall
axilla
unner outer Quadrant
unner inner Quadrant
lower outer quadrant
lower inner Quadrant
nipple
inframammary fold
midline chest wall
axilla
unner outer Quadrant
unner inner quadrant
lower outer Quadrant
lower inner Quadrant
nipple
inframammary fold
midline chest wall
axilla
unoer outer Quadrant
uoner inner quadrant
lower outer ouadrant
lower inner Quadrant
nipple
inframammary fold

RTOG
SCORE

DOSE

TOPICAL Rx
DATE

DRESSING

PAIN
SCORE

COMMENT\

-

>

"t,

i::,

a.

;r

m

.....
(!)
.,I).
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URMN sticker

'.}<:------------------------------------------------------------------PRIVATE AND CONFIDENTIAL
Predicting the severity of skin reactions in patients receiving
radiotherapy for cancer.
Data Collection Form - Breast Patients

ID code

l.

Age (in years at last birthday)

Diagnosis and Treatment

2.

Diagnosis/Histology _ _ _ _ _ _ _ _ _ _ _ _ _ _ __

3.

Time since diagnosis(weeks, months,years)

Reasons for oelay

Appendix F

197

'.}<:-------------------------------------------------------------------

...

a. Stage at diagnosis

Stage 0

Tis

NO

MO

Stage I

Tl

NO

MO

Stage IIA

TO
Tl
T2

NI
Nl
NO

MO
MO
MO

2

Stage IIB

T2
T3

NI
NO

MO
MO

3

Stage IIIA

TO
Tl
T2
T3

N2
N2
N2
NI.N2

MO
MO
MO
MO

4

Stage IIIB

T4
AnyT

AnyN
N3

MO
MO

5

Stage IV

AnyT

AnyN

Ml

6

0

b. Recurrences
0

No
Yes, number of times

PRJV ATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital
ID
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Combined Treatment Modality Details

5.

a. Condition of Hrcast Scar
Yes.
Yi:s.
Y cs.
Y cs.

scar fading
intlami:d
hacmoscrous discharge
purulent discharge

2
1
4

b. Axilla scar
0

No axillary clearance
Yes. scar fading
Yes. inflamed
Y cs. haemoserous discharge
Yes. purulent discharge

I
2
3
4

c. Lymphoce!e requiring drainage
0

No
If yes, approximate number of times
6.

a. Chemotherapy (Combined Modality Treatment)
No (go to# 7)
Yes

0

Regimen _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ __
If yes, go on to part b.

b. Chemotherapy commenced before radiotherap)
No (go to# 7)
Yes

0

c. Chemotherapy completed before radiotherapy commenced
0

No
Yes

PRIVATE AND CONFIDENTIAL
If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital

ID

J 98
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Personal and Family Cancer History

7.

a. Previous cancer
()

No

Yes. how many times

Please s p e c i f y - - - - - - - - - - - - - - - - - - - -

8.

a. Chemotherapy for Previous Cancer

No

0

Yes
b. Type and how long ago?

9.

a. Radiothera::,y for Previous Cancer

No

0

Yes, but not at same site
Yes, includes some or all of current treatment site

2

b. How long ago?

10.

a. Family history of cancer (1st and 2nd degree relatives only)

No

0

Yes, how many family members
Specify type of cancer and relationship

I 99

----------

PRIVATE AND CONFIDENTIAL
If found please return immediately to the Radiotherapy Department
Sir Charles Gairdncr I fospital
ID

Appendix F

General health
11.

Co-existing chronic disease
()

No
Yes. not known radioscnsitivc disease
Yes. known radiosensitivc disea~e

12.

a. Prescribed medications
0

No
yes. drugs not known to adversely affect healing
yes. drugs known to adversely affect healing

b. Other medications (over the counter/complementary/alternative
therapies)
0

No
general health

I

ii aid healing

iii anticancer

PRIVATE AND CONFIDENTIAL
lf found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital
ID

200
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13.

Smoking
a. Ha,·e you ever smoked regularly?
No (go to 4uestion 15)

(J

Yes

I
19

b. if yes, when did you start smoking'?
c. Average, number of cigarettes did/do you smoke each day?
d. Do you smoke now'!

19

i) if no. when did you quit'?
ii) if yes. how many per day?

14.

Alcohol

a. Have you ever drunk alcohol regularly?
0
l

No (go to question 16)
Yes

19

b. if yes, when did you start drinking regularly?

c. Average, standard drinks did/do have each time?
i) did
ii) do

d. Do you drink now?
i) if no, when did you stop
ii) if yes, once or twice per month or less
Yes, about once per week
Yes, 2-3 times per week
Yes, 4-6 times per week
Yes, everyday

15.

19

l
2
3
4

5

a. Current weight

_ _ _ kg

b. Usual weight

_ _ _ kg

c. Lowest v.,eight during this illness

_ _ _ kg

d. Height

cm

PRIVATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital
10

20 I
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Bra/cup sii:c

a. dress size
10

12

14

16

18

20

22

24

·24

b. cup
A

2

B

17.

C

3

D
DD
>DD

4

5
6

a. Nutritional intake
Excellent:
Eats most of every meal. Never refuses a meal.
Usually eats a total of 4 or more servings of proteins.
Occasionally eats between meals. Does not require supplementation.

2
Adequate:
Eats over half of most meals.
Eats a total of 4 servings of proteins each day.
Occasionally will refuse a meal. but will take a supplement if offered.
OR
Is on adequate tube feeding or TPN regimen
3
Probably inadequate:
Rarely eats a complete meal and generally eats on I /2 of any food offered.
Protein intake only 3 servings per day.
Occasionally will take dietary supplement.
OR
Receives less than optimum amount of liquid diet or tube feeding
~rypoo~

4

Never eats a complete meal, Rarely eats more than a I /3 of any food
offered.
Eats 2 servings or less of protein each day.
Takes fluids poorly. Does not take a liquid diet supplement.
OR
Is nil by mouth and/or maintained on clear liquids
or IV's for more than five days.
18.

f. Alternative/Complementary Diet

PRIVATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital
ID
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Skin Type and Condition
19.

20.

Skin type
Aways hums casil). never tans ( sensitive J
Always bums. tans minimally ( sen.sit ive)
Burns moderately. tans gradually ( light brown. normal)
Bums minimally. always tans well (modcratdy brown, normal)
Rarely burns. tans profusely (dark hrown. insensitive)
Never burns. deeply pigmentt:d (insensitive)

1
4

5
6

Skin type in treatment area
()

Oily
Normal

1
2

Dry

2 t.

2

Skin allergy problems eg contact dermatitis, eczema etc.
0

No (go to question 20)
If yes. please specif}

a. Frequency

Occasional problem(.:::: 4 times per year)
Frequent problem (once per month)
Constant problem (virtually always present)

2
3

b. Severity

Mild (dry and peeling)
Moderate reaction (as above plus red, itchy)
Severe reaction (as above plus blisters/oozing)

2
3

c. Family History (1st and 2nd degree relatives only)
No
Yes, how many family members

0

PRIVATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital

ID

201
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Accumulative UV Exposure
22.

a. How long have you lived in Australia'! (years)
h. Predominant place you have lived up to the age of 15'!
City/

lo\\11 .... . .

__ .

_

( ·ountry

c. Predominant place you have lived after the age of 15'!

Country

l'ityffown
23.

Cumulath·c UV ex(Josurc scale

iVhich o( rhe .fc,/lowin~ sra1emenrs hest descrihes your exposure to the .mn
up to the age cf 15:
a. Did you spend most of your free time ...
in indoor activities
in both indoor and outdoor activities
in outdoor activities

I

2
3

b. When outdoors, bow much did you protect yourself from the sun with a hat,
clothing and/or sunscreen ...
almost always
I
often
2
sometimes
3
almost never
4

Which of the following sta/ements best describes your exposure to the sun
after the age of 15:
c. Was or is your work mainly ...
indoors
both indoors and outdoors
outdoors

2
3

d. Did/do you spend most of your free time ...
in indoor activities
in both indoor and outdoor activities
in outdoor activities

3

2

e. When outdoors, bow much did/do you protect yourself from the sun with a bat,
clothing and/or sunscreen ...

ahnost always
often
sometimes
ahnost never

2
3
4

PRIVATE AND CONFIDENTIAL
If found please return immediately to the Radiotherapy Department
Sir Charles Gairdnr.r Hospital

ID
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Demographics

a. Marital status
never married
permanent relationship married/de facto
separated
widowed
divorced

')

3
4

5

b. occupation
unemployed
retired
home duties

2
3
4

skilled trade
professional
W1Skilled
clerical
student

5
6

7
8

c. education completed
primary school (years l - 7)
lower secondary school (years 8 - 10)
upper secondary school
trade/secretarial training
undergraduate diploma/degree
higher degree

2
3
4

5
6

d. usual accomodation
own home/flat
rent home/flat
nursing home

")

3
~~
4
other, specify _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ 5

OFFICE USE ONLY
f. area code (from addressograph)

PRIVATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital

ID
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Treatment Details
25.

F.lectrons

site
energy - - - - - - - - -

Overall length of whole breast treatment (in days)
Overall length of electron boost treatment (in days)
Comments

PRIVATE AND CONFIDENTIAL

If found please return immediately to the Radiotherapy Department
Sir Charles Gairdner Hospital

ID
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Content Validity Check
This set of questions relate to basic demographics and diagnosis and treatment details

Variable and Scoring

1. Not
relevant

2. Unable
to assess
without
item
revision

3.
Relevant
but needs
minor
alteration

4. Very
relevant
and
succinct.

Comments on clarity,
scoring etc.

1. Age _ _ _(in years at last birthday)
3. Histology
4. Time since diagnosis
5. TNM Staging.
7. Recurrence
9. Chemotherapy regimen
Chemo commenced with XRT
Chemo commenced before XRT

)>
"C

~0.

;:r

G)

How many cycles?

N

0

OJ

Diagnosis and treatment details continued

Variable and Scoring

I. Not
relevant

2. Unable
to assess
without
item
revision

3.
Relevam
but needs
minor
alteration

4. Very
relevant
and
succinct.

Comments on clarity,
scoring etc.

4.

Comments on clarity,
scorint? etc.

10. Chemotherapy for previous cancer

The next set of questions relate to cancer 'proneness'

Variable and Scoring

1.

2.

3.

11 a. Has patient had cancer before ?

b. Family history of cancer

f
:,

C.

x

C)
I'.)

0

<D

This set of questions relate to the patient's general state of health

.

Variable and Scoring

1.

3.

2.

4.

Comments on clarity,
scoring etc.

12. Co-existing disease
13. Prescribed medications

Nwnber of medications
List medications
14. Smoking habits

Cigarette years_ _ _
Current smoker
If yes (how many per day?)

--15. Alcohol intake

l>

-0

i:,

a.
>(.

G)
l'V

......

0

General health continued

Variable and Scoring

J.

2.

3.

4.

Comment~ on clarity.
scorinl! etc.

16. Nutritional intake
Weight
Height
Excellent:
Eats most of every meal. Never refuses a
meal. Usually eats a total of 4 or more
servings of proteins. Occasionally eats
between meals. Does not require
suoolementation
Adequate:

Eats over half of most meals. Eats a total of
4 servings of prc,teins each day. Occasionally
will refuse a meal, but will take a supplement
if offered. OR Is on adequate tube feeding or
TPN regimen
Probably inadequate:
Rarely eats a complete meal and generally
eats only 1/2 of any food offered. Protein
intake only 3 servings per day. Occasionally
will take dietary supplemt.'t.OR Receives
less than optimum amount ot liquid diet or
tube feeding

)>
"C

~a.

)(
C)

...........

N

General health continued

1.

Variable and Scoring

2.

3.

4.

Comments on clarity,
scorinK etc.

2.

3.

4.

Comments on clarity.
scorinl( etc.

Very poor:
Never eats a complete meal, Rarely eats
more than a 1/3 of any food offered. Eats 2.
servings or less of protein each day. Takes
fluids poorly. Does not take a liquid diet
supplement.OR Is nil by mouth and/or
maintained on clear liquids or IV's for more
than five days.

The following Items relate to skin type and condition

}.

Variable and Scoring
17.

Skin type

Always burns easily, never tans
(sensitive)
Always burns. tans minimally
(sensitive)
Burns moderately, tans gradually
(light brown, normal)
Bums minimally, always tans well
(moderately brown, normal)
Rarely burns, tans profusely
(dark brown, insensitive)
Never burns, deeply pigmented
(insensitive)

l

2
3
4

)>
"'O

i::,

C.

;:;;·

G)

5

"->

.....

N

6

Skin type and condition conflnued

1.

Variable and Scoring

2.

3.

4.

Comments on clarity,
scoring etc.

18. Skin allergy problems eg contact
dermatitis, eczema etc.
a. Frequency
0
Nil
Occasional problem
(:S 4 times per year)
Frequent problem
(once per month)
Constant problem
(virtually always present)

1
2
3

b. Severity
0
Nil
Mild/moderate reaction
(red, itchy dry and peeling) 1
Severe reaction
(as above plus blisters/oozing) 2

c. Family History
No
Number of family members

0

-

)>

"O

j

::,

C.

x

G)

.....
"'
(.,)

Skin condition - Ultmvlolet exposure

Variable and Scoring

1.

2.

3.

4.

Comments on clarity,
scoring etc.

19. UV exposure
a. Number of years in Australia
b. Predominant place lived in under 15
years of age
c. Predominant place after 15 years of

aee
20.

Accumulative UV exposure

Which of the fo!lowing statements best
describes your exposure to the sun area up
to the age of 15 years?
I spent most of my free time in
IndoOi: activities
I
And outdoor activities
2
3
Outdoor activities
I went out in the sun without the protection
of a hat, clothing and/or sunscreen
I
almonst never
2
Sometimes
3
Often
4
Almost always

)>

~:,

a.

x·

C)
N
_.
A

Skin condition • Ultraviolet exposure continued

Variable and Scoring

1.

2.

3.

4.

Comments on clarity,
scorine etc.

Which of the following statements best
describes your exposure to the sun during
your adult life:
I mainly had jobs that were
Indoors
Both indoors and outdoors
Outdoors
I spent most of my free time in
Indoor activities
And outdoor activities
outdoor activities

1

2
3

1
2
3

I went out in the sun without the protection
of a hat, clothing and/or sunscreen
1
almonst never
Sometimes
2
Often
3
4
almost always

,,

)>

~
:::,
C.

x

G)

N

.....
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Approval Letters from Ethics Committees
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Committee for the Conduct of Ethical Research

\b Da, 1na Puw,:k

Dear \Is Porock
Re:

Ethics Appmval

Code:

95-10-

Project Title:

Pr~Jidin's rhe severir;: of skin und orul rrwco1al reaciwn1
pmien;s receiving raJiorherapy for cancer.

tr.

inJr,iJ:1,-l,

This project was considered by the Committee for the Conduct of Ethical Research at its
meeting on 28 July 1995.

I am pleased to advise that the project complies with the provisions contained in the
l.Jni versity's policy for the conduct of ethical research. and has been cleartd ior
implementation.
Period of approval is from 3 l July 1995 to 30 June 1998.
Yours sincerely

ROD CRITTHERS

Executive Officer

31 July 1995
Please note: Srudents conduaing approved research are required co submit an erhics report
as an addendum to that which they submit to their Faculry's Higher Degrees Commirtee.

cc:

Dr Patricia Percival, Supervisor
tvtrs Genie Sherratt. Facultv Admin Officer
A/Prof S. Bame. Doctor.ii Studies Commmee

JOONOALUP CAMPUS
Joonclalup Orive. Jooru!alup
Western Australia 6027

Te!epllone (091 400 5555

MOUNT LAWLEY CAMPUS
2 Bradlonl S1reet. Mount Lawley
Western Australia 6050
Telepnone (09) 370 6111

CHURCHLANDS CAMPUS
Pearson Street. Cnurcnianas
Western Australia 6018
Telepnone (09l 273 8333

CLAREMONT CAMPUS
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Appendix I
Participant's Information Letter and Consent Form
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Research Title:

Predicting the degree of skin reaction in patients
receiving radiotherapy

Researcher:

Davina Porock, RN MSc(Curtin) PhD (Candidate),
Schoof of Nursing, Edith Cowan University

Skin reaction is a fairly common side effect of radiotherapy and individual
patients react to the treatment in different ways. Primarily the degree of
skin reaction patients will experience depends on the dose of radiation
they receive. However, previous research and clinical experience has
shown that the skin reaction varies from person to person even when the
same dose is given. This research project aims to develop a method of
accurately predicting the degree of skin reaction to be expected. The
benefits to future patients from this research will be in individualised
education to prepare for this side effect and individualised skin care
management.
You are invited to take part in this research project. It will involve
completing a questionnaire now that details personal information about
you and you.- skin and then a weekly check by me or a research nurse to
document any skin reaction you experience. No risks are envisaged during
this research. Your name will be kept on the data collection forms to assist
following your progress through treatment These details will be kept
confidential along with the normal medical record and your name will not
be used in any report or publication from this research.
You are free to choose whether you take part in this research and to
withdraw from the study at a later date should you so wish. Naturally, your
decision will not affect the treatment you receive from the radiotherapy
department in any way. If you should have any questions now or later,
please do not hesitate to discuss them with my research assistants Marie
Downes and Louise Good or contact me, Davina Porock on 273 8623 or
my supervisors, Dr Sue Nikoletti at the University on 273 8593 or Dr Fiona
Cameron in the Radiotherapy Department on 346 4900.
Thank you for your consideration

Davina Porock

PhD (Candidate)
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Consent Form

I ............................................................. (print name) agree to take part in
the research project being conducted by Davina Porock entitled
"Predicting the degree of skin reaction in patients receiving radiotherapy"
The study has been fully explained and I understand what is involved in
taking part. I know that I am free to withdraw from the research at any
time. I have been given the opportunity to ask questions now and given
details for contacting the researcher at any time.

Patient's signature
..........................................................date ........................ .

Witness' signature
..........................................................date .......................... .
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Self-medication and Complementary Therapies Used Regularly by
Participants
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--~~-----------------------~--Self-medication and ComQlementa!Y Medicines Used Regularll{ bl£ Part1c1Qants
------- -----Medicine

General

Aid Healing

Anticancer

Health
Echinacea

2

Multivitamins

7

5

Vitamin C

6

7

Iron

1

Calcium

2

Sandomycin

1

Garlic

1

Phenergrick

1

Vitamin A

1

Selenium

1

Vitamin B

3

5

Vitamin E

3

3

Cod liver oil / fish oil

2

2

Evening Primrose Oil

2

3

Cote a cola leaves

1

Bioace

1

Magnesium

1

Silicone Calcium Fluoride (SCF)

1

Lactoacid tablets

1

3

1

Zinc Silica Calcium

2

Celery Salt

1

Ginko Biloba

3

Corclio Silva

1

Antioxidants / Betacarotene

7

Chinese herbs {naturopaths own

2

prescription)
Naturopaths tonic

2

Manchuria I Kambucha tea

2

combination of wormwood, black
walnut drops and ground clove

1

tablets
Jungle Juice

1

Flower essence tea

1

Native Cuppa

1

~20TX

1

-
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Cross Validation Results

Random Sample 1 - 40% of total sample
Random sampling by SPSS produced a subset of 54 cases for this analysis
Logistic Regression Results for the Week Five Sternum Reaction
Data from 54 cases were available for analysis· 30 (55 6%) had a scores of
D-RTOGO and 24 (44.4%) scored D··RTOG1. Two variables entered the mode.
history of skin cancer and age. These variables correctly predicted 80.00% of cases
with mild or no reaction. and 41.67% of cases with a severe reaction giving an
overall accuracy of 62.96% for the model. The model is significantly reliable when
compared with the constant only model. ,.2(2) = 11.135, p = 0.0035.

Variables

B

SE

Wald

DF

History of
skin cancer

2.941

1.166

6.364

1

Age

-.059

.032

3.421

1

R

Exp(B)

95%CI

012

.242

18.934

1.927 186.050

0644

-.138

Sig

.943

8661.004

{Constant}

2.582

1.696

2.318

1

.128

Logistic Regression Results for the Week Five Axilla Reaction
Due to missing values, data from 53 cases were available for analysis: 28

(52.8%) had a score of 0-RTOGO and 25 (47.2%) scored D-RTOG1. One variable
entered the model: lymphocele aspiration. This variable correctly predicted 71.43%
of cases with mild or no skin reactions and 52.00% of severe reactions. giving an
overall accuracy of 62.26% of cases overall. The model was significantly reliable
when compared with the constant only model, /(1) = 3.053, p

= 0.0806.
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Variables

B

SE

Wald

DF

Sig

Lymphocele
aspirated

.996

579

2.961

1

085

(Constant)

- 511

365

1.957

R
115

226

Exp(B)

95% Cl

2 708

871 8 425

162

Logistic Regression Results for the Week Five UOQ Reaction
Due to missing values, data from 53 cases were available for analysis. 34
(64.1%) had a score of D-RTOGO and 19 (35.9%) scored D-RTOG1. Three
variables entered the model: breast size, lymphocele aspirated and smoking. These
variables correctly predicted 79.41 % of mild or no skin reactions and 52.63% of
severe skin reactions giving an accuracy of 69.81 % overall. The model was
significantly reliable when compared with the constant only model, :/(4) = 13 179. p

= 0.0104.

Variables

B

SE

Breast size

1.378

.743

Lymphocele
aspirated

1.306

.679

*Smoking

OF

Sig

R

Exp(B)

95%CI

3.439

1

.064

.144

3.967

.92517.017

3.698

1

.055

.157

3.693

.97513.982

4.302

2

.116

.066

Wald

Ex-smoker

1.092

.714

2.344

1

.126

.071

2.982

.73612.073

Current
smoker

1.827

.994

3.378

1

.066

.141

6.213

.88643.584

-2.193 .650
11.387 1
.001
(Constant)
*Reference group for smoking is the ·never smoked" group

•
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Logistic Regression Results for the Week Five LOO Reaction
Due to missing values, data from 53 cases were available for analysis 38
(71.7%) had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. One variable
entered the model: smoking. This variable correctly predicted 92.11 % of mild or no
reactions and 26.67% of severe reactions, giving an accuracy of 73.58% ov~rall
The model was significantly reliable when compared with the constant only model.
/(2) = 6.569, p = 0.0375.

Variables

8

SE

*Smoking

DF

Sig

R

5.916

2

.052

.174

Wald

Exp(B)

95%CI

Ex-smoker

1.339

.725

3.414

1

.06S

.150

3.186

.92215.796

Current
smoker

2.079

.935

4.940

1

.026

.216

7.996

1.278 50.006

-1.791
.540
11.005 1
{Constant}
.001
*Reference group for smoking is the ·never smoked" group

Logistic Regression Results for the Week Five LIQ Reaction
Due to missing values, data from 53 cases were available for analysis: 38
(71.7%) had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. Two variables
entered the model: breast size and smoking. These variables correctly predicted
92.11 % of mild or no reactions, and 66.67% of severe reactions. giving an accuracy
of 84.91% overall. The model was significantly reliable when compared with the
constant only model, x2(3)

= 13.515, p = 0.0036.
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Sig

R

4.489

1

.034

.199

7.197

2

.027

.225

.778

1.383

1

.240

1.046

7.165

1

.007

B

SE

Breast size

1.609

.760

"Smoking
Ex-smoker
Current
smoker

.915
2.801

-~-~,

DF

Variables

Wald

-·--~--Exp(B)

228

95% Cl

4.998

1.128 22143

.000

2.498

.54311.483

.286

16.462

2.117 127.989

.000
12.661 1
-2.224 .625
(Constant}
*Reference group for smoking is the "never smoked" group

Logistic Regression Results for the Week Five Nipple Reaction
Due to missing values. data from 53 cases were available for analysis: 38

(71.7%} had a score of D-RTOGO and 15 (28.3%) scored D-RTOG1. One variable
entered the model: smoking. This model correctly predicted 97.37% of mild or no
reactions and 26.67% of severe reactions, giving an accuracy of 77.36% overall.
The model was significantly reliable when compared with the constant only model,

/(2) = 12.465, p = 0.0059.

Variables

B

SE

*Smoking

Wald

OF

Sig

R

8.089

2

.018

.255

Exp(B)

95%CI

Ex-smoker

1.217

.752

2.621

1

.106

.099

3.379

.77414.751

Current

3.407

1.238

7.581

1

.006

.297

30.185

2.670341.320

-1.676

.545

9.466

1

.002

smoker

{Constant}

*Reference group for smoking is the "never smoked" group
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Random Sample 2 - 40% of tctal sample
Random sampling by SPSS produced a subset of 50 cases for this analysis
Logistic Regression Results for the Week Five Sternum Reaction
Data from 50 cases were available for analysis: 42 (84 0%) had a scores of
D-RTOGO and 8 (16.0%) scored D-RTOG1. Only one variable entered the mode
history of skin cancer. This variable correctly predicted 96.55% of cases with mild or
no reaction. and 33.33% of cases with a severe reaction giving an overall accuracy
of 70.0% for the model. The model is significantly reliable when compared with the
constant only model. /(1)

=8.534. p =0.0035.

Variables

B

SE

Wald

DF

Sig

R

Exp(B)

95% Cl

History of
skin cancer

2.638

1.118

5.571

1

.018

.229

13.981

1.564124.960

(Constant)

-.693

.327

4.484

1

.034

Logistic Regression Results for the Week Five Axilla Reaction
Data from 50 cases were available for analysis: 31 (62.0%) had a score of DRTOGO and 19 (38.0%) scored D-RTOG1. One variable entered the model:
lymphocele aspirated. This variable correctly predicted 72.41 % of cases with mild or
no skin reactions and 52.38% of severe reactions, giving an overall accuracy of

64.00% of cases overall. The model was significantly reliable when compared with
the constant only model, :l(1) = 3.180, p = 0.0746.
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Variables

B

SE

Wald

OF

Sig

R

Exp{BJ

95%CI

Lymphocele
aspirated

1.060

.603

3.093

1

.079

.079

2.888

.9869 412

{Constant~

-.742

.384

3.729

1

.0535

Logistic Regression Results for the Week Five UOQ Reaction
Data from 50 cases were available for analysis: 46 (92 0%) had a score of DRTOGO and 4 (8.0%) scored D-RTOG1. Two variables entered the model·
lymphocele aspirated and stage. These two variables correctly predicted 96 97% of
mild or no skin reactions and 17.65% of severe skin reactions giving an accuracy of
70.00% overall. The model was significantly reliable when compared with the
constant only model, /(2)

=8.182. p =0.0167.

Variables

B

SE

Wald

DF

Sig

R

Exp(B)

95%CI

Lymphocele
aspirated

1.617

.692

5.460

1

.020

.023

5.036

1.29819.541

Stage

1.335

.735

3.298

1

.069

.142

3.801

.90016.057

~Constant}

-1.767

.568

9.6728

1

.CO2

Logistic Regression Results for the Week Five UIQ Reaction
Data from 50 cases were available for analysis: 46 (92.0%) had a score of 0RTOGO and 4 (8.0%) scored D-RTOG1. Two variables entered the model:
lymphocele aspirated and stage. These variables correctly predicted 97 .22% of mild
or no reactions, and 21.43% of severe reactions giving an accuracy of 76.00% of
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cases overall. The model was significantly reliable when compared with the constant
only model, x2(2)

= 5 961. p =0.0508.

OF

Sig

R

Exp(B)

95%Cl

3.685

1

.055

.169

3.857

.97215.305

.736

2.908

1

.088

.1238

3.508

.82914.845

.592

10.703

1

.0011

Variables

B

SE

Lymphocele
aspirated

1.350

.703

Stage group

1.255

{Constant)

-1.938

Wald

Logistic Regressior. Results for the Week Five LOQ Reaction
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0RTOGO and 8 ("16.0%) scored O-RTOG1. One variable entered the model: smoking.
This variable correctly predicted 89.19% of mild or no reactions and 30.77% oi
severe reactions, giving an accuracy of 74.00% overall. The model was significantly
reliable when compared with the constant only model, x2(2) = 6.449, p = 0.0398.

Variables

B

SE

*Smoking

Wald

OF

Sig

R

5.611

2

.061

.168

Exp(B)

95%CI

Ex-smoker

1.526

.802

3.619

1

.057

.168

4.600

.95522.160

Current
smoker

2.037

.936

4.732

1

.030

.216

7.667

1.22346.046

-2.037 .414
11.011 1
.001
(Constant}
*Reference group for smoking is the ·never smokeda group

I
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Logistic Regression Results for the Week Five LIQ Reaction
Due to missing values. data from 48 cases were available for analysis: 36
(75.0%) had a score of 0-RTOGO and 12 (25.0%) scored D-RTOG1. Two variables
entered the model breast size and smoking. These variables correctly predicted
91.43% of mild or no reactions. and 69.23% of severe reactions. giving an accuracy
of 85.42% overall. The model was significantly reliable when compared with the
constant only model. x2(3) = 14.561, p = 0.002.

Variables

B

SE

Breast size

1.918

.870

*Smoking
Ex-smoker
Current
smoker

.882
2.929

.84
1.098

Exp(B)

95%CI

6.804

1.236 37.449

.000

2.416

.427 13.668

.312

18.700

2.173160.917

OF

Sig

R

4.856

1

.028

.226

7.122

2

.028

.236

.995

1

.319

7.111

1

.008

Wald

-2.389 .695
11.836 1
.001
(Constant}
*Reference group for smoking is the "never smoked" group

L99istic Regression Results for the Week Five Nipple Reaction
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0RTOGO and 8 (16.0%} scored D-RTOG1. Only one variable entered the model:
smoking. This model correctly predicted 91.89% of mild or no reactions and 38.46%
of severe reactions, giving an accuracy of 78.00% overall. The model was
significantly reliable when compared with the constant only model, x2(2} = 8.249, p =

0.0162.
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Variables

8

SE

*Smoking

~-·~----

OF

S1g

R

7.205

2

.027

.237

Wald

233

Exp(B)

95% Cl

Ex-smoker

1.248

.817

2.334

1

127

.076

3485

70317.288

Current
smoker

2.548

.954

7.132

1

.008

.300

12.778

1.970 82.892

.001
11.011 1
-2.037 .614
{Constanti
*Reference group for smoking is the "never smoked" group

logistic Regression Results for the Week Five lnframammary Fold Reaction
Data from 50 cases were available for analysis: 42 (84.0%) had a score of 0RTOGO and 8 (16.0%) scored D-RTOG1. One variable entered the model: current
smoking. This variable was constructed combining those not currently smoking
(never smoked and ex-smokers) in one group and current smokers in the other
group. This model correctly predicted 90.63% of mild or no reactions and 27.78% of
severe reactions giving an accuracy of 68.00% overall. The model was significantly
reliable when compared with the constant only model, /(1)

=2.784. p =0.0952.

Variables

B

SE

Wald

OF

Sig

R

Exp(B)

95% Cl

Current
smoker

1.313

.803

2.675

1

.102

.102

3.718

.771 17.938

(Constant)
-.802
.334
5.779
1
.016
"Reference group for smoking is the "never smoked and ex-smokers" group

Appendix L

Appendix L

Rudimentary Assessment Tool for Radiation Skin Reactions

234

Appendix L

235

Probability Estimates for Sternum Reactions during Week Five

History of Skm Cancer

No History of Skin Cancer
Age (in 5 year
increments)

Probability of skin
reaction JRTOG 2

Age (in 5 year
increments)

Probability of skin
reaction )RTOG 2

20

60%

20

95%

25

56%

25

94%

30

53%

30

93%

35

49%

35

92%

40

45%

40

91%

45

42%

45

89%

50

38%

50

88%

55

34%

55

86%

60

31%

60

84%

65

28%

65

82%

70

25%

70

80%

75

22%

75

77%

80

20%

80

74%

85

17%

85

71%
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Probability Estimates for Axilla Reactions during Week 5

One or Mora Aspirations for
Lymphocele

No Aspirations for Lymphocele
Weight (in 5kg
increments}

Probability of skin
reaction ! RTOG 2

Weight (in 5kg
increments}

Probability of skrn
reaction ! RTOG 2

45

15%

45

28%

50

19%

50

35%

55

25%

55

42%

60

32%

60

50%

65

39%

65

58%

70

46%

70

66%

75

54%

75

72%

80

62%

80

78%

85

69%

85

83%

90

75%

90

87%

95

80%

95

90%

100

85%

100

92%

105

88%

105

94%

Probability Estimates for Upper Outer Quadrant Reactions at 45 Gy if Never
Smoked

Aspirations for
L:tmehocele

Stage~ II

Probability of skin
reaction > RTOG 2

X
X

X

X

19%

X

.,/

35%

X

.,/

X

40%

X

.,/

.,/

61%

.,/

X

X

39%

.,/

X

.,/

60%

.,/

.,/

X

65%

.,/

.,/

.,/

81%

Brassiere cup size

>D
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Probability Estimates for Upper Outer Quadrant Reactions at 45 Gy if ExSmoker

Brassiere cup size
>D

Aspirations for
Llm~hocele

Stage~ II

Probability of skin
reaction ,:: RTOG 2

X

X

X

27%

X

X

,/

47%

X

,/

X

52%

X

,/

,/

71%

,I

X

X

52%

,/

X

,/

71%

,/

,/

X

75%

,/

,/

,/

87%

Probability Estimates for Upper Outer Qu~drant Reactions at 45 Gy if
Currert Smoker

Brassiere cup size
>D

Aspirations for
Llm~hocele

Stage~ II

Probability of skin
reaction .::, RTOG 2

X

X

X

58%

X

X

,/

77%

X
X

,/

X

80%

,/

,/

90%

,/

X

X

80%

,/

X

,/

90%

,/

,/

X

92%

,/

,/

,/

96%
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Probability Estimates for Upper Inner Quadrant Reactions at 45 Gy

~

Aspirations for
L:tmQhocele

Probability of skin reaction

X

X

27%

X

,/

45%

,/

X

46%

,/

,/

65%

Brassiere cup size

D

> RTOG 2

Probability Estimates for Lower Outer Quadrant Reactions

Ex-Smoker

Current
Smoker

Probability of
skin reaction

Brassiere cup
size~ D

Never Smoked

X

,/

X

X

16%

X

X

,/

X

20%

45%

> RTOG 2

X

X

X

,/

,/

,/

X

X

36%

,/

X

,/

X

43%

,/

X

X

,/

70%

Probability Estimates for Lower Inner Quadrant Reactions at 45 Gy if Never
Smoked

Brassiere cup size ~ D

Aspirations for
Lymphocele

Probability of skin reaction

X

X

11%

X

,/

22%

,/

X

28%

,/

,/

48%

> RTOG 2
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Gy if Ex-

Smoker
-~--

Brassiere cup size ?: O

Aspirations for
L:tmehocele

Probability of skm reaction
> RTOG 2

X

X

13%

X

,I

26%

,I

X

32%

,I

,I

53%

Probability Estimates for Lower Inner Quadrant Reactions at 45

Gy if Current

Smoker

Brassiere cup size ?: D

Aspirations for
Lymphocele

Probability of skin reaction
~ RTOG 2

X

X

49%

X

,I

69%

X

76%
88%

Probability Estimates for Nipple Reactions at 45

Probability of skin reaction
~ RTOG 2 if Never

Probability of skin reaction
?: RTOG 2 if Ex-Smoker

Smoked

Gy

Probability of skin reaction
?: RTOG 2 if Current

Smoker
26%

34%

62%
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Probability Estimates for lnframammary Fold Reactions during Week Five

Brassiere cup
size~ D

Never Smoked

Ex-Smoker

Current
Smoker

-------Probability of
skin reaction
> RTOG 2

X

,/

X

X

15%

X

X

,/

X

36%
64%

X

X

X

,/

,/

,/

X

X

49%

,/

X

,/

X

75%

,/

X

X

,/

91%

